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D-aspartyl/L-isoaspartyl carboxyl methyltransferase (PIMT) into the extracellular
milieu, where it became trapped. Trapped PIMT was able to utilize radiolabeled
S-adenosyl-L-methionine (Ado Met) introduced into the circulation to methylate
blood vessel proteins containing altered aspartyl residues specifically at the site
of injury.In vitrostudies more fully characterized this endogenous PIMT activity
in thoracic aorta and inferior vena cava. At least 50% of the PIMT activity
released during injury, was resistant to non-ionic detergent extraction,
suggesting that the enzyme activity can become trapped within or behind the
extracellular matrix (ECM). Analysis of inferior vena cava, found that 90% of the
altered aspartyl residues in blood vessels are inaccessible to methylation by
intracellular PIMT under physiological conditions. Subfractionation of inferior
vena cava on the basis of solubility found that at least 40% of the altered
aspartyl containing proteins in blood vessels are insoluble in non-ionic detergent
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Introduction
1.1 Introduction
1.1.1 Why blood vessels are interesting
The leading cause of mortality in adults of Western countries are
pathologies associated with the vascular system, including coronary artery
disease (Goldberg 1982; Luscher and Noll 1994; Gary and Clarke 1995),
hypertension (Todorovich-Hunter et al. 1988; Schultze et al. 1994), diabetes
(Reiser et al. 1992; Tanno et al. 1993) and atherosclerosis (Pasquinelli et al.
1989; 0' Brien et al. 1994).In recognition of this, over the last several decades
a much greater understanding of the physiology, cell biology and biochemistry of
the vascular system has been pursued. Blood vessels are highly organized
tissues, consisting of several cell types whose homeostasis is dependent not
only on external cues in the bloodstream, but also on internal cues
communicated between the various cells in this tissue (Luscher et al. 1993).It is
disruptions in the normal homeostatic, proliferative and anti-proliferativecues,
due to undefined injury events, that are thought give rise to many of these
pathologies.This thesis describes how blood vessel injury can lead to
enzymatic methylation of altered aspartyl residues at sites of injury. How altered
aspartyl residues in blood vessel proteins can form and subsequently be
detected by enzymatic methylation is described below.2
1.1.2 Blood vessel function and structure
In the vascular system there are two main types of blood vessels; arteries
and veins. Arteries deliver oxygen and nutrients to the tissues, and veins carry
away waste products and carbon dioxide from these same tissues. Though the
two main types of blood vessels differ in function, structurally, they both can be
divided into three distinct layers; intima, media and adventitia (Anthony and
Thibodeau 1979) (Figure 3.1 of Chapter 3).
1.1.2.1 Intima
The intima consists of the lumen of the blood vessel through which blood
flows. The major constituents of this layer are endothelial cells and the basal
lamina upon which these cells grow. Endothelial cells form a continuous
monolayer throughout the vascular system and act as a permeability layer
against blood solutes, possess important synthetic-metabolic-secretory functions
and maintain a non-thrombogenic surface for proper blood flow (Gimbrone 1980;
Goldberg 1982). The basal lamina consists of a thin mat of filamentous proteins,
proteoglycans and glycoproteins upon which the endothelial cells grow (Alberts
and al 1994).
1.1.2.2 Media
This is the most complex structural layer of a blood vessel.It contains two
main cell types; large amounts of smooth muscle cells and small amounts of
fibroblasts. These cells are embedded in an extracellular matrix of proteins and3
glycoaminoglycans. Smooth muscle cells are under the control of the
sympathetic nervous system and are responsible for controlling the degree of
constriction or dilation of the blood vessel.They, along with fibroblasts, also
secrete most of the extracellular matrix components, primarily collagen, elastin
and various glycoaminoglycans (Carey 1991). Veins contain greater amounts of
collagen fibers while arteries contain more elastic fibers. Recent studies have
found that in the major arteries and veins virtually no turnover of elastin occurs
(Campbell et al. 1991; Johnson et al. 1993) and that vascular collagen hasa half
life of at least several years (Robert and Labat-Robert 1995).
1.1.2.3 Adventitia
This outermost layer is composed of a loose meshwork of connective
tissue and fibroblasts. Capillaries and nerve cells which feed and innervate the
media are found in this layer. The adventitia is less well defined than the other
two layers primarily because it often resembles the tissue of the organ through
which the blood vessel is passing. Its function is basically supportive and
protective (Rothe 1980).
1.1.3 Altered Aspartvl Residues
Since major blood vessels contain significant populations of metabolically
stable cells and proteins, it is likely that alterations in the aspartyl and
asparaginyl residues of proteins in this tissue will be present. Alterations at
these amino acid residues are known to arise spontaneously and accumulate in4
a time dependent manner (Bada 1984). These altered aspartyl residues are
formed as a result of a reaction initiated by attack of the amide nitrogen of the
C-terminally neighboring amino acid upon the side chain carbonyl carbon, of
either aspartyl or asparaginyl residues. In the case of asparagine, this attack
also causes deamidation. The result of this attack is the formation of an
unstable succinimide intermediate, which may hydrolyze to yield either
L-aspartate or L-isoaspartate (Geiger and Clarke 1987; Stephenson and Clarke
1989).(Figure 1.1). Alternatively, the succinimide may also epimerize to the
D-configuration, yielding D-aspartate and D-isoaspartate upon hydrolysis.
However, the major product of succinimide hydrolysis is the L-isoaspartyl form.
Aspartyl and asparaginyl residues, account for nearly 10% of amino acids in a
typical protein, so the multiple products formed as a result of this reactionare
thought to account for a large part of the micro-heterogeneity observed within
proteins (Aswad 1995). The accumulation of altered aspartyl residues in proteins
is a relatively slow process, typically affecting between 0.1% to 5% of the
proteins in a given protein population (Johnson and Aswad 1990; Chazin and
Kossiakoff 1995). Factors such as primary sequence, pH, temperature and
importantly, the metabolic stability of a protein, are known to affect the rate and
extent of altered aspartyl accumulation in proteins (Johnson and Aswad 1990;
Ota and Clarke 1990). Reports on the effects that altered aspartyl residues
have upon the activity of proteins range from complete loss tono effect (Johnson
and Aswad 1990; Teshima et al. 1995).5
Figure 1.1 Formation of altered aspartyl residues. L-aspartyl and
L-asparaginyl residues cyclize to an L-succinimide, losing water and ammonia,
respectively. Epimerization at the a-carbon results in a mixture of L- succinimide
and D-succinimide. Hydrolysis of the succinimides at either the a- or 0-carbonyl
groups results ultimately in a mixture of L-aspartyl, D-aspartyl, L-isoaspartyl and
D-isoaspartyl residues.H2
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In light of the metabolic stability of blood vessels and the potentially
deleterious effects of altered aspartyl accumulation in proteins, a means to
assay for altered aspartyl content in the vascular system was sought.
1.1.4 Protein D- aspartyl /L- isoaspartyl carboxyl methyltransferase (PIMT)
In 1982, an enzyme now called protein D-aspartyl/L-isoaspartyl carboxyl
methyltransferase (E.C. 2.1.1.77) (PIMT), was shown by McFadden and Clarke
to be capable of methylating altered aspartyl residues (D-aspartyl) in membrane
proteins of erythrocytes and it was proposed that this reaction could lead to the
"repair" of these altered residues back to their normal L-configuration
(McFadden and Clarke 1982). Clarke and coworkers and Aswad and coworkers,
subsequently showed that PIMT can methylate L-isoaspartyl residues in
peptides which is followed by a non-enzymatic de-methylation step that leads
directly to the conversion of the altered aspartyl residue to the normal
L-configuration (O'Conner and Clarke 1983; Geiger and Clarke 1987; Johnson
et al. 1987; Johnson et al. 1987; McFadden and Clarke 1987). PIMT catalyzes
this reaction by transferring a methyl group from S-adenosyl-L-methionine to the
free carboxyl group of the altered aspartyl residue. This carboxyl methyl ester is
unstable at physiological pH and temperature and soon hydrolyzes, yielding
methanol. This leads to the formation of a succinimide intermediate, which
being unstable, can hydrolyze to the normal L-aspartyl configuration
approximately 25% of the time (O'Conner and Clarke 1983; Johnson and Aswad
1985; Murray and Clarke 1986; Ota and Clarke 1990) (Figure 1.2). Thus, several8
rounds of enzymatic methylation, followed by non-enzymatic de-methylationare
required to restore most of the L-isoaspartyl residues in a population to the
normal L-configuration. However, in the case of altered aspartyl residues that
arise from asparagine, repair is not complete, since only L-aspartyl is generated
following methylation.
Evidence of a widespread, physiological repair function for PIMT, is
supported by the finding that almost every protein examined, canserve as a
substrate for PIMT and the fact that PIMT, a cytosolic enzyme is widely
distributed in nature and has been found in virtually all tissues assayed (Aswad
1995). More importantly, incubation of PIMT with Ado Met and proteins knownto
contain altered aspartyl groups has been shown to lead to the regeneration of
normal aspartyl residues and restoration of activity insome enzymes (Johnson
et al. 1987; Johnson, Murray et al. 1987; Lowenson and Clarke 1992; Brennan
and Clarke 1995).
The broad substrate specificity of PIMT, implies that to varying degrees,
most proteins contain altered aspartyl residues.It also suggests that this
enzyme along with Ado Met, could serve as a molecular probe for identifying
altered aspartyl residues in the vascular system and may have potentialas a
therapeutic in restoring these alterations to the normal L-configuration.9
Figure 1.2 Methylation of altered aspartyl by P1MT leads to formation of
normal aspartyl residues in protein. PIMT incorporatesa methyl group from
S-adenosyl-L-methionine into an ester linkage either with the a-carboxyl of
L-isoaspartyl residues or the j3- carboxyl of D-aspartyl residues. Enzymatically
formed methyl esters are subject to rapid non-enzymatic displacement by
nucleophilic attack by the amide nitrogen of the adjacent, C-terminal amino acid.
This results in succinimide formation which can spontaneously epimerize and
hydrolysis to form four products; L-asp, D-asp, L-isoasp and D-isoasp. Both
D-asp and L-isoasp can be re-methylated by PIMT and cycled through the
pathway illustrated.0
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1.1.5 Blood vessels, altered aspartvl residues and PIMT
In the initial stages of this thesis, in vitro perfusion of rat veins with
radiolabeled Ado Met, revealed that even in the absence of exogenously added
PIMT, methylation of blood vessel proteins occurs.In Chapter 2, experimental
results are presented identifying PIMT as the enzyme responsible for the
observed methylation. It is further shown that intracellular stores of PIMTare
released as a result of blood vessel injury. This released PIMT becomes
trapped in the extracellular matrix and is able to methylate blood vessel proteins
from luminally administered Ado Met, both in vitro and in vivo. Chapter 3 follows
up this work by focusing on the substrates that are methylated by PIMT as a
result of blood vessel injury.It is shown that the extracellular matrix contains the
majority of altered aspartyl residues in this tissue. Finally, Chapter 4 identifies
collagen as the major methyl accepting PIMT substrate in the extracellularmatrix
of blood vessels.
In summary, this thesis describes the discovery that blood vessel injury
causes a general release of intracellular enzymes into the extracellular matrix,
where they become entrapped and capable of reacting with substratesdelivered
by the blood stream. As a specific example, this thesis shows how trappedPIMT
can utilize luminally supplied S-adenosyl-L-methionine to methylate proteins in
the extracellular matrix, the major repository of altered aspartyl residuesin this
tissue.12
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Detection and Characterization of an Isoaspartyl
Methyltransferase which becomes Trapped in the Extracellular
Space during Blood Vessel Injury.
Darin J. Weber and Philip N. McFadden
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2.1. Abstract
Injury to rat blood vessels in vivo was found to release intracellular pools
of protein D-aspartyl/L-isoaspartyl carboxyl methyltransferase (PIMT) into the
extracellular milieu, where it became trapped. This trapped cohort of PIMT was
able to utilize radiolabeled S-adenosyl-L-methionine (Ado Met) introduced into
the circulation to methylate blood vessel proteins containing altered aspartyl
residues. Methylated substrates were detected only at the specific site of injury.
Detailed, in vitro studies more fully characterized this endogenous PIMT activity
in thoracic aorta and inferior vena cava. Methylation kinetics, immunoblotting
and the lability of methylated substrates at mild alkaline pH, were used to
demonstrate that both types of blood vessel contain an endogenous protein
D-aspartyl/L- isoaspartyl carboxyl methyltransferase (PIMT).At least 50% of
the PIMT activity was resistant to non-ionic detergent extraction, suggesting that
the enzyme activity can become trapped within or behind the extracellular matrix
(ECM). Quantities of lactate dehydrogenase (LDH), another soluble enzyme of
presumed intracellular origin, was found to be similarly trapped in the
extracellular space of blood vessels.
2.2. Introduction
Formation of altered aspartyl residues is one of the most common types
of spontaneous changes occurring in the polypeptide backbone of proteins
(Takemoto 1995). These altered aspartyl groups arise from spontaneous
racemization of L-aspartyl residues as well as from spontaneous deamidation18
and isomerization of L-asparaginyl residues (Clarke 1985). Protein D-aspartyl
/L-isoaspartyl carboxyl methyltransferase (PIMT), an enzyme widely distributed
in nature, has been shown to be capable of methylating these altered aspartyl
residues (McFadden and Clarke 1982).This unique post translational
modification can restore abnormal D-aspartyl or L-isoaspartyl residues back to
the normal L-aspartyl form (Clarke 1985). PIMT uses a methyl group donated by
S-adenosyl- L-methionine (Ado Met) to specifically identify altered aspartyl in
proteins by methylating the altered polypeptide residue through an ester linkage
on the free carboxyl group. 'Early in our efforts to detect altered aspartyl groups
in blood vessels, we were surprised to find that perfusion of veins with
radiolabeled S-adenosyl- L-methionine, in the absence of added PIMT, resulted
in detectable levels of methylated proteins in the vascular wall, suggesting that
blood vessels contain an endogenous PIMT which can utilize
S-adenosylmethionine delivered from the luminal side of the blood vessel. In
this report we describe how injury to blood vessels leads to the trapping of this
methyltransferase within the meshwork of extracellular proteins of the vessel
wall.
2.3. Experimental Procedures
2.3.1 Experimental Animals
Healthy, female Sprague-Dawley rats of approximately 300 grams and
three months of age were obtained through Oregon State University Lab Animal19
Resources. The animals were maintained in accordance to university guidelines
for animal care and were fed a standard rat chow diet (Purina) and water ad
libitum.
2.3.2 Excision of blood vessels
Rats were killed by asphyxiation with CO2.Three centimeter sections of
inferior vena cava were removed from each rat following a thoraco-abdominal
incision in the right side of the chest. Ten minutes were required to completely
excise the vein upon initiation of the procedure. Each blood vessel was
immediately perfused with RPM! 1640 cell culture medium (Gibco-BRL) pH 7.4
under low pressure to wash the lumen free of all blood cells and plasma
proteins. Veins were maintained at ice cold temperature in the above cell
culture medium until the vessels from the other rats used in each experiment
were obtained. Eight one centimeter vessel segments were obtained from four
rats in one hour. The loose adventitial connective tissue, which contained
capillaries, was carefully separated from the rest of the blood vessel and
discarded. Thoracic aortas were obtained in a similar manner. In some
experiments vessels were extracted with detergents, as described in the Figure
legends, prior to carrying out radiometric methylation assays (described below).
2.3.3 Blood Vessel Perfusion
One centimeter segments of blood vessel were affixed to plastic tissue
culture dishes (Falcon) using a 1% solution of low-melt agarose (Ultra-Pure,20
United States Biochemical) prepared in RPMI 1640 at 37° C. The agarose
served as a gas permeable support to immobilize the vessel and keep it
hydrated it in nutrient medium. The ends of the vessel were clamped to plastic
200 A pipet tips (Fisher Scientific) as inlets and outlets, to ensure that only the
vessel lumen was bathed during perfusion. Perfusion was done with the
radiometric assay mixture described below.
2.3.4 Radiometric Activity Assay
Unless otherwise noted, the assay mixture consisted of 7.6 p.M
S-adenosyl-L-[methy/-3H] methionine (New England Nuclear) at a specific
radioactivity of 2.5 Ci/mmol prepared in RPMI 1640 pH 7.4. Each assay was
carried out at 37 °C for 20 minutes, or as noted in the figure legends.In
experiments employing exogenously added isoaspartyl methyltransferase, a total
of 0.6 units of protein D- aspartyl /L- isoaspartyl carboxyl methyltransferase (EC
2.1.1.77) purified from rabbit erythrocytes (Gilbert et al. 1988) was added to the
assay mixture. For experiments testing the ability of blood vessel extracts
(described below) to methylate isoaspartyl containing substrates, one milligram
of ovalbumin (Sigma, A-5503) was added to the assay mixture. At the
conclusion of the reaction period, the blood vessel and its luminal contents were
immediately mixed with an equal volume of 20% trichloroacetic acid (TCA),
giving a final concentration of 10% TCA. Vein segments from the perfusion
experiments described above were subsequently transferred to 0.5 ml
polypropylene tubes containing 10% TCA.All samples were washed twice21
with 2001.11, of 10% TCA to remove any unincorporated S-adenosyl-
Lgmethy/-3Himethionine (3H-AdoMet).
2.3.5 Quantification of Volatile Radioactivity
Following the radiometric assay just described, TCA washed substrates
were treated with 0.2 M sodium hydroxide for twenty minutes at room
temperature, in tightly capped polypropylene tubes. Following base treatment,
the alkaline samples were re-acidified to pH 2.0 by adding 20 pi of 3M citric acid.
Aliquots (801.11) of each sample, in duplicate, were transferred to one dram glass
vials (Kimble) which were then placed inside a 20 ml polypropylene scintillation
vial (Fisher) containing 4.0 ml of scintillation fluid (Scintiverse E, Fisher) and
tightly capped. The [3H]- methanol formed via ester hydrolysis was allowed to
volatilize and partition into scintillation fluid from the inner vial of the tightly
capped scintillation vial for 24 hours. Radioactivity trapped in the scintillation
fluid was measured to an accuracy of +/- 5% using a Beckman LS 6000
scintillation counter. Volatilization efficiencies (typically 50%) were obtained by
an internal standard of [14C]- methanol.
2.3.6 Endogenous Activity Extracts
One centimeter vein and artery segments were finely homogenized in
liquid N2 using mortar and pestle. The homogenate was resuspended by
vortexing in 50 lit of phosphate buffered saline (PBS), containing 1% (v/v)
2-mercaptoethanol (Sigma, St. Louis, Mo.), pH 7.4. The soluble material was22
then collected following centrifugation at 10,000 x g for five minutes at 4° C. This
extract contained at least 95% of the endogenous enzyme activity detected in
blood vessels and was used without further purification.
2.3.7 Cellular Localization of Endogenous Enzyme Activity
One centimeter segments of veins and arteries were enzymatically
dissociated to obtain separate populations of endothelial and smooth muscle
cells (Chameley-Campbell et al. 1979; Campbell et al. 1989). Briefly,
endothelial cells were obtained from blood vessel segments by perfusion with
0.1% collagenase type I (Worthington) for fifteen minutes at 37° C in RPMI, pH
7.4, followed by perfusion with 0.1% Trypsin (Worthington) for an additional
fifteen minutes under the same conditions. Smooth muscle cells were then
obtained by cutting up endothelial stripped blood vessels into several pieces
followed by incubation in RPMI pH 7.4 containing 0.05% elastase and 0.1%
collagenase (Worthington) for two hours at 37° C. The cells obtained from each
treatment were collected by centrifugation at 1,000 x g for one minute at room
temperature. The pellets were washed twice with 1.0 ml of PBS and centrifuged
as before to remove digestive enzymes. Finally, the cell pellets were
resuspended in 100 [LL of PBS and frozen in liquid N2 to lyse the cells. After
thawing on ice, the lysates were clarified by centrifugation at 10,000x g for ten
minutes at 4° C. The supernatants derived from both the endothelial cells and
the smooth muscle cells were assayed for enzymatic activity as described under
section 2.3.4.23
2.3.8 pH Lability of Methylated Vein Substrates
Following the radiometric activity assay described previously, the loss of
volatile radioactivity from methylated blood vessel substrates was monitored as
a function of pH. The following buffers were prepared: 0.1M Na+ citrate; pH 4.0,
0.1M Na+ citrate; pH 5.0, 0.1M Na+ citrate; pH 6.0, 0.1M NaH2PO4.7.0, 0.1M
Tris-HCI; pH 8.0, 0.1M NaH2PO4; pH 9.0, NaH3BO3 ;pH 10, and 0.1M NaOH.
Each vein segment was immersed in 200 ul of the appropriate buffer for twenty
minutes at 25° C. At the end of the incubation, an equal volume of 20% TCA
was added for a final concentration of 10% TCA. Any volatilized radioactivity
was detected by placing aliquots of the 10% TCA into an inner vial within a
tightly capped scintillation vial containing 4.0 mls of scintillation fluid and
allowing volatile radioactivity to diffuse from the inner vial into the scintillant. To
detect radioactivity remaining associated with each vein segment after the pH
treatment, the veins were washed twice with 10% TCA and then 0.2M NaOH was
added to release any remaining volatile radiolabel, which was quantified as
previously described. Methylation of one milligram ovalbumin with purified rabbit
PIMT was used to directly compare the lability of isoaspartyl methyl esters with
the lability of blood vessel substrates methylated by the endogenous enzyme
activity.24
2.3.9 Immunoblottinq
One centimeter segments of vein were each extracted with 100111 of 1%
Triton X-100 (v/v) in PBS for ten minutes on ice with occasional vortexing. The
detergent soluble fractions (TX-100 soluble) were retained and the extracted
vein and artery were each washed twice with 200111 of PBS to remove excess
detergent. The detergent insoluble vein and artery were each powdered in liquid
N2 and any enzyme released by this treatment was recovered by extraction in
1000 of PBS (TX-100 insoluble). Additionally, a one centimeter untreated vein
and artery segments were each homogenized in liquid N2 using a mortar and
pestle and the released enzyme activity was recovered by extracting in 100111 of
1% TX-100 (v/v) in PBS. The extracts prepared from these homogenates were
considered to contain all of the PIMT activity (Total) in each blood vessel type.
Ten microliters of each extract was assayed for enzymatic activity using the
radiometric assay described above. The remainder was lyophilized in a
centrifugal concentrator (Savant Speed Vac). Each sample was then
electrophoresed on a 12% polyacrylamide gel (Laemmli 1970). The resolved
proteins were transferred to nitrocellulose and probed with rabbit antisera
developed against a zebrafish (Branchio danio) PIMT fusion protein (Lindquist et
al. 1996).Immunoreactive bands were visualized with bromochloroindolyl/nitro
blue tetrazolium (BCIP/NBT) reaction after probing the blot with an alkaline
phosphatase conjugated secondary antibody as described (Harlow and Lane
1988).25
2.3.10 Cell Viability Assay
A modified assay procedure for lactate dehydrogenase (LDH) (Decker
and Lohmann-Matthes 1988) was used to assess the extent of cell lysis and
enzyme entrapment occurring in various vein preparations. After each treatment
(described in the Figure legends), lumens of one centimeter vein segments were
perfused with 300nM of NADH (Sigma) and 300nM of pyruvate (Sigma) in 50W
of Dulbecco's Modified Eagle Medium pH 7.4 without sodium pyruvate or phenol
red (Life Technologies). The assay was carried out for four minutes at 25° C and
then stopped by recovering the perfusate and bringing it to a volume of 1.0 ml in
PBS containing 16mM oxamate (Sigma), an inhibitor of LDH. The LDH
dependent decrease in absorbance at 340nm was measured within one hour in
a Hewlett-Packard HP8452A Diode Array spectrophotometer. Percent lysis was
calculated relative to the maximal amount of LDH activity detected in aqueous
extracts of veins powdered in liquidN2.
2.3.11 In Vivo Blood Vessel Injury
Rats were anaesthetized with sodium pentobarbital ( 50 mg/kg) by
interperitoneal injection. Once a deep state of anesthesia was obtained (15
minutes), a small incision, two centimeters in diameter, was made in the left side
of the chest. This allowed access to the inferior vena cava, thoracic aorta and
heart. Hemostatic forceps (14 cm, crile-style) were inserted through the incision
and each blood vessel clamped for five seconds, using the second locking26
position on the forceps. The inferior vena cava was clamped approximately one
centimeter below it's junction with the heart. The thoracic aorta was clamped
approximately 0.5 centimeters below the heart (halfway between heart and
diaphragm muscle). Immediately after unclamping of blood vessels, 551Ci of
[3H- methyl]- AdoMet in 50µI of saline was injected into the left ventricle of the
heart through a 26 gauge syringe needle. Following an incubation period of ten
minutes, the rat was asphyxiated with CO2.Each injured blood vessel was
excised (1.0 cm for aorta and 2.6 cm for vein) and luminally perfused with saline
to remove all blood. Blood vessels were then cut into 0.2 segments and
individually immersed in 10% TCA.. Due to the elastic nature of the thoracic
aorta, it was necessary to stretch it to it's original one centimeter length in order
to obtain segments. Segments were washed twice in 200µI of 10% TCA and
methyl esterified proteins were quantified as described above.
To determine the distribution of radiolabel in rat tissues, 0.2 grams of the
following tissues, brain, lung, liver and muscle, were homogenized in liquid N2.
Each sample was then resuspended in 0.2 ml phosphate buffered saline, pH 7.4,
containing 1% SDS (w/v). The samples were decolorized with 0.2 ml of 5.25%
sodium hypochlorite and acidified with 0.2 ml glacial acetic acid. Aliquots of 0.2
ml were added to 4.0 ml of scintillation fluid to detect any radiolabel present in
the samples. Radio label present in blood plasma was determined by adding 0.1
ml of plasma to scintillation fluid as above.Additionally, as a control, the leftsaphenous leg vein was analyzed for radiolabel content as described for the
injured blood vessel segments.
2.4. Results
27
In the course of evaluating the therapeutic potential of intravenous
administration of PIMT and Ado Met, isolated segments of rat inferior vena cava
were tested for their content of PIMT substrates. Unexpectedly, substrates in
the vascular wall became radioactively methylated even in the absence of
exogenously added methyltransferase. Furthermore, this radioactivity could
subsequently be released as a volatile compound following treatment with
alkaline solutions (Figure 2.1), suggesting that the linkages were methyl esters
to blood vessel proteins. Several experiments were performed to examine the
nature of this methylation. Methylation of blood vessel substrates was found to
be optimal at physiological body temperatures (Figure 2.2.) The lack of a
reaction a low temperature and heat inactivation of the reaction suggests
strongly that an enzymatic process is involved rather than a non-catalyzed
reaction (Kimzey and McFadden 1994).
To confirm that a methyltransferase is involved, radiometric assayswere
performed in the presence of either S-adenosyl L-homocysteine or sinefungin,
potent competitive inhibitors of all known methyltransferases. These inhibitors
caused in a sharp reduction of radioactively labeled substrates, as did addition
of unlabeled Ado Met (Table 2.1).28
Figure 2.1. Perfusion of blood vessels with 3H-AdoMet results in methyl
esterification of substrates both in the presence and absence of exogenously
added PIMT.Immediately after isolation and washing, the lumen of one
centimeter segments of inferior vena cava were perfused with RPMI 1640 cell
culture medium, pH 7.4, containing radiolabeled AdoMet +1- purified rabbit PIMT.
Following the conclusion of the radiometric assay, base volatile radioactivity was
quantitated as described under Experimental Procedures. Solid bar represents
veins perfused with radiometric assay mixture plus exogenous PIMT. Open bar
represents volatile radioactivity detected in the absence of added PIMT. Error
bars represent +1- s.e.m. of triplicate measures.Figure 2.1
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Figure 2.2. Blood vessel methylation is enzymatic. One centimeter segments of
inferior vena cava were incubated with the radiometric assay mixture described
under experimental procedures at 4° C and 37° C for thirty minutes. The 95° C
bar represents a vein that was pre-incubated at 95° C for five minutes and then
at 37° C in the presence of the radiometric assay mixture for thirty minutes. The
assays were terminated by addition of 10% TCA and volatile radioactivity
quantitated as described under Experimental Procedures. The solid bar
represent veins incubated at 4° C, the striped bar represents veins incubated at
37° C and the open bar represent veins subjected to 95° C, followed by a 37° C
incubation.Error bars represent +1- s.e.m. of duplicate measures.1.0-
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Table 2.1.Effects of various compounds upon enzyme activity. For thirty
minutes prior to the radiometric assay, one centimeter vein segments were
immersed in RPM' 1640, pH 7.4 containing the compounds listed. The
radiometric assay and quantification of radioactivity was carried out as described
under Experimental procedures. The percent decrease was determined by
subtracting the mean of duplicate measures for each compound from the mean
of duplicate measures for an untreated vein
Compound % Decrease
No Treatment 0
5.6gM Ado Met (unlabeled) 53
4011M S-adenosyl homocysteine 91
10gM Sinefungin 9333
The class of carboxyl methyltransferase involved in the methyl
esterification of blood vessels was next investigated by characterizing the pH
lability of the methyl moiety attached to the substrate (Paik and Kim 1990). A
defining attribute of protein D-aspartyl/L-isoaspartyl carboxyl methyltransferases
(PIMT), is the lability of their substrate's methyl ester moiety under mild alkaline
conditions (Clarke 1985). The experiment was set up by incubating vein
segments first with [3H- methyl] - AdoMet in order to allow the endogenous
enzyme activity to radiolabel substrates. Next, individual radiolabeled veins
were exposed to a wide range of pH's to determine the pH sensitivity of the
methyl ester moiety. At slightly alkaline pH, substrates radiolabeled by the
endogenous blood vessel enzyme released their radiolabeled methyl moietyas
a volatile product (figure 2.3). The tendency of the endogenous
methyltransferase's substrates to lose their methyl moieties at relatively mild
alkaline pH, is indicative of the involvement of an isoaspartyl methyltransferase
in ester formation.Methylation of ovalbumin, a model isoaspartyl containing
protein, by purified PIMT, followed by treatment with the samerange of pH
buffers, gave a similar methyl group lability profile (Figure 2.3), showing that the
nature of the methyl ester linkage catalyzed by the blood vessel enzyme is the
same.
In other tissues, PIMT has been shown to be localized intracellularly
(Boivin et al, 1995; Gingras et al, 1991). The ability of endogenous blood
vessel PIMT to utilize Ado Met delivered from the lumen to methylate protein34
Figure 2.3. pH lability of methylated vein substrates. One centimeter segments
of vein which had been radiometrically methylated as described under
Experimental Procedures were treated with buffers of various pH. The release
of volatile radioactivity was then measured afteran incubation period of twenty
minutes at room temperature. Closed symbols show the pH profile of methylated
blood vessel substrates. Open symbols show pH profile of ovalbumin
methylated by rabbit PIMT. Squares show the percent of the total volatile
radioactivity that was lost as a result of each pH treatment. Circles showpercent
of volatile radioactivity remaining after each pH treatment. Error barsrepresent
+1- s.e.m. of duplicate measures.Figure 2.3
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substrates is revealing.It suggests that in the course of blood vessel injury,
PIMT leaks from the cells of this tissue, but remains trapped or cannot otherwise
diffuse away from the blood vessel. This hypothesis implies that this trapped
form of PIMT arises from cells located deep within the blood vessel wall, since
PIMT leaking from cells near the lumen would likely be able to diffuse away. A
series of experiments were designed to test this theory. First, since PIMT from
other tissues has been shown to be effectively solubilized with non-ionic
detergents (Lowenson and Clarke 1992; Pema et al. 1993), the lumens of veins
were extracted with Triton X-100 and subsequently perfused with radiolabeled
Ado Met to determine if PIMT activity was diminished. This treatment resulted in
an approximate six fold increase in detectable methylation over untreated veins
(Figure 2.4a). This is consistent with the hypothesis that PIMT becomes trapped
within the blood vessel wall. Extraction with non-ionic detergent allows increased
permeability of radiolabeled Ado Met into the blood vessel wall and also releases
intracellular PIMT exposing it to new protein substrates, resulting in increased
methylation.
Second, proteins circulating through the lumen of a blood vessel are likely
to be inaccessible to methylation by deeply trapped PIMT. To determine if this is
the case, TX-100 stripped veins were perfused with radiolabeled Ado Met and
ovalbumin. No apparent methylation of luminal substrates was detectable
(Figure 2.4b) yet, incubating purified rabbit PIMT along with radiolabeled
Ado Met and ovalbumin in the vein lumen showed that there are no37
Figure 2.4.Effects of TX-100 extraction upon methylation by endogenous PIMT
of vessel wall substrates and lumina! substrates. A) Prior to perfusion with
radiolabeled Ado Met, the lumen of one centimeter segments of inferior vena
cava were extracted with 1.0% TX-100 in RPMI 1640, pH 7.4 for twenty minutes
on ice. The vein segments were then washed three times with PBS to remove
excess detergent. Each segment was then perfused with RPMI 1640, pH 7.4
containing radiolabeled Ado Met for twenty minutes at 37° C. The solid bar
represents untreated veins, the open bar, TX-100 extracted vein. B) Veins
prepared as just described were perfused with RPMI 1640, pH 7.4 containing
radiolabeled Ado Met one milligram of ovalbumin for twenty minutes at 37° C. At
the end of the radiometric assay, the ovalbumin in the perfusate was recovered
and precipitated with 10% TCA. Volatile radioactivity associated with the
ovalbumin was quantified as described under experimental procedures. Solid
bars represent ovalbumin perfusate from untreated veins, open bars, ovalbumin
perfusate from TX-100 extracted veins. C) As a positive control, veins prepared
as described in panel A, were incubated with ovalbumin as described in panel B,
that also contained 0.6 units of purified rabbit PIMT, to determine if a methylation
inhibitor was present. Solid bars represent ovalbumin perfusate from untreated
veins, open bars, ovalbumin perfusate from TX-100 extracted veins.Error bars
denote +1- s.e.m. of duplicate measures for all panels.3.5-
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inhibitors of protein methylation present in blood vessel lumens (Figure 2.4c).
The results of these experiments imply that the endogenous PIMT is unable to
methylate substrates present in the lumen of blood vessels because the
methyltransferase is trapped deeper within the blood vessel wall.
Third, to show that PIMT is normally localized intracellularly, blood
vessel walls were enzymatically disassociated to obtain fractions enriched in the
two major cell types of blood vessels; endothelial cells and smooth muscle cells.
Lysates prepared from smooth muscle cells and endothelial cells of inferior vena
cava revealed that smooth muscle cells contain greater than 65% of the PIMT
activity, with the remainder found in the endothelial cell fraction (Table 2.2).
Slightly different results were obtained with thoracic aortas. In thiscase,
enzymatic activity was distributed almost equally among the two cell fractions.
The localization of significant levels of PIMT within smooth muscle cells lends
additional support to the hypothesis that this enzyme becomes trapped within
the blood vessel wall, since these cells are located deep within this structure.
To more fully characterize blood vessel PIMT, several experimentswere
done. First, physically disrupting blood vessels by homogenization in liquid N2
with mortar and pestle, was found to be capable of releasing greater than 95% of
the PIMT activity in this tissue in a soluble form. This released PIMT activitywas
capable of methylating ovalbumin with a substrate 'clop of about 711M,a value
within the 0.5gM 10gM range typically reported for thisenzyme (Figure 2.5)40
(McFadden et al. 1983; Aswad 1995). Second, immunoblotting coupled with
activity assays confirm that PIMT can be detected in a form that is extracted by
non-ionic detergent as well as a form resistant to detergent extraction (Figure
2.6). These results correlate well with those presented in Table 2.2, suggesting
that the most of the detergent soluble PIMT activity may arise from endothelial
cells and the detergent resistant activity from smooth muscle cells, which are
found deeper within the blood vessel wall. The finding that PIMT is localized
within cells of the blood vessel wall, strongly suggested that our initial
observation of detectable methylation of blood vessel proteins following luminal
perfusion with radiolabeled Ado Met, is a result of blood vessel injury. To quantify
the extent of injury occurring during the isolation procedure as well as to
determine if other enzymes can become trapped, an assay employing the well
known intracellular enzyme, lactate dehydrogenase (LDH) was used.It was
found that even under gentle isolation procedures, around 10% of the cells in
blood vessels are compromised (Table 2.3). As expected, progressively harsher
treatments results in greater LDH release, similar to what is seen for PIMT
activity. Thus, "trapping" of enzymes from compromised cells within the blood
vessel wall is likely to be a general phenomenon.41
Table 2.2. Localization of endogenous enzyme. Shown in the table is the
distribution of endogenous enzyme activity between endothelial cells and
smooth muscle cells for both veins and arteries. +1- s.e.m.are shown in
parentheses.
Blood Vessel % Endothelial % Smooth Muscle
Inferior Vena Cava33.8 ( 0.08) 66.2 (0.13)
Thoracic Aorta 48.4 ( 0.17) 51.6 ( 0.11)42
Figure 2.5. Kinetics of substrate methylation by crude extracts of veinsand
arteries. Extracts of veins and arteries, preparedas described under
Experimental Procedures, were added to a radiometricassay mixture containing
0.2M citrate, pH 6.0, various concentrations of ovalbumin andradiolabeled
Ado Met. The assays were allowed to proceed for twenty minutesat 37° C,
before being terminated with 10% TCA. Volatile radioactivitywas quantitated as
described under Experimental Procedures. Solid circles representenzyme
extracts from arteries and open circles representenzyme extracts from veins.
Error bars denote +1- s.e.m. of duplicatemeasures.Figure 2.5
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Fiaure 2.6. Immunological identification and activity of PIMT in vein and artery
extracts. The upper portion of the figure represents the level of PIMT activity in
various blood vessel subfractions relative to the total amount of enzyme activity
present in one centimeter of vein or two centimeters of aorta. Error bars
represent s.e.m. of duplicate measures. The lower portion of the figure shows
immunodetection of PIMT against anti-PIMT sera after SDS-PAGE and transfer
to nitrocellulose of the same preparations used to determine activity in the upper
portion of the figure. Molecular weight is shown on the right.R
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Table2.3Extent of cell lysis in various vein preparations. One centimeter
segments of veins were treated as follows prior to assaying for released lactate
dehydrogenase (LDH) activity; no treatment (Intact), extraction with 1% TX-100
(TX-100) or uniformly crushed with forceps for thirty seconds (Crush). Each vein
segment was then luminally perfused with NADH and pyruvate, as described
under Experimental Procedures. At the end of four minutes at room temperature
assays were stopped and any decrease in absorbance at340nm was
measured. Percent of lysis was calculated relative to total LDH activity present in
aqueous extracts of homogenized veins. Numbers in parentheses denote s.e.m.
of duplicate measures.
Preparation % Cell Lvsis
Intact 10.2(1.2)
Crush 25.1(2.4)
TX-100 41.2(3.6)47
Figure 2.7. Methylation by PIMT is confined to the site of invivo blood vessel
injury. A) Inferior vena cava: bars represent volatile methylesters present in
each 0.2 cm segment. Site of injury was approximately atone centimeter in the
2.6 cm of vein. B) Thoracic aorta: bars represent volatile methylesters present
in each 0.2 cm segment. Site of injury was approximately in thecenter of the
one centimeter artery. Base volatile radioactivity was quantifiedas described
under Experimental procedures.0.50
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Finally, the in vitro phenomenon of PIMT methylation within injured blood
vessels, was examined in vivo. Small regions of thoracic aorta and inferior vena
cave of anaesthetized rats were injured prior to administration of radiolabeled
Ado Met into the left ventricle of the heart. Subsequent isolation of the affected
artery and vein, clearly show that only the area of injury correspond to significant
amounts of base volatile methylation (Figure 2.7 A&B). Similar results were
obtained when radiolabeled Ado Met was administered by tail vein injection
(data not shown). At least 62% of the radiolabeled Ado Met administeredcan be
accounted for in the tissues assayed (Table IV) and the remainder is assumed to
associated with tissues that were not assayed.
2.5. Discussion
This investigation is the first to demonstrate that blood vessel injurycan
lead to the trapping of cytosolic enzymes within the extracellular matrix of the
vascular wall.Further, it also represents the first example that circulating levels
of Ado Met can be utilized by PIMT released from injured blood vessels, to
methylated substrates within the vessel wall, in vivo.
Detecting intracellular PIMT in the vascular wall was expected, but the
inability to completely extract the enzyme activity after treating the lumen with
vigorous extraction procedures is unprecedented, as far as we know. The
necessity of using mechanical homogenization to release PIMT from vessels
supports a model in which PIMT is trapped within the mesh-like extracellular
matrix, which has been shown by others to exclude molecules on the basis of50
size (Meyer et al. 1977; Pearce and Laurent 1977; Bert et al. 1980; Monos et al.
1995). Furthermore, the entrapment of PIMT explains how blood vessel injury
could allow a normally intracellular enzyme to catalyze covalent modifications of
matrix proteins with circulating Ado Met as methyl donor.This meshwork
probably acts as a selective permeability barrier allowing small molecules, such
as Ado Met or NADH, to diffuse into the vessel wall, yet prevents larger
macromolecules, such as protein substrates present in the lumen, from
interacting with enzymes trapped within or behind the extracellular matrix.51
Table 2.4. Distribution of radiolabeled adomet in rat tissues after blood vessel
injury.For each of the tissues listed in the table, with the exception of blood
plasma and saphenous vein, 0.2 grams of tissue was analyzed. Each sample
was prepared as described under experimental procedures. For the blood
plasma, 0.1m1 was precipitated with 10% TCA immediately after spinning out of
blood cells.In the case of the saphenous vein, a one centimeter segment was
obtained from the left leg and washed free of blood and subsequently immersed
in 10% TCA. It is a control to demonstrate that no radiolabel is associated with
uninjured blood vessels.
Tissue % Total Ado Met
Plasma 37.5
Brain 1.2
Heart 6.2
Lung 1.7
Muscle 8.9
Saph. Vein >0.0152
Our in vitro studies showing that luminally administered radiolabeled
Ado Met can penetrate the vascular wall and be utilized by endogenous PIMT
can be understood in light of the finding that even gentle isolation procedures
compromise up to 10% of the cells in blood vessels.Even briefly clamping a
blood vessel with hemostatic forceps, can lead injury and PIMT release as our in
vivo experiment revealed. This implies that surgical procedures directly
involving the manipulation of blood vessels, such as grafting, angioplasty and
atherectomy (Ahn et al. 1990) are likely to injury blood vessels and release PIMT
into the extracellular spaces.Clearly, these extracellular spaces contain
altered aspartyl residues, as were detected in the course of this investigation
(see chapter 3). Thus, therapeutic administration of Ado Met (Cutrin et al. 1992;
Angelico et al. 1994; Barak et al. 1994; Bell et al. 1994; Dunne et al. 1994;
Loguercio et al. 1994) following these and other events could conceivably allow
extracellular PIMT to methylate and subsequently restore any altered aspartyl
residues in proteins to their native L-configuration.
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Chapter 3
The Extracellular Matrix is the Major Locus of AlteredAspartyl
Residues in Blood Vessels.
Darin J. Weber and Philip N. McFadden
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3.1. Abstract
Blood vessel injury has been previously shown to result in the release of
intracellular stores of protein D-aspartyl/L-isoaspartyl carboxyl methyltransferase
(PIMT), as well as other cytoplasmic enzymes into the extracellular matrix.
Additionally, it is known that both in vitro and in vivo, PIMT is capable of utilizing
luminally supplied AdoMet to methylate substrates at the site of injury (Weber
1996). However, until now, nothing was known about the altered aspartyl
containing substrates methylated by PIMT as a result of blood vessel injury. In
this report blood vessels were enzymatically and chemically dissected in order to
characterize the distribution and quantity of these proteins in both inferior vena
cava and thoracic aorta of rats. Analysis of inferior vena cava, found that 90%
of the altered aspartyl residues in blood vessels are inaccessible to methylation
by intracellular PIMT under physiological conditions. Subfractionation of inferior
vena cava on the basis of solubility found that at least 40% of the altered
aspartyl containing proteins in blood vessels are insoluble in non-ionic detergent
containing buffers and are highly resistant to extraction by protein denaturants.
Analysis of peptides revealed that the majority of the altered aspartylgroups in
blood vessels are located extracellularly. Amino acid analysis of the highly
methylated blood vessel subfraction, revealed the presence of hydroxyproline,
indicating that collagen may be a major substrate for PIMT in the ECM.It is
estimated that one centimeter of vein contains on the order of 5x 1014 altered
aspartyl residues involving 1% to 5% of the total extracellular protein.58
3.2. Introduction
Blood vessels represent a complex tissue of several cell types situated in
a three dimensional protein scaffold of extracellular matrix (ECM) (Figure 3.1).
In the preceding manuscript, we described how blood vessel injury can lead to
entrapment of intracellular enzymes, such as, protein D-aspartyl/L-isoaspartyl
carboxyl methyltransferase (PIMT) and lactate dehydrogenase (LDH), within the
extracellular meshwork. In this report we extend our prior observations by
examining the distribution of proteins containing altered aspartyl groups in
blood vessels and examine the ability of PIMT to covalently modify these
substrates in the injured blood vessel.
3.3. Experimental Procedures
In all the experiments described, three month old, female Sprague-Dawley
rats, weighing 200 grams were used as sources for veins and arteries. Details of
how blood vessels were excised, perfused with radiometricassay mixture,
enzymatically digested, and how volatile radioactivity was quantifiedare
described in the preceding report (Weber 1996).
3.3.1 Blood Vessel Fractionation
One centimeter vein or artery segments were homogenized in liquid N2
using a mortar and pestle. The homogenized material was resuspended by
vortexing in 50 iil of phosphate buffered saline (PBS), pH 7.4. The soluble59
Figure 3.1. Schematic of Idealized Blood Vessel. The figure depicts the
common structural features found in blood vessels. The blood vessel lumen is
lined by a single cell layer of endothelial cells. Immediately beneath is thin layer
of extracellular proteins called the basal lamina. Endothelial cells and the basal
lamina make up the blood vessel intima. The media consists primarily of smooth
muscle cells and extracellular matrix proteins. The outermost blood vessel layer
is known as the adventitia and consists of loose connective tissue and is
sparsely populated with fibroblasts and sympathetic nerves. Arteries and veins
share all of these common features, but differ somewhat in their proportions.
For example, thoracic aortas, contain less smooth muscle cells in the medial
layer and more elastic fibers than inferior vena cava which contain more smooth
muscle cells and collagen.Endothelium
(Intima)
Smooth Muscle
Cells
(Media)
Figure 3.1
Basal
Lamina
Adventitia
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material was then collected following centrifugation at 10,000x g for five
minutes at 4° C. This material was designated "water soluble" (WS). The
insoluble material was then resuspended in 50p1 of the above buffercontaining
1% TX-100 (v/v) and vigorously mixed by vortexing. "Detergent soluble"(DS)
material was collected by centrifugation as just described. Detergentinsoluble
material was further extracted with 2.5 M NaCI in 1% TX-100 toremove
glycoaminoglycans [[Maurel, 1990 #68;Starcher, 1976 #433]. The remaining
insoluble material (DI) was washed twice with ten volumes ofwater to remove
excess salt and detergent and finally resuspended in 50 pl of PBS.
3.3.2 Proteolvtic Digestion of Blood Vessel Protein
In some experiments, blood vessel subfractionswere cleaved into
peptides with cyanogen bromide (Adelstein and Kuehl 1970; Ozols1991).
Samples were suspended in 100 pl 70% formic acid containing0.1M cyanogen
bromide (Sigma) and reacted 18 hours under a nitrogen atmosphere.Solubilized
material was collected following centrifugation at 13,000x g for one minute and
lyophilized as described below. Protein thatwas not solubilized by cyanogen
bromide treatment was wash twice in 10 volumes of water andfurther digested
with 20 pg of pepsin (Worthington Biochemical, 2x crystallized) in 100 µl of 0.5
M acetic acid for twelve hours at 37° C. The pepsin digestedmaterial and CNBr
solubilized material was diluted to 1.0 ml H2O and lyophilizedtwo times using a
centrifugal concentrator (Savant Speed-vac).62
3.3.3 Amino Acid Analysis
Various artery and vein subfractions were hydrolyzed in 6M HCL at 110
°C for 24 hours under mild vacuum. Amino acid analysis using phenyl
isothiocyanate (PITC) derivitization and isocratic reverse phase HPLC (Alltech
C18 Econosphere, 5m, 4.6 X 250 mm) was used to quantify total amino acids in
each protein fraction against a standard curve with detection at 254 nm (Green
and Reagan 1992). The standard curve consisted of equal amounts of PITC
derivitized glycine, alanine, proline and hydroxyproline. A single peak
containing all of the derivitized amino acids was obtained with 60% acetonitrile
(Burdick and Jackson, HPLC grade) at 1m1/min for 5.0 minutes. Specific amino
acids (glycine, alanine, proline and hydroxyproline) were identified using the
same column setup but gradient elution with a different solvent system. Solvent
A: 10% methanol /90% H2O containing 2.5 ml/L glacial acetic acid and 0.05mI/L
acetone, pH 4.4. Solvent B: 90% methanol /10% H2O containing 0.25 ml/L glacial
acetic acid. Amino acids were eluted using a gradient of 5% B to 50% B over
thirty minutes at a flow rate of 0.85 ml/min (Bhown et al. 1978; Harris et al.
1980). Specific peaks were identified using amino acid standards (Sigma).
3.3.4 Separation of Radioactive Peptides from PH-methyll-AdoMet by Aaarose
Gel Electrophoresis
Since peptides are not quantitatively precipitated by TCA, an alternative
means to separate excess [3H-methyl] -AdoMet from methylated peptides was
used. At the conclusion of radiometric assays with peptides, aliquots of reaction
mixture were loaded onto 10% agarose gels (pH 2.4) and electrophoresed ina63
horizontal mini-agarose gel apparatus (BRL, Gaithersburg, Md) for 30 minutes at
100 V. The excess [3H-methyl]-AdoMet comigrates with the cathode dye, while
the radiolabeled peptides are distributed between two dye fronts, with the
majority of radiolabeled peptide migrating only one to two centimeters beyond
the gel wells. Half centimeter gel slices of each lane were made and the
radioactivity quantified as previously described (Weber and McFadden 1996).
The total number of methyl esters present in each fraction was determined by
taking the sum of the methyl esters present in each gel slice.
3.3.5 In vitro generation of altered aspartyl groups in blood vessel protein.
One centimeter vein segments were immersed in various buffers
containing the following protease inhibitors: EDTA (1mM), aprotinin (2.5µg /ml),
leupeptin (2.5µg /ml), pepstatin A (1µg /ml) and PMSF (100µg /ml). Sodium azide
(0.02%) was added as a bacteriostatic agent. The solutions usedwere: 0.2M
citrate; pH 6.0, PBS; pH 7.4, 0.2 M borate; pH 9.0, and NaOH, pH 12. Vein
segments were incubated in these buffers for 24 hours at 37 °C. Vein segments
were also incubated in PBS with protease inhibitors for 24 hours at the following
temperatures: 4°,25°,37° and 50° C. Additionally, vein segmentswere
incubated for 24, 72, and 168 hours at 37° C in PBS, pH 7.4 plus protease
inhibitors. At the end of a given incubation, samples were frozen in liquid N2
and stored at -20 °C. The samples were then homogenized in liquid N2, usinga
mortar and pestle, and the detergent insoluble fraction (DI) obtainedas
described above. Any newly generated altered aspartylgroups in these sampleswere detected by incubation with [3H- methylj- AdoMet and purified PIMT from
rabbit erythrocytes.
3.4. Results
64
As previously reported, injured blood vessels release PIMTinto the
extracellular milieu. Subsequent administration of radiolabeled AdoMet, results
in the methylation of blood vessel substrates by the releasedPIMT (Weber
1996). In order to characterize the quantity and distribution ofPIMT substrates
in the injured blood vessel a series of enzymatic and chemicaldissections of the
blood vessel wall were performed.
As a first approach, blood vessels were examined to determineif most of
the altered aspartyl containing proteins are associated withendothelial cells
(EC) or deeper sites with in the vessel wall. Thiswas done by enzymatically
stripping blood vessels of their endothelial lining. Examination ofthe released
endothelial cells and the EC depleted blood vessels revealedthat about 25% of
the altered aspartyl proteins are associated with endothelialcells. The
remaining altered aspartyl containing protein that is accessibleby luminal
perfusion, is located deeper within the vessel wall (Figure3.2). Greater than
80% of the altered aspartyl containing protein that becomesmethylated in EC
depleted veins was found to be highly resistant to extraction byprotein
denaturants (Table 3.1).65
Figure 3.2. Distribution of Proteins containing AlteredAspartyl Residues in
Vein +/- Endothelium. Freshly isolated 1cm segments of vein were perfused
with bacterial collagenase IV for 20 minutes at 37° C inRPM! 1640, pH 7.4. This
treatment has been shown to release at least 85% of endothelialcells, intact
(Jaffe et al. 1973). The released cellswere recovered by low speed
centrifugation and washed twice with fresh cell culturemedium. The cells were
then incubated in cell culture medium containing purifiedrabbit PCM and 3H
Ado Met for 20 minutes at 37° C. The collagenase treatedvein was washed
twice to remove any remaining collagenase and thenperfused with cell culture
medium containing 3H Ado Met for 20 minutes at 37° C.Error bars represent +/-
s.e.m. of duplicate measures.Perfused
Vein
Figure 3.2
Endothelium
Stripped
Perfused
Vein
Vein
Endothelium
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Table 3.1. Ability of protein denaturantsto extract methylated proteins from
blood vessels. Following perfusion of veinsegments as described under
Experimental Procedures, unincorporatedradiolabel was removed by washing
the vessels with 10 volumes of 0.2Mcitrate, pH 6.0. The veinswere then
extracted in the listed solvents for 10 minutesat room temperature. The % of
total extracted was determined bysubtracting the mean of duplicatemeasures
for each treatment from themean of duplicate measures for and untreated vein.
Denaturant % of Total Volatile Radioactivity
0.1% TX-100 / 1% SDS 15
0.1% TX-100 / 6M Urea <5
1% SDS / 3M Urea <12
80% Formic Acid < 5
10% Methanol / 7% Acetic Acid < 5
Chloroform:Methanol (2:1) 1868
Since it is known that these highly insoluble proteins are arranged ina
dense meshwork, it seemed likely that molecules of PIMT entrapped during
blood vessel injury, would be diffusionally restricted and incapable of
methylating all of the potential substrates within the extracellular milieu. This
hypothesis was tested by chemically and physically disrupting the blood vessel
architecture followed by addition of radiolabeled Ado Met to allow the released
PIMT to methylate any substrates in the now disrupted meshwork. Non-ionic
detergent extraction, or a cycle of freeze/thawing of veins led toa four fold
increase in detectable methylation, while complete disruption of veinsor arteries
by homogenization in liquid N2 resulted in a 10-12 fold increase indetectable
protein methylation relative to untreated vein segments (Figure 3.3). Thus,the
architecture of the blood vessel wall, plays a significant role in determining the
extent of altered aspartyl containing proteins that are accessible to methylation
by PIMT.
The above results indicated that the highly insoluble proteins ofthe blood
vessel extracellular matrix, not only trap PIMT released during injury,but also
may be the major substrate for the methyltransferase. Alternatively, during blood
vessel injury, a wide variety of cellular proteins would be alsoexpected to
become entrapped within the extracellular meshwork of the blood vesselwall.
These cellular proteins also could be major substrates for themethyltransferase
yet appear insoluble and resistant to extraction since theyare entrapped along
with the methyltransferase. To measure ifany particular category of protein69
Figure 3.3. Physical disruptions of blood vessel architectureare necessary to
expose the majority of isoaspartyl containing proteins. Immediately after
isolation and washing, one centimeter vein segmentswere either extracted with
0.1% TX-100 in RPMI 1640 pH 7.4, for 20 minutes, frozen inliquid N2 and
thawed on ice, or frozen in liquid N2 and ground toa fine powder with a mortar
and pestle. Segments of thoracic aortawere also ground in a mortar and pestle
as described for the vein. The detergent extracted vein was washed with cell
culture medium twice and then perfused with [3H- methyl]- adomet in RPMI 1640,
pH 7.4 for 20 minutes at 37° C. The ground vein andartery were resuspended
in RPMI 1640, pH 7.4, containing thesame amount of 3H-AdoMet and incubated
as described for the detergent extracted vein. Error bars represent +1-s.e.m. of
duplicate measures.V
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substrate present within an injured blood vessel isa major substrate for PIMT,
radiolabeled Ado Met was added to vein homogenates andany proteins present
were allowed to become methylated by the endogenous PIMT. Variousprotein
fractions were recovered on the basis of solubility andexamined for methyl ester
content.Nearly equal distributions of methyl accepting proteinsin the water
soluble and detergent insoluble protein fractionswas observed (Figure 3.4).
Thus, substrates methylated by PIMT inan injured blood vessel are likely to be
both cellular and extracellular in origin.
To quantify the amount of altered aspartyl containingproteins in blood
vessel soluble and insoluble fractions, proteolyticcleavage methods were
employed in order to completely solubilize proteins.This had several
advantages, including elimination ofany secondary or higher structures in the
proteins, so that all altered aspartyl sites presentare accessible to methylation
by PIMT. Also, it ensured that only exogenouslyadded PIMT would responsible
for any observed methylation, since each bloodvessel subfraction would be
expected to contain variable amounts of the endogenousPIMT. On the basis of
equimolar amounts of amino acids, thesame concentration of peptides from
each subfraction were assayed for altered aspartylcontent using radiolabeled
Ado Met and purified rabbit PIMT. Peptidesderived from the detergent insoluble
fraction of veins were found to be enrichedfour-fold in altered aspartyl residues,
above the soluble vein proteins. For insolubleartery proteins, a greater than72
Figure 3.4. Distribution of altered aspartylcontaining proteins in vein
subfractions. One centimeter segments of veinwere subfractionated and
subjected to the radiometric assayas described under Experimental Procedures.
Bars show what percent of the total isoaspartylcontaining protein in each
fraction that is accessible to methylation byisoaspartyl methyltransferases.1
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eight-fold enrichment in altered aspartyl containing proteins was found in this
fraction as compared to artery soluble proteins (Figure 3.5).
By solubilizing the insoluble protein fraction of blood vesselsas peptides,
eliminating the endogenous PIMT activity present in the soluble protein
fractions, and assaying equal amounts of peptides, it became clear that proteins
in the extracellular matrix are the major altered aspartyl substrates in blood
vessels.
Amino acid hydrolysis of this highly insoluble protein fraction, revealed
that these proteins contain significant amounts of hydroxyproline, glycine and
proline, suggesting that collagen may be one of the major methyl accepting
proteins in this fraction (Figure 3.6).
To confirm that the results presented above did not arise during sample
preparation, several control experiments were performed. First, since the
formation of altered aspartyl residues within proteins is known to be affectedby
several well defined parameters, including time, temperature and alkalinepH
(Brennan and Clarke 1995), veins segments were incubated for varioustimes
under each of these conditions. Only at extremes of time, temperature and
alkaline pH could increases of methylatable substrates be detected (Figure3.7).
These conditions were much more extreme than those used duringthe
experiments presented here. Thus, even though blood vessels injurycan occur
under mild handling procedures, blood vessel proteinsare not similarly prone to
altered aspartyl formation under the same conditions.75
Figure 3.5. Methylation of equal amounts of peptides fromsubfractionated
blood vessels. Peptides were generated by proteolytic digestionof vein
subfractions as described under Experimental Procedures.Based upon amino
acid analysis, one micro mole of amino acids in each peptidefraction were
methylated for 60 minutes at 37° C in 0.2 M citrate pH 6.0containing 15 mM
3H-AdoMet (2.5Ci/mmol) and 1.2 units of rabbiterythrocyte PCM. The
methylated peptides were then separated from free radiolabeledAdo Met by
electrophoresis in 10% agarose gels. The bars represent thesum of the total
number of volatile methyl esters present in each gel slice. Blackbar equals the
number of methyl esters contained in one micro mole of aminoacids of the total
protein fraction in a vein. Open bar represents methyl esters inone micro mole
of amino acids from peptides in the water soluble subfraction.Striped bar shows
the number of methyl esters in one micro mole of amino acidsfrom peptides in
the detergent insoluble fraction.Error bars depict +/- s.e.m of duplicate
measures.4
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Figure 3.6. HPLC chromatogram of amino acids content of ECMfrom arteries
and veins. Amino acid hydrolysis of the highly insoluble proteinfraction of blood
vessels (DI) and separation of PITC derivitized residues, revealsthe presence of
significant levels of hydroxyproline (Hypro), proline (pro) and glycine(gly),
suggesting that collagen could be a major methyl accepting proteinin this
fraction.00
time (minutes)
Figure 3.6
13.0
7879
Figure 3.7.In vitro generation of isoaspartylgroups in blood vessel protein.
One centimeter vein segments were incubated in buffersof various pH, or at
several temperatures and times, in thepresence of protease inhibitors, as
described under Experimental Procedures. Open bars showpicomoles of methyl
esters in veins pre-incubated in buffers of various pH. Hatchedbars show
picomoles of methyl esters in veins pre-incubated at 37°Cfor various times.
Solid bars show picomoles of methyl esters of veinspre-incubated in PBS pH
7.4, at various temperatures. The detergent insolublesubfraction was obtained
as described and subjected to the radiometric assay using rabbiterythrocyte
PCM and radiolabeled Ado Met in 0.2 M citrate, pH 6.0at 37 °C for forty minutes.
Error bars represent +1- s.e.m. of duplicatemeasures.6-
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Second, the proteolytic conditions employed to generatepeptides were
examined to determine if they couldcause the formation of altered aspartyl
residues in the insoluble subfraction. To test this, bovineserum albumin (BSA)
was exposed to the same proteolytic conditions as the blood vessel fractions.
BSA, a naturally poor PIMT substrate,can become an excellent PIMT substrate
under the appropriate conditions [McFadden, unpublishedobservation].
Increases in detectable groups were onlyseen after proteolytic digestion which
would be expected due to the increasedaccess of PIMT to sites that were
inaccessible in the native protein (Figure 3.8). Thus, digestionof peptides under
the conditions used, does not lead to the formation ofaltered aspartyl residues
in peptides, but does allow altered residues thatare already present but,
inaccessible in the native proteins to become accessibleto PIMT and
subsequently detected following methylation.
3.5. Discussion
This study is the first description of the distribution ofaltered aspartyl
residues in blood vessels. In an uninjured arteryor vein, up to 90% of the
altered aspartyl residues, are masked or otherwise inaccessibleto endogenous
PIMT under physiological conditions. This is basedupon our previous work
which demonstrated that PIMT in blood vessels islocated intracellularly and the
current work which found the majority of proteins containingaltered aspartyl
residues are located extracellularly.82
Figure 3.8. Does proteolytic digestion cause formation of altered aspartyl
residues. One milligram aliquots of bovine serum albuminwere incubated with
reagents (100W) used to proteolytically cleave blood vessel proteins. A:
negative control; 0.2 M Na+ citrate buffer pH 6.0, overnight at 4° C. B: 0.5 M
acetic acid, overnight at 4° C. C: 0.5 M acetic acid containing 20ji,g pepsin,
overnight at 4° C. D: 0.5 M acetic acid containing 20pig pepsin and 5 jig of
pepstatin A, overnight at 4° C. E: 70% formic acid, overnight at 37° C. F: 70%
formic acid containing 0.1M CNBr, overnight at 37°.Following the incubations,
each sample was brought up 1.0 ml with water and lyophilized. Subsequently,
the samples were resuspended and subjected to a radiometricassay with
purified PIMT and radiolabeled Ado Met. Methylated residueswere quantified
following agarose electrophoresis as described. Error bars represents.e.m. of
duplicate measures.c
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Progressively, increasing the extent of blood vessel injury, led to
increasingly greater amounts of detectable altered aspartyl containing proteins,
reflecting greater access by PIMT to altered aspartyl containing substrates.
However, even in completely homogenized arteries or veins, only about 30% of
the total amount of altered aspartyl residues present in blood vessels is
accessible to methylation by endogenous PIMT. The remainder only becomes
accessible and therefore detectable, following proteolytic cleavage.Using
proteolytic cleavage and examining equal amounts of peptides from various
blood vessel subfractions,it is clear that the highly insoluble proteins of the
extracellular matrix are major repositories of potential PIMT substratesin this
tissue. The significant amount of hydroxyproline present in this fraction
suggests that collagen, an abundant and highly insoluble protein, is likelyto be
at least one of the PIMT substrates in the ECM.
Very little is known about the extent of altered aspartyl formationin
complex tissues.Total amino acid analysis of the highly insoluble blood vessel
protein fraction, coupled with our data from the methylation ofpeptides from this
same fraction enabled us to calculate that 1.2% to 5.4% of the proteins in this
fraction contain one or more altered aspartyl residues, assumingan average
molecular weight of 50,000- 200,000 Daltons, respectively for the proteins in
this fraction. Our calculations correlate well with studieswhich have shown that
in a wide variety soluble proteins, the formation of alteredaspartyl residues is85
sub-stoichiometric, typically ranging from 0.1% to less than 5.0% ina given
protein population (Johnson and Aswad 1990; Chazin and Kossiakoff 1995).
The consequences of altered aspartyl accumulation in the largely
structural proteins of the extracellular matrix is currently unclear.However, there
are several well documented instances with enzymes, where these alterations
have led to diminished protein function (Venkatesh and Vithayathil 1984;
Di Augustine et al. 1987; Johnson et al. 1987; George-Nascimentoet al. 1988;
Friedman et al. 1991; Sun et al. 1992). In tissues suchas blood vessels,
proteins of the extracellular matrix, including collagen, playimportant structural
roles and contain peptide sequences important for cell binding. Aspartyl
residues are a key feature of these cell bindingsequences (Yamada 1991;
Humphries 1993; Yurchenco and O'Rear 1993; Service 1995).It is likely that an
accumulation of altered aspartyl residues in these cell bindingsequences, would
impact this protein-protein organization. Byour calculations, one centimeter of
blood vessel contains on the order of 5x 1014 altered aspartylresidues in the
highly insoluble protein fraction.
Our previous work found that even under gentle isolationprocedures, up
to 10% of the cells in blood vessels are compromised,as evidenced by detection
of LDH leakage. Additionally, it was shown thata significant amount of
endogenous PIMT from compromised cells can become trappedwithin the ECM.
Thus, PIMT that is released by blood vessel injury and trappedwithin the86
Thus, PIMT that is released by blood vessel injury and trapped withinthe
extracellular matrix, is poised to utilize circulating Ado Met to methylatealtered
aspartyl containing extracellular proteins.
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Chapter 4
Injury-induced Enzymatic Methylation of Aging Collagen in the
Extracellular Matrix of Blood Vessels
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4.1. Abstract
As a result of blood vessel injury, intracellular enzymes such as protein
D-aspartyl/L-isoaspartyl carboxyl methyltransferase (PIMT) become trapped
within the meshwork of the vascular extracellular matrix. Previous work in this
lab established that the extracellular matrix (ECM), is a major repository of
altered aspartyl residues in both arteries and veins (Weber 1996). Digestion of
these extracellular matrix proteins with cyanogen bromide (CNBr), followed by
methylation with (PIMT), found that about 60% of the altered aspartyl residues in
the ECM are solubilized by this treatment. Thepresence of hydroxyproline in
amino acid hydrosolates of this fraction and acidic pH gel electrophoresis of
methylated peptides, allowed the identification of collagenas the major PIMT
substrate in the CNBr-soluble material. CNBr peptides derived from both type I
and type III collagen were found to methylated. Chemical injury to blood vessel
lumens with the non-ionic detergent Triton X-100, followed by luminal
administration of radiolabeled S-adenosyl-methionine (Ado Met), further
confirmed that collagen is a major substrate for the endogenous
methyltransferase.
4.2. Introduction
In previous reports from this lab, it has been shown that blood vessel
injury results in the release of intracellularenzymes such as PIMT and LDH into
the intracellular spaces where they become entrapped. In vitroit was
demonstrated that small molecules such as Ado Met and NADHare able to
penetrate the extracellular meshwork from the lumen and subsequentlybe91
utilized by enzymes trapped there. This finding may have physiologically
relevant consequences, since it is well known that blood vessel injury damages
the integrity of the plasma membranes of both endothelial and smoothmuscle
cells (Hawkins et al. 1988; Finger le et al. 1989; Majesky et al. 1990; Lindnerand
Reidy 1991; Douek et al. 1992; Hassenstein et al. 1992; Lindneret al. 1992;
Aliev et al. 1993; Hanke et al. 1994). PIMT appears to representa novel
example in that its substrate specificity extends to the proteins ofthe
extracellular matrix itself. Thus, in vivo administration of radiolabeledAdo Met
into injured blood vessels enabled us to show that methylation ofsubstrates
occurs only at the site of injury. Partial characterization of these substrates
found that they are extremely resistant to extraction by strong protein
denaturants and likely to consist of proteins localized in the extracellularspaces.
This report focuses on identifying the major PIMT substratesof the extracellular
matrix, as they also represent the largest population of alteredaspartyl proteins
in blood vessels.
4.3. Materials and Methods
Cyanogen bromide soluble and insoluble fractionswere obtained from rat
blood vessels and the insoluble fraction subsequently solubilizedby pepsin
digestion as previously described in the preceding manuscript(Weber 1996).92
4.3.1 Amino Acid Analysis
Phenylisothiocyanate (PITC) pre-column derivitizationwas used in all
amino acid analyses (Furst et al. 1990; Green and Reagan 1992).Total amino
acids were quantified as described in the preceding manuscript. Contentof
alanine, hydroxyproline, glycine and proline in each samplewas determined
using standard curves following gradient reversed phase HPLC (AlltechC18
Econosphere, 5p, 4.6 mm X 250 mm). Solvent A: 10% methanol /90% H2O
containing 2.5 ml/L glacial acetic acid and 0.05m1 /L acetone, pH 4.4.Solvent B:
90% methanol /10% H2O containing 0.25 ml/L glacial acetic acid.Amino acids
were eluted using a gradient of 5% B to 50% B over thirty minutes ata flow rate
of 0.85 ml/min with detection at 254 nm (Bhown et al. 1978;Harris et al. 1980).
Since aspartic acid and glycine co-elute in this solventsystem, a different
solvent system, using the same column setupwas employed in order to
determine the content of aspartic acid and asparagine ineach sample (Yang and
Sepulveda 1985). Solvent A: 0.14 M sodium acetate/ 0.05%triethylamine/ 6%
acetonitrile, pH 6.35. Solvent B: 60% acetonitrile. Gradientelution was
employed using 0% B to 10% B over ten minutes ata flow rate of 1.0 ml/min.
Standard curves of aspartic acid and asparaginewere used for quantification.
4.3.2 Methylation of Peptides by PIMT and PH- methyll-AdoMet
Equal quantities (based upon amino acid content) ofCNBr-soluble and
insoluble peptides from arteries and veinswere assayed for their content of
altered aspartyl residues by methylation using 2.0 units ofprotein
D-aspartylk-isoaspartyl carboxyl methyltransferase (PIMT) (EC2.1.1.77) purified93
from rabbit erythrocytes (Gilbert et al. 1988) and 15 piM of
S-adenosyl-L-[3H-methyl] -methionine (Ado Met) (New England Nuclear)at a
specific radioactivity of 2.5 Ci/mmol prepared in 0.2 M Na+ citrate pH 6.0. Each
altered aspartyl assay (50 gl) was carried out at 37 °C for 40 minutes.Reactions
were terminated by addition of an equal volume of 0.13% TFA in water.
Samples were stored on ice until HPLC injection.
4.3.3 HPLC of Peptides Radio labeled by PIMT and PH-methyll-AdoMet
Radiolabled peptides were separated by multi-step gradient reversed
phase HPLC (Vydac protein C4,4.6 mm X 250 mm) at a flow rate of 1.0
ml/minute and detection at 214 nm. Solvent A: 0.13% triflouroacetic acid(TFA)
/H20. Solvent B: 0.1% TFA/90% acetonitrile. Resolution of peptideswas
achieved using the following solvent program: (time(minutes), %B);0,1; 1, 20; 5,
25; 7.5, 31.6; 12, 34.3; 15, 35; 16, 80. Twenty 1.0 ml fractionswere collected
from each run. 3H-methyl esterified peptideswere detected as a volatile product
(3H-methanol) following base hydrolysis in 0.1 M sodiumhydroxide.
4.3.4 Acidic pH Electrophoresis of Radio labeled Peptides
Equal quantities (based on total amino acid content) of CNBr-solubleand
insoluble peptides were assayed for altered aspartylgroups as described above.
Reactions were terminated by mixing withan equal volume of 2X pH 1.4 gel
loading buffer and stored at -20 °C until needed. Peptideswere separated by
polyacrylamide gel electrophoresis on the basis of size usinga 4% (pH 1.4)94
stacking gel and a 12% (pH 2.4) resolving gel, in a water- cooled electrophoresis
apparatus (Owl Scientific). Gels were prepared and radiolabeled peptides
quantified as described (Weber and McFadden 1996).In some cases,
methylated peptides were separated from excess radiolabeled Ado Met in pH 2.4
10% agarose gels as previously described (Weber and McFadden 1996).
4.4 Results
As we previously reported, significant amounts of the amino acid
hydroxyproline, were detected in the highly methylated and highly insoluble
protein fraction of blood vessels (Weber 1996). This modified amino acid is
reportedly found only in collagen. The experiments presented herewere
designed to determine if collagen is indeed a major PIMT substrate in the
extracellular matrix.
Proteolytic cleavage methods followed by amino acid analysis indicated
that the majority of hydroxyproline containing protein can be selectively
solubilized with cyanogen bromide (CNBr) (Figure 4.1). Additionally, this
fraction also contains detectable levels of aspartyl and asparaginyl residues.
The CNBr-insoluble protein fraction was found to be relatively devoid of
hydroxyproline and contains diminished levels of aspartyl and asparaginyl amino
acids (Table 4.1). This result strongly suggested that the CNBr-soluble fraction
contained collagen peptides and that this fraction would also likely contain most
of the substrates for PIMT since the majority of aspartyl and asparaginyl95
Figure 4.1. Distribution of hydroxyproline in CNBr-soluble and insoluble ECM
proteins. Following subfraction of blood vessels, the highly insolublepresent
were digested with CNBr as described under Experimental Procedures. PITC
derivitized amino acid hydrosolates were then resolved by HPLC. Specific
amino acids were identified based upon the elution times of amino acid
standards.CU
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Table 4.1.Mole % of Selected Amino Acids in CNBr-soluble and Insoluble
Fractions. Amino acid hydrosolates of each fraction were separated by HPLC
and specific amino acids identified based upon the elution times of amino acid
standards and standard curves of each amino acid of interest. Peakareas were
used to calculate the moles of each amino acid in each fraction, relative to the
total number of moles of all amino acids present in the fraction. Error bars
represent s.e.m. of duplicate separations.
Amino Acid Soluble
Artery Mole %
Soluble
Vein Mole %
Insoluble Insoluble
Hy Pro 8.8(1.8) 2.1(.47) 8.2(.91) 1.7(.53)
Asp 4.5(.87) 1.9(.32) 4.8(1.6) 2.3(.37)
Asn 4.3(1.4) 2.2(.58) 4.2(.62) 2.1(.44)98
residues are located there. Further evidence for this hypothesis was provided by
methylating equal amounts of peptides in each fraction with purified rabbit PIMT
and radiolabeled Ado Met. The methylated CNBr-soluble and CNBr-insoluble
were then resolved on acidic pH polyacrylamide gels. Surprisingly, no peptide
bands were observed after staining with Coomasie in the CNBr-insoluble fraction
(data not shown).This suggests that only very small peptides are present in
this fraction after pepsin digestion. In contrast, very distinct peptide bands were
observed in the CNBr-soluble fraction (Figure 4.2). Cyanogen bromide digests
of commercially obtained collagen standards were used to positively identify the
methylated peptides as fragments of collagen (Bornstein and Sage 1980). To be
certain that the observed methylation associated with the collagen CNBr
peptides was not due to co-migration of unknown peptides of similar molecular
weight, a different separation technique was employed. Methylated
CNBr-soluble and CNBr-insoluble fragments were separated by reverse phase
HPLC and column fractions assayed for methyl esterified peptides (Figure 4.3).
This method also enabled the total amount of altered aspartyl containing
peptides in each fraction to be determined. In arteries, nearly 70% of PIMT
substrates in the extracellular matrix are CNBr-soluble with the remaining 30%
being CNBr-insoluble. For veins the relative proportions are 66% soluble and
34% insoluble (Table 4.2). This finding confirmed that peptides in the
CNBr-soluble fraction are major PIMT substrates.It also revealed that the
peptide content of the CNBr-insoluble fraction is markedly different from the99
Figure 4.2. Electrophoretic identification of methylated CNBr peptides.
Following methylation of CNBr-soluble peptides as described above, aliquots
were resolved on acidic pH polyacrylamide gels. Coomasie stained bands were
excised and analyzed for content of methyl esters as described. Histograms
reflect the amount of picomoles of methyl esters found in each band. Bands
corresponding to various collagen types were identified followingcyanogen
bromide digestion of commercially prepared collagen standards (Sigma). Greek
letters refer to monomer chains of collagen. Subscript indicates whichmonomer
chain. Roman numerals in parenthesis identify the type of collagen species. CB
refers to cyanogen bromide fragment. The numbers identifying thecyanogen
bromide fragments are used for historical reasons.artery
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Figure 4.3. Analysis of Methylated CNBr-soluble and insoluble peptides by
HPLC. Equal amounts of peptides from the CNBr-soluble and CNBr-insoluble
fraction were methylated by purified PIMT and radiolabeled Ado Metas
described under Experimental Procedures. At the conclusion of the incubation
period, the reaction mixtures were injected onto the HPLC. Nineteen 1.0 ml
fractions were collected and assayed for the presence of methyl esterified
peptides. Upper panel: HPLC chromatograms of artery CNBr-soluble and
CNBr-insoluble peptides. Open triangles show the picomoles of methylesters in
each fraction of CNBr-soluble peptides and the opensquares show the same for
CNBr-insoluble peptides. Lower Panel: HPLC chromatograms of vein
CNBr-soluble and insoluble peptides. Open squares show the picomoles of
methyl esters in each fraction of CNBr-soluble peptides andopen circles the
same for CNBr-insoluble peptides.0 2 4 81012141618
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Table 4.2. Picomoles of Methyl Esters in CNBr-soluble and Insoluble Peptides.
Equal amounts of peptides from the CNBr-soluble and CNBr-insoluble fractions
were methylated with PIMT and radiolabeled Ado Met as described above.
Methylated peptides were separated from excess free [3H-methyl]-AdoMet by
electrophoresis in 10% agarose gels. Gels slices were excised and content of
methyl esters present in each fraction determined as described under
Experimental Procedures. Numbers in parenthesis represent s.e.m. of duplicate
methylations.
Fraction Artery Vein
Total 33.37 (2.16) 35.19(2.63)
CNBr-soluble 23.02(1.37) 23.22(1.72)
CNBr-insoluble 10.35(.62) 11.95(.47)104
CNBr-soluble fraction. Separating methylated CNBr peptides by HPLC first
followed by acidic pH gel electrophoresis, strongly supports the hypothesis that
collagen is the dominant PIMT substrate in the CNBr-soluble fraction (Figure
4.4). The pattern of methylation of peptides in the gel ( Figure 4.2), indicates
that altered aspartyl residues are distributed throughout the polypeptide
sequence of collagen, rather than being localized to any specific fragment
(Table 4.3).
It is clear that upon blood vessel subfractionation and proteolytic
cleavage of the insoluble fraction that collagen acts as a major substrate for
PIMT. However, an important question to be addressed is whetheras a result of
blood vessel injury, does PIMT that is trapped in the ECM, methylatecollagen.
To test this hypothesis, blood vessels were chemically injured by washingthe
lumens of vein segments with non-ionic detergent, followed by perfusion with
radiolabeled Ado Met. The veins were then homogenized and all the protein
present subjected to digestion by cyanogen bromide. The solubilized proteins
were then separated by acidic pH gel electrophoresis (Figure 4.5). As can be
seen, the endogenous PIMT, released as a result of chemical injury, is able to
methylate proteins that when fragmented by CNBr, exhibita mobility identical to
collagen peptides. This evidence strongly suggests thatupon blood vessel
injury, that collagen is a substrate for the endogenous PIMT along withother yet
to be identified fragments, which migrate differently than the major collagen
fragments.105
Figure 4.4 Two-dimensional separation of methylated CNBr-soluble peptides.
CNBr-soluble peptides from veins were methylated exactly as described for
figure 4.3. Methylated peptides were then separated by RP-HPLC and 1.0 ml
fractions collected (1st dimension = hydrophobicity). Fractions nine to fourteen,
which encompassed the major peak of radioactivity were lyophilized.
Subsequently, each fraction was resuspended in pH 1.4 gel loading buffer and
separated by acidic pH gel electrophoresis as described for figure 4.2 (2nd
dimension = size). HPLC fractions corresponding to each gel laneare shown at
top of figure and the gel bands excised shown to right of figure.Coomassie
stainable bands, previously identified as CNBr peptides of collagenwere
excised and content of methyl esters determined. Gel bandsare identified as
follows: (letter, collagen CNBr fragment), a, a2(I)-CB-5, b, ai(I)-CB-7;c,
a,(1)-CB-8; d, a,(111)-CB-5, e, ai(I)-CB-6; f, ai(III)-CB-4.For quantification of
methyl esters in each fragment, see Table 4.3.HPLC Fraction >.-91011121314
Figure 4.4
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Table 4.3 Picomoles of methyl esters in CNBr fragments of collagen. Following
a two dimensional separation of methylated CNBr-soluble peptides as described
in figure 4.4, coomassie staining bands, previously identifiedas CNBr fragments
of collagen were excised and methyl ester content determined. The picomoles
of methyl esters for specific collagen CNBr fragments was obtained by summing
the picomoles each identifiable CNBr fragment excised from each HPLC fraction.
Percent of total picomoles refers to the total number of picomoles of methylated
peptide in all HPLC fractions of the CNBr-soluble resolved material.
Band Collagen CNBr Fraa.pmoles % of Total
a a2(I)-CB 3-5 2.2 10
b a,(I)-CB-7 3.6 16
c a,(I)-CB-8 4.4 19
d a,(III)-CB-5 2.7 12
e a,(I)CB-6 1.4 6.0
f a,(III)-CB-4 1.3 51
Sum = 15.6 68 %108
Figure 4.5. Following blood vessel injury, collagen becomes methylated by
endogenous PIMT. The lumens of one centimeter vein segments were treated
with 1% TX-100 and then perfused with radiolabeled Ado Met. Segments were
the homogenized and all the protein present subjected to digestion with
cyanogen bromide. Solubilized protein was then separated by acidic pH gel
electrophoresis and stained with coomassie blue. One half centimeter gel slices
were then made of the entire sample lane and assayed for methyl ester content
as described above. For comparison, a vein segment was homogenized and
then subjected to methylation by addition of radiolabeled Ado Met. Upper graph
shows methyl esters in each gel slices for chemically injured blood vessels.
Lower graph show methyl ester profile in gel slices of veins homogenized and
then methylated. Note difference in scales between the two graphs. Error bars
show the s.e.m. of duplicate samples run on the same gel. For simplicity, onlya
single sample lane for each treatment is shown.Figure 4.5
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4.5 Discussion
The results presented in this study demonstrate that as aconsequence of
blood vessel injury, collagen, located in the extracellular matrix, becomesa
major PIMT substrate.
To date, there are at least nineteen known proteins identified as
collagens (Prockop 1995). In blood vessels, several fibril forming collagens
(Types I, Ill & V) are major constituents of the medial layer with small amounts of
network forming collagens (Type IV) found in the basal lamina. Type I collagen
is the major form found in blood vessels (-60% of total) with Type Ill accounting
for about 15% and Type V less than 5% (Morton and Barnes 1982; Murata et al.
1986; Maurel et al. 1990; Murata and Motoyama 1990).
Relying on the well known fact that each of the fibril forming collagens
has a unique CNBr digestion pattern (Bornstein and Sage 1980; Sage et al.
1980; Maurel, Azema et al. 1990; Murata and Motoyama 1990; Takasago et al.
1992), enabled us to demonstrate that the two major types of collagen present in
blood vessels (Type I & III), become methylated by PIMT following blood vessel
injury. By separating these methylated peptides on the basis of both
hydrophobicity (HPLC) and size (PAGE), and recovering nearly 70% of the total
amount of methyl esters in the entire fraction in these peptides, minimizes the
possibility that non-collagen peptides co-migrating with the identified fragments
is the source of altered aspartyl residues. Other types of collagen species, if
present, could not be identified due to their low abundance.111
The finding that collagen contains altered aspartyl residues is not
unexpected, since it known that in this tissue it is relatively metabolically stable
(Johnson et al. 1993). Additionally, the extracellular matrix is probably normally
devoid of PIMT, so there is no opportunity to eliminate these altered aspartyl
residues by methylation-dependent mechanisms (reviewed in (Aswad 1995).
Though about 70% of the altered aspartyl residues in the extracellular
matrix are located in the collagen-containing, CNBr-soluble fraction, about
one-third of the altered aspartyl residues remain insoluble after digestion with
cyanogen bromide. A likely candidate for the majority of protein in the
CNBr-insoluble fraction is elastin, an abundant protein of the extracellularmatrix
that is unusual in that it lacks methionine and is nearly 95% non-polar amino
acids in composition (Tanno et al. 1993). Thougha positive identification of
elastin could not be made with the techniques employed, circumstantial
evidence comes from the amino acid analysis of the CNBr-insolublefraction
which shows that this fraction contains significant amounts of late eluting,and
thus likely non-polar, amino acids.
At this time, the consequences on the vascular system of alteredaspartyl
residues in proteins of the extracellular matrixare not known. Above some
threshold level it is likely that protein-protein interactions would be disrupted,
since aspartyl residues are known to be critical amino acids insome cell binding
sequences (Chen et al. 1991; Massia and Hubbell 1992; Cardarelli et al. 1994;
Collen et al. 1994; Lin et al. 1994; Yamamoto and Yamamoto 1994).112
Since it is known that PIMT released from injured blood vessels is
capable of utilizing luminally supplied Ado Met to methylate substrates in the
extracellular matrix (Weber 1996), it raises several interesting questions: Does
endogenous methylation of collagen ever occur? If so, does this effect collagen
metabolism in any way? The concentration of Ado Met in rat plasma is
reportedly about 0.13 011(Giulidori and Stramentinoli 1984), which is a
magnitude lower than Ado Met's KM for PIMT. So, while blood vessel injury no
doubt places PIMT in contact with collagen, an important question that remains
to be addressed is whether there is sufficient circulating Ado Met to promote
physiological enzymatic modification at the site of injury.
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Chapter 5
General Discussion
5.1 Discussion
5.1.1. Extracellular matrix trapping of intracellularenzymes.
The existence of formerly intracellularenzymes trapped in the
extracellular spaces, reacting with substrates in the blood streamwas not
previously known, but may offer insights into tissueresponses as a result of
injury. For example, coronary artery balloon catheterization (angioplasty)and
vein graft bypass surgery, are both known to damage endothelialand smooth
muscle cells of the vascular wall. Severalgroups have proposed that mitogens,
such as basic fibroblast growth factor (bFGF),are released from injured cells
which can then stimulate smooth muscle cells to proliferate andmigrate into the
intimal layer. This process, known as restenosis, quickly leadsto partial
obstruction of blood flow, causing the need for additionalsurgery (Ip et al. 1991;
Hassenstein et al. 1992; Lindner and Reidy 1993; Hanke et al. 1994;Indolfi et
al. 1995). The finding that intracellular proteins become trappedin the ECM,
suggests that enzymes of intracellular origin could also be involved.
5.1.2. New biochemical methods instrumental to the thesis
Prior to the work presented here, no investigations had examinedthe
occurrence of altered aspartyl residues in vascular tissues. The primary
hindrance has been lack of suitable techniques. The lability ofmethyl esterified117
proteins at neutral and above pH, prevents the use of common techniques, such
as polyacrylamide gel electrophoresis, which typically utilize buffering systems
at alkaline pH (Laemmli 1970). Though several acidic pH gel systems have
been developed, the resolving power of complex mixtures of proteins is poor.
In the course of the work described in this thesis it was necessary to
develop two techniques, to make possible the described work of mapping altered
aspartyl sites in blood vessel proteins.
5.1.2.1 Acidic pH, discontinuous polyacrtylamide electrophoresis
The first technique is an acidic pH, discontinuous polyacrylamide gel
electrophoresis system (see Appendix 1). The discontinuous gel system made it
possible for the first time to obtain excellent resolution of complex mixtures of
proteins and peptides, while at the same time, minimizing the loss of methyl
esters from methylated proteins.
5.1.2.2 Acidic pH, 10% agarose gel system
The second method is an acidic pH 10% agarose gel system (see
Appendix 2). This system made it practical to rapidly separate, methylated
peptides from the bulk of excess radiolabeled Ado Met present in methylation
reactions. This was necessary, since traditional methods of removingexcess
radiolabel from reaction mixtures, such as precipitation of protein with
trichloroacetic acid, are not quantitative for peptides.
Without these two systems, it would not have been possible to show
peptides derived from vascular collagen, are major PIMT substrate inthe118
extracellular matrix.Both of these techniques can be applied in tissues other
than blood vessels and should be useful for research in the area of age-related
protein modifications.
5.1.3. Possible consequences of altered aspartyl formation in collagen
At this time, the physiological significance of the accumulation of altered
aspartyl residues, on the structural functions of collagen, are unknown. But in
addition to structural roles, some collagens also contain cell binding motifs in
which aspartyl residues are critical elements (Humphries 1993). Thepresence
of an altered aspartyl residue in this motif would likely abolishany cell binding
activity.
The collagen family of proteins are the most abundant proteins in
vertebrates, and are relatively metabolically stable (Martin et al. 1985). Thus, in
some tissues, collagen molecules may continue to accumulate progressively
greater amounts of altered aspartyl residues until they are turnedover. Yet,
several groups have reported that the 0-peptide linkage connecting L- isoaspartyl
residues and its neighbor on the carboxyl side are resistant to hydrolysis by
peptidases (Murray and Clarke 1984; Johnson and Aswad 1990), implying that
complete degradation of the polypeptide may not be possible. This could
impede some processes such as bone remodeling (Martin and Burr 1989).
Recently, an isoaspartyl dipeptidase was discovered in Escherichia coli,
suggesting vertebrates may have an as yet undiscoveredmeans of hydrolyzing
these peptide bonds (Gary and Clarke 1995).119
Though the physiological role that altered aspartyl residues play in the
extracellular proteins of the vascular system is poorly defined, this thesis has
demonstrated that they are the major repository of altered aspartyl residues in
blood vessels. Since PIMT, an intracellular protein, is the only knownenzyme
capable of restoring these altered sites, blood vessel injury may inadvertantly
mitigate the accumulation of altered aspartyl residues at sites accessible to the
injury-released methyltransferase.
5.2. References
Gary, J. D. and Clarke, S. (1995). Purification and characterization ofan
isoaspartyl dipeptidase from Escherichia coli. J. Biol. Chem. 270(8): 4076-4087.
Hanke, H.,Hassenstein, S., et al. (1994). Accumulation of macrophages in the
arterial vessel wall following experimental balloon angioplasty. Eur-Heart-J
15(5): 691-8.
Hassenstein, S.,Hanke, H., et al. (1992). Vascular injury and timecourse of
smooth muscle cell proliferation after experimental holmium laser angioplasty.
Circulation 86(5): 1575-83.
Humphries, M. J. (1993). peptide sequences in matrix proteins recognized by
adhesion receptors. Cell Biology: A Series of Monographs: 289-308. San Diego,
Academic Press.
Indolfi, C.,Esposito, G., et al. (1995). Smooth muscle cell proliferation is
proportional to the degree of balloon injury in a rat model of angioplasty.
Circulation 92(5): 1230-5.
Ip, J. H.,Fuster, V., et al. (1991). The role of platelets, thrombin and hyperplasia
in restenosis after coronary angioplasty. J-Am-Coll-Cardiol 17(6 Suppl B):
77b-88b.
Johnson, B. A. and Aswad, D. W. (1990). Fragmentation of isoaspartyl peptides
and proteins by carboxypeptidase Y: release of isoaspartyl dipeptidesas a
resulte of internal and external cleavage. Biochem. 29(4373-4379).120
Laemmli, U. K. (1970). Cleavage of Structural Proteins during the Assembly of
the Head of Bacteriophage T4. Nature 227: 680-685.
Lindner, V. and Reidy, M. A. (1993). Expression of basic fibroblast growth factor
and its receptor by smooth muscle cells and endothelium in injured rat arteries.
An en face study. Circ-Res 73(3): 589-95.
Martin, G. R., Timpl, R., et al. (1985). The genetically distinct collagens. Trends
Biochem. Sci. 10: 285-287.
Martin, R. B. and Burr, D. B. (1989). Structure, function and adaptation of
compact bone: 214-233. New York, Raven Press.
Murray, E. J. and Clarke, S. (1984). Synthetic peptide substrates for the
erythrocyte protein carboxyl methyltransferase. Detection of a new site of
methylation at isomerized L-aspartyl residues. J Biol Chem 259: 10722-32.121
Bibliography
Adelstein, R. S. and Kuehl, M. W. (1970). Structural studieson rabbit skeletal
actin. I. Isolation and characterization of the peptidesproduced by cyanogen
bromide cleavage. Biochem. 9(6): 1355-1364.
Ahn, S. S., Arca, M. J., et al. (1990). histologicaland morphologic effects of
rotary atherectomy on human cadaver arteries. Ann. Vasc.Surg. 4: 563-569.
Alberts, B. and al, e. (1994). Molecular Biology ofthe Cell: 971-1009,. New
York
London, Garland Publishing,.
Aliev, G.,Cirillo, R., et al. (1993). Changes in vesselultrastructure during
ischemia and reperfusion of rabbit hindlimb: implicationsfor therapeutic
intervention. Microvasc-Res 46(1): 65-76.
Angelico, M.,Gandin, C., et al. (1994). OralS-adenosyl-L-methionine (SAMe)
administration enhances bile salt conjugation withtaurine in patients with liver
cirrhosis. Scand-J-Clin-Lab-Invest 54(6): 459-64.
Anthony and Thibodeau (1979). Anatomy andPhysiology: 380-388. St. Louis
London, C.V. Mosby Co.
Aswad, D. (1995). Purification and properties ofprotein 1-isoaspartyl
methyltransferase. Deamidation and Isoaspartate Formationin Peptides and
Proteins. D. W. Aswad. Boca Raton, CRC Press: 32-45.
Aswad, D. W. (1995)..Deamidation and Isoaspartate Formation inPeptides and
Proteins: 260. Boca Raton, CRC Press.
Aswad, D. W. and Deight, E. A. (1983). Endogenoussubstrates for protein
carboxyl methyltransferase in cytosolic fractionsof bovine brain. J. Neurochem
31: 1702-1709.
Aswad, D. W. and Guzzetta, A. W. (1995). Methodsfor analysis of deamidation
and isoaspartate formation in peptides andproteins. Deamidation and
isoaspartate formation in peptides and proteins. D.W. Aswad. Boca Raton, FL,
CRC Press: 7-29.
Backlund, P. S. and Aksamit, R. R. (1988). Guaninenucleotide-dependent
carboxyl methylation of mammalian membraneproteins. J. Biol. Chem. 263:
15864-15867.122
Bada, J. L. (1984). Racemization of Aspartyl Residues. Methods.Enzvmol. 106:
98-115.
Baldessarini, R. J. and Kopin, I. J. (1966). S-Adenosylmethionine inbrain and
other tissues. J. Neurochem. 13: 769-777.
Barak, A. J., Beckenhauer, H. C. and Tuma, D. J. (1994). S-adenosylmethionine
generation and prevention of alcoholic fatty liver by betaine. Alcohol11(6):
501-3.
Barber, J. R. and Clarke, S. (1983). Membrane protein carboxylmethylation
increase with human erythrocyte age. J. Biol. Chem. 258(2): 1189-1196.
Barber, J. R. and Clarke, S. (1984). Inhibition of protein carboxylmethylation by
S-adenosyl-L-homocysteine in intact erythrocytes. J. Biol. Chem. 259(11):
7115-7122.
Barten, D. M. and O'Dea, R. F. (1989). Protein carboxylmethyltransferase
activity in intact, differentiated neuroblastoma cells: Quantitationby
S-[3-H]Adenosylmethionine prelabeling. J. Neurochem. 53: 1156-1165.
Bell, K. M., Potkin, S. G., et al. (1994). S-adenosylmethionineblood levels in
major depression: changes with drug treatment. Acta Neurol ScandSuppl 154:
15-8.
Ben, B. G.,Paz, A., et al. (1993). The uniquely distributed isoprenylatedprotein
methyltransferase activity in the rat brain is highly expressed in thecerebellum.
Biochem Biophys Res Commun 195: 282-8.
Bert, J. L., Pearce, R. H., et al. (1980). Chracterization of collagenous
meshworks by volume exclusion of dextrans. Biochem.J. 191: 761-768.
Bhown, A. S., Mole, J. E., et al. (1978). Methanol solventsystem for rapid
analysis of phenylthiodantoin amino acids by high-pressure liquid
chromatography. J. Chromatography 148: 532-535.
Boivin, D., Bilodeau, D. and Beliveau, R. (1995). Immunochemical
characterization of L-isoaspartyl-protein carboxyl methyltransferasefrom
mammalian tissues. Biochem-J 309(Pt 3): 993-8
Bornstein, P. and Sage, H. (1980). Structurally distinct collagentypes. Ann. Rev.
Biochem. 49: 957-1003.
Bower, V. E. and Bates, R. G. (1955). pH Values of the Clarkand Lubs buffer
solutions at 25 C. J. Res. Natn. Bur. Stand. 55(4): 197- 200.123
Brennan, T. V. and Clarke, S. (1995). Deamidation and isoaspartate formation in
model synthetic peptides: the effects of sequence and solution environment.
Deamidation and Isoaspartate Formation in Peptides and Proteins. D. W.
Aswad. Boca Raton, CRC Press: 66-88.
Campbell, E., Pierce, J., et al. (1991). Evaluation of extracellular matrix turnover.
Chest 99(3): 49S.
Campbell, J.,Kocher, 0., et al. (1989). Cytodifferentiation and Expression of
alpha-smooth Muscle Actin mRNA and Protein during Primary Culture of Aortic
Smooth Muscle Cells. Arteriosclerosis 9: 633-643.
Cardarelli, P. M.,Cobb, R. R., et al. (1994). Cyclic RGD peptide inhibitsalpha 4
beta 1 interaction with connecting segment 1 and vascular cell adhesion
molecule. J-Biol-Chem 269(28): 18668-73
Carey, D. J. (1991). Control of growth and differentiation of vascular cellsby
extracellular matrix proteins. Annu. Rev. Physiol. 53: 161-77.
Chamberlain, J. P. (1979). Fluorographic detection of radioactivity in
polyacrylamide gels with the water soluble fluor, sodium salicylate. Anal.
Biochem. 98: 132.
Chameley-Campbell, J., Cambell, G. R. and Ross, R. (1979). The Smooth
muscle cell in culture. Physiological Reviews 59(1):2 -61.
Chazin, W. J. and Kossiakoff, A. A. (1995). The role of secondary andtertiary
structures in intramolecular deamidation of proteins. Deamidation and
Isoaspartate formation in Peptides and Proteins. D. W. Aswad. Baco Raton,
CRC Press: 194-206.
Chelsky, D., Sobotka, C. and O'Neil, C. L. (1989). Lamin B methylationand
assembly into the nuclear envelope. J. Biol. Chem. 264: 7637-7643.
Chen, C. S.,Papayannopoulos, I. A., et al. (1991). A modified Arg-Asp-Val(RDV)
peptide derived during the synthesis of Arg-Glu-Asp-Val (REDV),a tetrapeptide
derived from an alternatively spliced site in fibronectin, inhibits thebinding of
fibrinogen, fibronectin, von Willebrand factor and vitronectin to activated
platelets. Biochim-Biophys-Acta 1075(3): 237-47
Clarke, S. (1985). Protein carboxyl methyltransferases: two distinctclasses of
enzymes. Ann. Rev. Biochem. 54: 479-50.124
Clarke, S. (1992a). The biological functions of protein methylation. In Chemistry
of the Living Cell: 413-436.,JAI Press.
Clarke, S. (1992b). Protein isoprenylation and methylation at carboxyl-terminal
cysteine residues. Ann. Rev. Biochem. 61: 355-86.
Clarke, S. (1993). Protein methylation. Curr Opin Cell Biol. 5: 977-83.
Clarke, S., Vogel, J. P., et al. (1988). Posttranslational modification of the
Ha-ras oncogene protein: Evidence for a third class of protein carboxyl
methyltransferases. Proc. Natl. Acad. Sci. (USA) 85: 4643-4647.
Cohen, D.,Lu, H. R., et al. (1994). Antithrombotic effects and bleeding time
prolongation with synthetic platelet GPIlb/Illa inhibitors in animal models of
platelet-mediated thrombosis. Thromb-Haemost 71(1): 95-102
Cutrin, C.,Menino, M. J., et al. (1992). Effect of nifedipine and
S-adenosylmethionine in the liver of rats treated with CCI4 and ethanol forone
month. Life Sci 51(10): L113-8.
Decker, T. and Lohmann-Matthes, M. (1988). A quick and simple method for the
quantitation of lactate dehydrogenase release in measurements of cellular
cytotoxicity and tumor necrosis factor (TNF) activity. J. Immuno. Methods 15:
61-69.
Di Augustine, R. P.,Gibson, B. W., et al. (1987). Evidence for isoaspartyl forms of
mouse epidermal growth factor. Anal. Biochem. 165: 420-429.
Douek, P. C.,Correa, R., et al. (1992). Dose-dependent smooth muscle cell
proliferation induced by thermal injury with pulsed infrared lasers. Circulation
86(4): 1249-56.
Dunne, J. B., Davenport, M., et al. (1994). Evidence that S-adenosylmethionine
and N-acetylcysteine reduce injury from sequential cold and warm ischemia in
the isolated perfused rat liver. Transplantation 57(8): 1161-8.
Fairbanks, G. and Avruch, J. (1973). Four gel systems forelectrophoretic
fractionation of membrane proteins using ionic detergents. J. Supramol. Struct.
1: 66-75.
Favre, B., Zolnierowicz, S., et al. (1994). The catalytic subunit of protein
phosphatase 2A is carboxyl-methylated in vivo. J Biol Chem 269: 16311-7.125
Finger le, J.,Johnson, R., et al. (1989). Role of platelets in smooth muscle cell
proliferation and migration after vascular injury in rat carotid artery.
Proc-Natl-Acad-Sci-U-S-A 86(21): 8412-6.
Freitag, C. and Clarke, S. (1981). Reversible methylation of cytoskeletaland
membrane proteins in intact human erythrocytes. J. Biol. Chem. 256(12):
6102-6108.
Friedman, A. R.,Ichhpurani, A. K., et al. (1991). Degradation of growthhormone
releasing factor analogs in neutral aqueous solution is related to deamidationof
asparagine residues. Int. J. Peptide Protein Res. 37: 14-20.
Fung, B. K., Yamane, H. K., et al. (1990). The gamma subunit of brain
G-proteins is methyl esterified at a C-terminal cysteine. Febs Lett260: 313-7.
Furst, P.,Pollack, L., et al. (1990). Appraisal of Four Pre-column Derivatization
Methods for the High Performance Liquid Chromatographic Determinationof
Free Amino Acids in Biological Materials. Journal of Chromatography499:
557-569.
Gary, J. D. and Clarke, S. (1995). Purification and characterization ofan
isoaspartyl dipeptidase from Escherichia coli. J. Biol. Chem. 270(8):4076-4087.
Geiger, T. and Clarke, S. (1987). Deamidation, isomerization, andracemization
at asparaginyl and aspartyl residues in peptides. J. Biol. Chem 262(2):785-794.
George-Nascimento, C.,Gyenes, A., et al. (1988). Characterization of
recominant human growth factor produced in yeast. Biochemistry 27: 797-802.
Ghomashchi, F., Zhang, X., et al. (1995). Binding of prenylated andpolybasic
peptides to membranes: affinities and intervesicle exchange. Biochemistry
34(37): 11910-8.
Ghosh, S. K.,Syed, S. K., et al. (1990). Substrate specificity for myelinbasic
protein-specific protein methylase I. Biochim Biophys Acta 1039: 142-8.
Gilbert, J. M., Fowler, A., et al. (1988). Purification of homologousprotein
carboxyl methyltransferase isozymes from human and bovineerythrocytes.
Biochemistry 27: 5227-5233.
Gimbrone, M. A. (1980). Atherosclerosis V. Proceedings of the Fifth
International Symposium.: 415-425.,Springer-Verlag.126
Giner, J. L. and Rando, R. R. (1994). Novel methyltransferase activitymodifying
the carboxy terminal bis(geranylgeranyl) -Cys- Ala -Cys structure ofsmall
GTP-binding proteins. Biochemistry 33(50): 15116-23.
Gingras, D., Boivin, D. and Beliveau, R. (1994). Asymmetricaldistribution of
L-isoaspartyl protein carboxyl methyltransferases in the plasmamembranes of
rat kidney cortex. Biochem. J. 297: 145-150.
Gingras, D., Menard, P. and Beliveau, R. (1991). Proteincarboxyl methylation
in kidney brush-border membranes. Biochim. Biophys. Acta.1066: 261-267.
Giulidori, P. and Stramentinoli, G. (1984). A Radioenzymaticmethod for
S-adenosyl-L-methionine determination in biological fluids. Anal.Biochem. 137:
217-220.
Glazer, R. I. and Peale, A. L. (1978). Measurement ofs-adenosyl-l-methionine
levels by sp sephadex chromatography. Anal. Biochem. 91:516-520.
Goldberg, I. D. (1982). The endothelium: injury and repair ofthe vascular wall.
The Coronary Artery. S. Kalsner. New York, Oxford UniversityPress: 417-430.
Green, G. D. and Reagan, K. (1992). Determination ofhydroxyproline by high
performance liquid chromatography. Analytical Biochemistry201: 265-269.
Hanke, H.,Hassenstein, S., et al. (1994). Accumulation ofmacrophages in the
arterial vessel wall following experimental balloon angioplasty.Eur-Heart-J
15(5): 691-8.
Harlow, E. and Lane, D., Eds. (1988). Antibodies-ALaboratory Manual, Cold
Spring Harbor Laboratory.
Harris, J. U., Robinson, D. and Johnson, A. J. (1980).Analysis of
(3- Phenyl,2- thio)hydanoin amino acids by high-performanceliquid
chromatography. Anal. Biochem. 105: 239-245.
Hassenstein, S.,Hanke, H., et al. (1992). Vascular injuryand time course of
smooth muscle cell proliferation after experimentalholmium laser angioplasty.
Circulation 86(5): 1575-83.127
Hawkins, M. L.,Carraway, R. P., et al. (1988). Pulmonary arterydisruption from
blunt thoracic trauma. Am-Surg 54(3): 148-52.
Hrycyna, C. A., Yang, M. C. and Clarke, S. (1994). Protein carboxylmethylation
in Saccharomyces cerevisiae: evidence for STE14-dependentand
STE14-independent pathways. Biochemistry 33: 9806-12.
Humphries, M. J. (1993). Peptide sequences in matrix proteinsrecognized by
adhesion receptors. Cell Biology: A Series of Monographs:289-308. San Diego,
Academic Press.
Indolfi, C.,Esposito, G., et al. (1995). Smooth muscle cellproliferation is
proportional to the degree of balloon injury ina rat model of angioplasty.
Circulation 92(5): 1230-5.
Ip, J. H.,Fuster, V., et al. (1991). The role of platelets,thrombin and hyperplasia
in restenosis after coronary angioplasty. J-Am-Coll-Cardiol17(6 Suppl B):
77b-88b.
Iversen, L. L., Mortishire-Smith, J., et al. (1995). The toxicityin vitro of B-amyloid
protein. Biochem. J. 311: 1-16.
Johnson, B. A. and Aswad, D. W. (1985).Enzymatic protein carboxyl
methylation at physiological pH: cyclic imide formationexplains rapid methyl
turnover. Biochemistry 24: 2581-6.
Johnson, B. A. and Aswad, D. W. (1990). Fragmentation ofisoaspartyl peptides
and proteins by carboxypeptidase Y: release of isoaspartyldipeptides as a
resulte of internal and external cleavage. Biochem.29(4373-4379).
Johnson, B. A. and Aswad, D. W. (1990). Identities, originsand metabolic fates
of the substrates for eukaryotic protein carboxylmethyltransferases. Protein
Methylation. W. K. Paik and S. Kim. Boca Raton, CRC Press:196-207.
Johnson, B. A. and Aswad, D. W. (1991). Optimal conditionsfor the use of
protein L-isoaspartyl methytransferase in assessing theisoaspartate content of
peptides and proteins. Anal. Biochem. 192: 384-391.
Johnson, B. A., Langmack, E. L. and Aswad, D. W. (1987).Partial repair of
deamidation-damaged calmodulin by protein carboxyl methyltransferase.J. Biol.
Chem. 262(25): 12283-12287.
Johnson, B. A.,Murray, E., Jr., et al. (1987). Proteincarboxyl methyltransferase
facilitates conversion of atypical L-isoaspartyl peptidesto normal L-aspartyl
peptides. J. Biol. Chem. 262: 5622-5629.128
Johnson, B. A.,Murray, E., Jr., et al. (1987). Protein carboxylmethyltransferase
facilitates conversion of atypical L-isoaspartyl peptides to normalL-aspartyl
peptides. J. Biol. Chem. 262: 5622-5629.
Johnson, B. A., Najbauer, J. and Aswad, D. W. (1993). Accumulationof
substrates for protein L-isoaspartyl methyltransferase in adenosine
dialdehyde-treated PC12 cells. J. Biol. Chem. 268(9): 6174-6181.
Johnson, D. J., LaBourene, J., et al. (1993). Relative efficiency ofincorporation
of newly synthesized elastin and collagen into aorta, pulmonaryartery and
pulmonary vein of growing pigs. Connect. Tissue Res. 29:213-221.
Kimzey, A. L. and McFadden, P. N. (1994). Spontaneousmethylation of
hemoglobin by S-adenosylmethionine by a specific and saturablemechanism. J.
Protein Chem. 13: 537-546.
Klein, Z.,Ben, B. G., et al. (1994). Characterization of theprenylated protein
methyltransferase in human endometrial carcinoma. BiochimBiophys Acta 1226:
330-6.
Kloog, Y., Axelrod, J. and Spector, I. (1983). Protein carboxylmethylation
increases in parallel with differentiation of neuroblastoma cells.J. Neurochem.
40: 522-529.
Ladino, C. A. and O'Connor, C. M. (1992). Methylation of atypicalprotein
aspartyl residues during the stressresponse of He La cells.J. Cell. Physiol.
153: 297-304.
Laemmli, U. K. (1970). Cleavage of structural proteins duringthe assembly of
the head of bacteriophage T4. Nature 227: 680-685.
Lee, J. and Stock, J. (1993). Protein phosphatase 2A catalyticsubunit is
methyl-esterified at its carboxyl terminus bya novel methyltransferase. J Biol
Chem 268: 19192-5.
Lerner, S., Haklai, R. and Kloog, Y. (1992). Isoprenylation and
carboxylmethylation in small GTP-binding proteins of pheochromocytoma
(PC-12) cells. Cell Mol Neurobiol 12(4): 333-51.
Lin, H. B.,Sun, W., et al. (1994). Synthesis, surface, andcell-adhesion
properties of polyurethanes containing covalently graftedRGD-peptides.
J-Biomed-Mater-Res 28(3): 329-42129
Lindner, V., Olson, N. E., et al. (1992). Inhibition of smooth muscle cell
proliferation in injured rat arteries. Interaction of heparin with basic fibroblast
growth factor. J-Clin-Invest 90(5): 2044-9.
Lindner, V. and Reidy, M. A. (1991). Proliferation of smooth muscle cells after
vascular injury is inhibited by an antibody against basic fibroblast growth factor.
Proc-Natl-Acad-Sci-U-S-A 88(9): 3739-43.
Lindner, V. and Reidy, M. A. (1993). Expression of basic fibroblast growth factor
and its receptor by smooth muscle cells and endothelium in injured rat arteries.
An en face study. Circ-Res 73(3): 589-95.
Lindquist, J. A., Barofsky, E. and Mcfadden, P. N. (1996). Determination of two
sites of automethylation in bovine erythrocyte (D-aspartyl/L-isoaspartyl) carboxyl
methyltransferase. J. Protein. Chem. in press.
Lischwe, M. A. (1990). Amino Acid Sequence of Arginine Methylation Sites.
Protein Methylation. W. K. Paik and S. Kim. Boca Raton, CRC Press: 98-120.
Loguercio, C.,Nardi, G., et al. (1994). Effect of S-adenosyl-L-methionine
administration on red blood cell cysteine and glutathione levels in alcoholic
patients with and without liver disease. Alcohol-Alcohol 29(5): 597-604.
Lou, L. L. and Clarke, S. (1987). Enzymatic methylation of band 3 anion
transporter in intact human erythrocytes. Biochem. 26: 52-59.
Lowenson, J. D. and Clarke, S. (1992). Recognition of D-aspartyl residues in
polypeptides by the erythrocyte L-isoaspartyl/D-aspartyl protein
methyltransferase. Implications for the repair hypothesis. J Biol Chem 267(9):
5985-95.
Luscher, T., Tanner, F. C., et al. (1993). Endothelial dysfunction incoronary
artery disease. Annu. Rev. Med 44: 395-41.
Luscher, T. F. and Noll, G. (1994). Endothelium dysfunction in thecoronary
circulation. J. Cardiovasc. Pharm. 24(suppl 3): S-16-26.
MacFarlane, D. E. (1984). Inhibitors of cyclic nucleotides phosphodiesterases
inhibit protein carboxyl methylation in intact blood platelets. J. Biol. Chem.
259(2): 1357-1362.
Majesky, M. W.,Schwartz, S. M., et al. (1990). Smooth muscle diversity in arterial
wound repair. Toxicol Pathol 18(4 Pt 1): 554-9.130
Martin, G. R., Timpl, R., et al. (1985). The genetically distinct collagens. Trends
Biochem. Sci. 10: 285-287.
Martin, R. B. and Burr, D. B. (1989). Structure, function and adaptation of
compact bone: 214-233. New York, Raven Press.
Massia, S. P. and Hubbell, J. A. (1992). Vascular endothelial cell adhesion and
spreading promoted by the peptide REDV of the IIICS region of plasma
fibronectin is mediated by integrin alpha 4 beta 1. J-Biol-Chem 267(20):
14019-26
Maurel, E., Azema, C., et al. (1990). Collagen of the normal and the varicose
human saphenous vein: a biochemical study. Clin.Chim.Acta 193: 27-38.
McFadden, P. N. and Clarke, S. (1982). Methylation at D-aspartyl residues in
erythrocytes: possible step in the repair of aged membrane proteins. Proc Natl
Acad Sci U S A 79: 2460-4.
McFadden, P. N. and Clarke, S. (1987). Conversion of isoaspartyl peptides to
normal peptides: implications for the cellular repair of damaged proteins. Proc.
Natl. Acad. Sci. U.S.A. 84: 2595.
McFadden, P. N., Horwitz, J. and Clarke, S. (1983). Protein carboxyl
methytransferase from cow eye lens. Biochem. Biophys. Res. Comm. 113(2):
418-424.
Meyer, F. A., Koblentz, M. and Silberberg, A. (1977). Structural investigation of
loose connective tissue by using a series of dextran fractionsas non-interacting
macromolecular probes. Biochem. J. 161: 285-291.
Monos, E., Berczi, V. and Nadasy, G. (1995). Local control of veins:
biomechanical, metabolic and humoral aspects. Physiological Reviews 75(3):
611-666.
Morton, L. F. and Barnes, M. J. (1982). Collagen polymorphism in the normal
and diseased blood vessel wall. Atherosclerosis 42: 41-51.
Murata, K., Motayama, T. and Kokake, C. (1986). Collagen types in various
layers of the human aorta and their changes with atheroscleroticprocess.
Athereosclerosis 60: 251-262.
Murata, K. and Motoyama, T. (1990). Collagen species in various sized human
arteries and their changes with intimal proliferation. Artery 17(2): 96-106.131
Murray, E. D. and Clarke, S. (1986). Metabolism of a synthetic
L-isoaspartyl-containing hexapeptide in erythrocte extracts. J. Biol. Chem. 261:
306-312.
Murray, E. J. and Clarke, S. (1984). Synthetic peptide substrates for the
erythrocyte protein carboxyl methyltransferase. Detection ofa new site of
methylation at isomerized L-aspartyl residues. J Biol Chem 259: 10722-32.
Najbauer, J., Johnson, B. A. and Aswad, D. W. (1991). Amplification and
detection of substrates for protein carboxyl methyltransferases in PC12 cells.
Anal Biochem, 197: 412-20.
Najbauer, J., Johnson, B. A. and Aswad, D. W. (1992). Analysis of stable
protein methylation in cultured cells. Arch Biochem Biophys 293: 85-92.
Neuhoff, V.,Stamm, R., et al. (1988). Essential problems in quantification of
proteins following colloidal staining with Coomassie brilliant blue dyes in
polyacrylamide gels, and their solutions. Electrophoresis 9: 255-262.
0' Brien, E. R.,Garvin, M. R., et al. (1994). Osteopontin is synthesized by
macrophage, smooth muscle, and endothelial cells in primary and restenotic
human coronary atherosclerotic plaques. Arterioscler-Thromb 14(10): 1648-56
O'Conner, C. M., Aswad, D. W. and Clarke, S. (1984). Mammalian brain and
erythrocyte carboxyl methyltranserases are similarenzymes that recognize both
D-aspartyl and L-isoaspartyl. Proc. Natl. Acad. Sci. USA 81: 7757.
O'Conner, C. M. and Clarke, S. (1983). Methylation of erythrocytemembrane
proteins at extracellular and intracellular D-aspartyl sites in vitro.J. Biol. Chem.
258(13): 8485-8492.
O'Conner, C. M. and Clarke, S. (1984). Carboxyl methylation of cytosolic
proteins in intact human erythrocytes. Identification ofnumerous
methyl-accepting proteins including hemoglobin and carbonic anhydrase.J. Biol.
Chem. 259(4): 2570-2578.
O'Conner, C. M. and Clarke, S. (1985). Analysis of erythrocyteprotein methyl
esters by two-dimensional gel electrophoresis under acidic separating
conditions. Anal. Biochem. 148: 79-86.
O'Dea, R. F., Mirkin, B. L., et al. (1987). Effect of adenosine analogueson
protein carboxylmethyltransferase, S-adenosylhomocysteine hydrolase,and
ribonucleotide reductase activity in murine neuroblastoma cells. CancerRes 47:
3656-61.132
Ohta, K.,Seo, N., et al. (1987). Tubulin and high molecular weight
microtubule-associated proteins as endogenous substrates for protein carboxyl
methyltransferase in brain. Biochemie 69: 1227-1234.
Ong, 0. C., Ota, I. M., et al. (1989). The membrane bindingdomain of rod
cGMP phosphodiesterase is posttranslationally modifiedby methyl
esterification at a C-terminal cysteine. Proc Natl Acad Sci U S A86: 9238-42.
Ota, I. M. and Clarke, S. (1989). Enzymatic methylationof 23-29-kDa bovine
retinal rod outer segment membrane proteins.Evidence formethylester
formationat carboxyl-terminal cysteinyl residues. J Biol Chem 264:12879-84.
Ota, I. M. and Clarke, S. (1990). The function and enzymologyof protein
D-aspartyl/L-isoaspartyl methyltransferases in eukaryotic andprokaryotic cells.
Protein Methvlation. W. K. Paik and S. Kim. Boca Raton, CRCPress: 179-194.
Ozols, J. (1991). Multiple forms of liver microsomal flavin-containing
monooxygenases:complete covalent structure of form 2. Arch-Biochem-Biophys
290(1): 103-15.
Paik, W. K. and Kim, S., Eds. (1990). Protein Methylation.Protein Methvlation.
Boca Raton, FL, CRC Press.
Park, I. K. and Paik, W. K. (1990). Theoccurrence and analysis of methylated
amino acids. Protein Methvlation. W. K. Paik and S. Kim.Boca Raton, FL, CRC
Press.: 1-22.
Pasquinelli, G.,Cavazza, A., et al. (1989). Endothelial injuryin human
atherosclerosis. Scanning-Microsc 3(3): 971-81; discussion981-2.
Payan, I. L.,Chou, S. J., et al. (1992). Altered aspartatein Alzheimer
neurofibrillary tangles. Neurochem Res 17(2): 187-91.
Paz, A.,Ben, B. G., et al. (1993). Prenylated proteinmethyltransferase of rat
cerebellum is developmentally co-expressed with itssubstrates. Febs Lett 332:
215-7.
Pearce, R. H. and Laurent, T. C. (1977). Exclusionof dextrans by meshworks of
collagenous fibres. Biochem. J. 163: 617-625.
Pema, A. F.,Ingrosso, D., et al. (1993). Enzymaticmethyl esterification of
erythrocyte membrane proteins is impaired in chronicrenal failure. Evidence for
high levels of the natural inhibitor S-adenosylhomocysteine.J-Clin-Invest 91(6):
2497-503.133
Prockop, D. J. (1995). Collagens: molecular biology, diseases,and potentials for
therapy. Ann. Rev. Biochem. 64: 403-434.
Rajpurohit, R., Park, J. 0., et al. (1994). Enzymatic methylationof recombinant
heterogenous nuclear RNP protein Al. Dual substratespecificity for
S-adenosylmethionine:histone-arginine N-methyltransferase. J.Biol. Chem 269:
1075-82.
Rattan, S. I., Derventzi, A. and Clark, B. F. C. (1992).Protein synthesis,
posttranslational modifications and aging. Ann. N.Y. Acad.Sci. 663: 48.
Reiser, K. M., Amigable, M. and Last, J. A. (1992).Nonenzymatic glycation of
type i collagen. J. Biol. Chem. 267(34): 24207-24216.
Robert, L. and Labat-Robert, J. (1995). ExtracellularMatrix. Molecular Basis of
Aainq. A. Macieira-Coelho. Boca Raton, CRC Press:459-488.
Roher, A. E.,Lowenson, J. D., et al. (1993). Structuralalterations in the peptide
backbone of beta-amyloid core proteinmay account for its deposition and
stability in Alzheimer's disease. J Biol Chem 268(5):3072-83.
Rothe, C. F. (1980). The Cardiovascular System,.Handbook of Physiology,
section 2: 408-410. Bethesda, American Physiological Society.
Sage, H., Pritzl, P. and Bornstein, P. (1980). Aunique pepsin-sensitive collagen
synthesized by aortic endothelial cells in culture. Biochemistry19: 5747-5755.
Schultze, A. E.,Gunaga, K. P., et al. (1994). Lactatedehydrogenase activity and
isozyme patterns in tissues and bronchoalveolarlavage fluid from rats treated
with monocrotaline pyrrole. Toxicol-Appl-Pharmacol126(2): 301-10.
Sellinger, 0. Z. and Wolfson, M. F. (1991). Carboxylmethylation affects the
proteolysis of myelin basic protein by staphylococcusaureus V8 proteinase.
Biochim. Biophys. Acta. 1080: 110-118.
Service, R. F. (1995). Designer tissues take hold.Science 270: 230-232.
Siegel, F. L.,Vincent, P. L., et al. (1990). Calmodulinand protein methylation.
Protein Methvlation. W. K. Paik and S. Kim. Boca Raton,FL, CRC Press.:
33-58.
Skinner, M. K. and Griswold, M. D. (1983).Flourographic detection of
radioactivity in polyacrylamide gels with 2, 5-diphenyloxazolein acetic acid and
its comparison with existing procedures. Biochem.J. 209: 281-284.134
Stephenson, R. C. and Clarke, S. (1989). Succinimide formation from aspartyl
and asparaginyl peptides as a model for the spontaneous degradationof
proteins. J. Bio.Chem. 264(11): 6164-6170.
Stephenson, R. C. and Clarke, S. (1990). Identification ofa C-terminal protein
carboxyl methyltransferase in rat liver membranes utilizinga synthetic farnesyl
cysteine-containing peptide substrate. J Biol Chem 265: 16248-54.
Stephenson, R. C. and Clarke, S. (1992). Characterization ofa rat liver
protein carboxyl methyltransferase involved in the maturation ofproteins with
the -CXXX C-terminal sequence motif. J Biol Chem 267: 13314-9.
Sun, A. Q., Yuksel, K. U. and Gracy, R. W. (1992). Relationship betweenthe
catalytic center and primary degradation site of triosephosphate
isomerase:effects of active site modification and deamidation. Arch.Biochem.
Biophys. 293(2): 382-390.
Takasago, T.,Nkamua, K., et al. (1992). Analysis of Collagen type III by
uninterrupted sodium dodecyl sulfate-polyacrylamide gel electrophoresisand
immunoblotting: Changes in collagen type III polymorphism in Aging Rats.
Electrophoresis 13: 373-378.
Takemoto, L. J. (1995). Degradation of aspartyl and asparaginylresidues of lens
protein in vivo. Deamidation and Isoaspartate Formation in Proteinsand
Peptides. D. W. Aswad. Boca Raton,CRC Press: 157-166.
Tanno, T., Yoshinaga, K. and Sato, T. (1993). Alteration of elastin inaorta of
Diabetics. Atherosclerosis 101: 129-134.
Terwilliger, T. C. and Clarke, S. (1981). Methylation of membraneproteins in
human erythrocytes: Identification and chracterization of polypeptides
methylated in lysed cells. J. Biol. Chem. 256(6): 3067-3096.
Teshima, G., Hancock, W. S. and Canova-Davis, E. (1995). Effect of
deamidation and isoaspartyl formation on the activity of proteins. Deamidation
and Isoaspartate Formation in Peptides and Proteins. D. W. Aswad.Boca,
Raton, CRC Press: 167-192.
Todorovich-Hunter, L.,Johnson, D. J., et al. (1988). Altered elastin andcollagen
synthesisi associated with progressive pulmonary hypertension inducedby
monocrotaline. Lab. Invest. 58(2): 184-195.
Tomiyama, T.,Asano, S., et al. (1994). Racemization of Asp23 residueaffects
the aggregation properties of Alzheimer amyloid beta proteinanalogues.
J-Biol-Chem 269(14): 10205-8135
Venkatesh, Y. P. and Vithayathil, P. J. (1984). Isolation and characterization of
monodeamidated derivatives of bovine pancreatic ribonuclease A. Int. J. Peptide
Protein Res. 23: 494.
Volker, C., Pillinger, M. H., et al. (1995). Prenylcysteine analogs to study
function of carboxylmethylation in signal transduction. Methods Enzymol 250:
216-25.
Weber, D. J., Isoaspartyl methylation at the site of blood vessel injury,
Biochemistry and Biophysics, Oregon St.University, Corvallis, 1996,pp. Chapter
1.
Weber, D. J., Isoaspartyl methylation at the site of blood vessel injury,
Biochemistry and Biophysics, Oregon St. University, Corvallis, 1996,pp.
Chapter 2.
Weber, D. J. and McFadden, P. N. (1995). A Heterogeneous Set of
Urea-Insoluble Proteins in Dividing PC12 Pheochromocytoma Cells is Passed
on to at least the Generation of Great-Granddaughter Cells. J. Protein. Chem.
14(5): 283-289.
Weber, D. J. and McFadden, P. N. (1996). Identification of proteins modified by
protein (d-asparty1/1-isoaspartyl) carboxyl methyltransferase. Protein Protocols
Handbook. J. M. Walker. Totawa, New Jersey, Humana Press: 507-515.
Weber, D. J. and McFadden, P. N. (1996). Protein Methylation in thenervous
system. Neuromethods. H. C. Hemmings. Totawa, New Jersey, Humana Press,
INC: [in press].
Wolf, M. E. and Roth, R. H. (1985). Dopamine autoreceptor stimulation
increases protein carboxyl methylation in striatal slices. J. Neurochem. 44:
291-298.
Xie, H. and Clarke, S. (1993). Methyl esterification of C-terminal leucine
residues in cytosolic 36-kDa polypeptides of bovine brain. A novel
eucaryotic protein carboxyl methylation reaction. J Biol Chem 268: 13364-71.
Xie, H. and Clarke, S. (1994a). An enzymatic activity in bovine brain that
catalyzes the reversal of the C-terminal methyl esterification of protein
phosphatase 2A. Biochem Biophys Res Commun 203: 1710-5.
Xie, H. and Clarke, S. (1994b). Protein phosphatase 2A is reversibly modified
by methyl esterification at its C-terminal leucine residue in bovine brain.J Biol
Chem 269: 1981-4.136
Yamada, K. M. (1991). Fibronectin and other cell interactive glycoproteins. Cell
Biology of Extracellular Matrix New York and London, Plenum Press.
Yamamoto, K. and Yamamoto, M. (1994). The failure to reconstitute the second
extracellular matrix-integrin-cytoskeleton system in human endothelial cellson
type V collagen. Artery 21(2): 76-93.
Yang, C.-Y. and Sepulveda, F. I. (1985). Separation of phenylthiocarbamyl
amino acids by high performance liquid chromatography on Spherisorb
octadecylsilane columns. J. Chromatography 346: 413-416.
Yurchenco, P. D. and O'Rear, J. (1993). Supramolecular organization of
basement membranes. Cell Biology: A Series of Monographs: 19-47. San Diego,
Academic Press.137
Appendices138
Appendix 1
Electrophoretic Identification of Altered Aspartyl Containing
Protein Substrates of Protein (D-Aspartyl/ L-Isoaspartyl) Carboxyl
Methyltransferase
Darin J. Weber and Philip N. McFadden
Published in The Protein Protocols Handbook (1996)
J. M. Walker. Totawa, New Jersey,
Humana Press, pp. 507-515.139
A1.1 Introduction
The several classes of S-adenosyl-L-methionine-dependentprotein
methyltransferases are distinguishable by the type of aminoacid that they
modify in a substrate protein. The protein carboxylmethyltransferases
constitute the subclass of enzymes which incorporatea methyl group into a
methyl ester linkage with the carboxylgroups of proteins. Of these, protein
(D-aspartyl/L-isoaspartyl) carboxyl methyltransferase, EC2.1.1.77 (PIMT)
specifically methyl esterifies aspartyl residues thatthrough age-dependent
alterations are in either the D-aspartylor the L-isoaspartyl configuration (Aswad
and Deight 1983; Lou and Clarke 1987). Thereare two major reasons for
wishing to know the identity of protein substrates forPIMT. First, the proteins
which are methylated by PIMT in the living cell,most of which have not yet been
identified, are facets in the age-dependentmetabolism of cells. Second, the
fact that PIMT can methylatemany proteins in vitro, including products of
overexpression systems, can be takenas evidence of spontaneous damage that
has in these proteins occurred since the time oftheir translation.
The biggest hurdle in identification of substratesfor PIMT arises from the
extreme base-lability of the incorporated methylesters, which typically hydrolyze
in a few hours or less at neutral p1-1. Thus,many standard biochemical140
Figure A.1.1 Schematic of acidic discontinuous gel system. The system
employs a pH 1.4 stacking gel on top of a pH 2.4 resolving gel with chlorideas
the leading ion and acetate as teh trailing ion to stack the proteinstightly. The
presence of the anionic detergent SDS allows separation of proteins on the
basis of molecular weight. The low pH preserves labile protein methylesters,
and so allows the identification of age-altered substrates of PIMTG
O
Figure A1.1
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techniques for separating and characterizing proteins are not usefully applied
to the identification of these methylated proteins. In particular, the
electrophoresis of proteins by the most commonly employed techniques of SDS
polyacrylamide gel electrophoresis result in a complete loss of methyl esters
incorporated by PIMT, due to the alkaline pH of the buffers employed.
Consequently, a series of systems employing polyacrylamide gel electrophoresis
at acidic pH have been utilized in efforts to identify the substrates of PIMT. A pH
2.4 sodium dodecyl sulfate (SDS) system (Fairbanks and Avruch 1973) usinga
continuous sodium phosphate buffering system has received the most attention
(Bower and Bates 1955; Aswad and Deight 1983; McFadden et al. 1983; Barber
and Clarke 1984; O'Conner and Clarke 1984; Johnson and Aswad 1985;
O'Conner and Clarke 1985; Lou and Clarke 1987; Neuhoff et al. 1988; Gingras
et al. 1991; Sellinger and Wolfson 1991; Johnson et al. 1993). The main
drawback of this system is that it produces broad electrophoretic bands.Acidic
discontinuous gel systems using cationic detergents (MacFarlane 1984), have
proven useful in certain situations (Freitag and Clarke 1981; O'Conner and
Clarke 1983; O'Conner et al. 1984; O'Conner and Clarke 1984; Ohta et al. 1987;
Gingras et al. 1994; Aswad and Guzzetta 1995) and can be recommended if the
cationic detergent is compatible with other procedures that might be utilized by
the investigator (e.g., immunoblotting, protein sequencing).Recently, we have
developed an electrophoresis system which employs SDS andan acidic
discontinuous buffering system (Figure A1.1).This procedure results in sharp143
electrophoretic bands and would be a good choice for investigators wishing to
adhere to SDS as the anionic detergent. This system is described below and
examples of its ability to resolve proteins are provided.
A1.2 Materials
A1.2.1 Equipment
1. Slab gel Electrophoresis Unit. We have used the mini-gel electrophoresis
units from Idea Scientific (10 cm x 10 cm x 0.1cm) with great success,as well as
the Sturdier large format gel system from Hoeffer Scientific Instruments (16cm x
18 cm x 0.15 cm).
2. Electrophoresis power supply, constant current.
3. X-ray film and photo dark room.
4. Scintillation counter.
A1.2.2 Reagents
1. 40% (w/v) acrylamide stock solution containing 37:1 ratio of acrylamide to
N,N'-methylene-bis-acrylamide (Biorad).
2. Resolving gel buffer: 0.1 M Na H2PO4 (Sigma), 2.0 % SDS (United States
Biochemical (USB), ultrapure), 6 M urea (USB, ultrapure) pH 2.4 with HCI.
3. Modified Clark and Lubs Buffer(C & L buffer): 25.0 ml of 0.2 M NaCI to 26 ml
of 0.2M HCI bring to a final volume of 0.1 L. The buffer pH should be -1.4(see
Note 1).144
4.Stacking gel buffer (2X): 2.0 % (w/v) SDS, 6.0 M urea and C & L buffer such
that the C & L buffer makes up 66% (v/v) of the total volume with the remaining
34% consisting of water and other buffer components. Buffer will be 0.033 M in
NaCI. Re-adjust pH to 1.4 with HCI.
5. Sample solubilization buffer (2X): 2.0 % (w/v) SDS, 6.0 M urea, 10% glycerol
((USB), ultrapure), 0.01 % pyronin Y dye (Sigma) and C & L 33 % (v/v) of the
total volume with the remaining 67% consisting of water and other buffer
components. Buffer will be 0.0165 M in NaCI. Re-adjust pH to 1.4 with HCI.
6. Electrode Buffer (1X): 0.03 M Na H2PO4, 0.1 % SDS, 0.2M acetate, pH 2.4
with HCI.
7. Gel Polymerization catalysts: 0.06 % FeSO4, 1.0 % H202, 1.0% ascorbic acid,
prepared fresh in separate containers.
8. Colloidal Coomassie G-250 protein stain stock solution: 125 g ammonium
sulfate, 25 mls 86% phosphoric acid, 1.25 g Coomassie brilliant blue G-250
(Sigma), de-ionized water to 1.0 L. The dye will precipitate, so shake well
immediately before use. Stable indefinitely at room temperature (Neuhoff,
Stamm et al. 1988).
9. De-stain solution: 10% (v/v) Acetic acid.
10.Flourography solution: 1.0 M sodium salicylate brought to pH 6.0with acetic
acid (Chamberlain 1979).
11.X-ray film. Kodak X-Omat AR or equivalent.145
A1.2.3 Gel Recipes
A1.2.3.1 12 % Acrylamide Resolving Gel pH 2.4
The following volumes are sufficient to prepare one 7.5cm x 10.5 cm x
0.15 cm slab gel:
2X Resolving Gel Buffer3.75 ml
40 % acrylamide (37:1)2.25 ml
0.06 % FeSO4 0.06 ml
1.0 % ascorbic acid 0.06 ml
0.3 % H202 0.06 ml.
A1.2.3.2 4.0 % Stacking Gel pH 1.4
The following volumes are sufficient to prepare one 3.0cm x 10.5 cm x
0.15 cm stacking gel:
2X stacking gel buffer 3.75 ml
40 % acrylamide (37:1) 0.75 ml
0.06 % FeSO4 0.06 ml
1.0 % Ascorbic acid 0.06 ml
0.3% H202 0.06 ml146
A1.3. Methods
A1.3.1 Sample solubilization
1. An equal volume of 2X solubilizationbuffer is added and the samplesare
heated in a 95°C heating block forno more than 30 seconds (see Note 2).
2. To separate samples under reducingconditions, it is critical to add the
reducing agent just prior to the addition of thesolubilization buffer. Up to 10gg
per gel protein band can be resolved with thissystem; total sample loaded ina
single well should not exceed about 10014.
A1.3.2 Gel Preparation
A1.3.2.1 Resolving gel
1. Add all the components listed under2.3.1, except the 0.3 % H202, togetherin
a small erlenmeyer side-arm flask.
2. De-gas the solution for at least 5.0minutes using in-housevacuum.
3. Assemble together gel plates andspacers that have been scrupulously
cleaned and dried.
4. Using a pen, make a mark 3.0cm from the top of the gel plates to denote the
space left for the stacking gel.
5. To the de-gassed gel solution, addthe H202 catalyst. Gently mix solutionby
pipeting the solution in and out severaltimes. Avoid introducing air bubblesinto
the solution.
6. Quickly pipet the acrylamidesolution between the glass gel platesto the mark
denoting 3.0 cm from the top of the gelplates.147
7. Carefully overlay the acrylamide solution with about a 2.0 mm layer of water
saturated butanol using a pasteur pipet, so that the interface will be flat upon
polymerization.
8. Allow the gel to polymerize at room temperature until a distinct gel-butanol
interface is visible.
9. After polymerization is complete, pour off the overlay and gently rinse the top
of the gel with de-ionized water. Invert the gel on paper towels to blotaway any
remaining water between the gel plates.
A1.3.2.2 Stacking gel:
1. Add all the components listed under 2.3.2, except the 0.3 % H202, together in
a small erlenmeyer side-arm flask.
2. De-gas the solution for at least 5.0 minutes using in-house vacuum.
3. Soak the well forming combs in the the H202 catalyst solution while preparing
the stacking gel.
4. To the de-gassed gel solution, add the H202 catalyst. Gently mix solution by
pipeting the solution in and out several times. Avoid introducing air bubbles into
the solution.
5. Quickly pipet the acrylamide solution between the glass gel plates to thevery
top of the gel plates.
6. Remove the combs from the H202 catalyst solution, shake offsome of the
excess solution and insert the comb in between the gel plates by angling the148
comb with one hand and guiding the comb between the plates with the other
hand.
7. Ensure the comb is level relative to the top of the resolving gel and that no
bubbles are trapped under the comb.
8. After the stacking gel has completely polymerized, carefully remove the comb.
Remove any unpolymerized acrylamide from each well by rinsing with de-ionized
water (see Note 3).
A1.3.3 Electrophoresis
1. Assemble the gel in the electrophoresis unit.
2. Add sufficient electrode buffer to cover the electrodes in both the upper and
lower reservoirs.
3. Remove any air bubbles trapped under the bottom edge of the plates witha
bent 25 gauge needle and syringe containing electrode buffer.
4. Rinse each well with electrode buffer immediately before adding samples.
5. Load all wells with 40u1-60u1 of protein samples; load 1X solubilization buffer
into any empty wells.
6. Run the gels at 15 mA, constant current, at room temperature for 4-6 hours, or
until proteins of interest have been adequately resolved (see Note 4).
7. Fix the gel in 12 % (v/v) TCA with gentle shaking for 30 minutes.
8. Pour off fixative and mix 1 part methanol with 4 parts with colloidal Coomassie
G-250 stock solution. Slowly shake gel with staining solution 12 hours (see
Note 5).149
9. Pour off staining solution. Any non-specific background staining of the gel
can be removed by soaking the gel in 10% (v/v) acetic acid. Little destaining of
protein bands occurs even after prolonged times in 10% acetic acid.
A1.3.4 Detection of Radioactively Methylated Proteins
Several protocols exist for radioactively methylating proteins with PIMT
(Lou and Clarke 1987; Aswad and Guzzetta 1995). Following electrophoresis,
gel bands containing radioactively labeled proteins can be detected by
fluorography or scintillation counting of gel slices.
A1.3.4.1 Fluorography of gels
1. If gels have been stained they are destained under using 10% methanol/7%
acetic acid to de-colorize the gel bands.
2. Expose the gel to flourography solution for 30 minutes atroom temperature
with gentle shaking.
3. The gels are then placed on a piece of filter paper and dried undervacuum
without heat for 3 hours.
4.In a dark room, x-ray film (Kodak X-Omat AR) is pre-flashed twice ata
distance of 15 cm with a camera flash unit fitted with white filterpaper (3M) to
act as a diffuser.
5. The gel is placed in direct contact with the film and taped into place. For
future alignment, puncture holes in an asymmetric pattern ina non-crucial area
of the gel-film sandwich. A 25 gauge needle is useful for thispurpose.150
6. After sealing in a film cassette, the cassette is wrapped with aluminum foil and
exposure takes place at -70° C for several weeks.
7. After exposure, remove the cassette from -70° C and allow to warm toroom
temperature. Develop film in dark room. An example of this technique is shown
in Figure A1.2.151
Figure A1.2. Comparison of discontinuous acid gel with continuous acidgel.
The following experiment tested for the presence of age-altered proteinsin a
commercial preparation of collagenase. The collagenase preparation (Sigma,
type IV) was methylated with purified rabbit erythrocyte PIMT and 3H-AdoMet.
Aliquots from the same methylation reaction were then resolvedon (top) 12%
discontinuous acid gel, described in text, or (bottom) 12% continuous acid gel
system according to the method of Fairbanks and Auruch. Lane: Rainbow
molecular weight markers (Amersham); Lane 2: 18 lig of methylated collagenase
were loaded on each gel. Following electrophoresis and staining, 0.5 cm gels
slices were treated with base to detect radioactivity as described under section
A.3. Both gel systems are capable of preventing the loss of methylesters from
protein samples, but the discontinuous system provides much higherresolution
of individual polypeptide bands.Methyl Esters (pmoles)
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A1.3.4.2 Scintillation counting radioactive methanol evolved by base
hydrolysis of protein methyl esters in gel slices
1. Stained gels are soaked in 10% acetic acid containing 3% (v/v) glycerol for
1.0 hour, placed upon a piece of filter paper and dried under vacuum without
heat for 3.0 hours. The glycerol keeps the gel from cracking and pliable for the
steps described below.
2. Using a ruler and fine tip marking pen, a grid is drawn directly upon the
surface of the dried gel.
3. A sharp scalpel is then used to precisely cut out uniform slices from each gel
lane. Alternatively, selected bands can be individually excised from the gel.
4. 4.0 ml of scintillation fluid is added to each 20 ml scintillation vial. A glass 1
dram vial is then placed inside the scintillation vial, carefully avoiding spilling
scintillation fluid into the 1 dram vial.
5. Each dried gel slice is then placed in the inner dram vial of a scintillation vial.
6. After all the gel slices have been placed in a separate inner 1 dram vial, 0.3
ml of 0.2 M sodium hydroxide is added to each inner vial. The scintillation vial is
then immediately tightly capped and allowed to sit undisturbed for at least 3
hours. Several hours are required for any volatile methanol that has formed by
methyl ester hydrolysis to equilibrate and partion into the organic scintillation
fluid where can then be detected by the scintillation counter.
8. Controls for measuring the efficiency of equilibration are performed by usinga
14C methanol standard which is added to an inner 1 dram vial containinga154
non-radioactive gel slice and base hydrolysis solution. This is then placed
inside a scintillation vial and allowed to equilibrate along with the other samples.
9. Figures A1.3 and A1.4 show examples gels that have been sliced and
counted in a scintillation counter under the conditions just described.
A1.4. Notes
1. The buffering system employed in the stacking gel and sample solubilization
buffer is based on a modification of the Clark and Lubs buffering system. NaCI is
employed rather than KCI of the original system, because K+ ionscause SDS to
precipitate out of solution.
2 .On occasion, the solubilization buffer will contain precipitates, thesecan be
brought back in to solution by briefly heating the buffer at 37°C.The
solubilization buffer is stable for at least two weeks at room temperature; by
storing the buffer in small aliqouts at -20° C, it is stable indefinately.
3. Gels can be stored for up to two weeks at 4°C by wrapping them in damp
paper towels and sealing tightly with plastic wrap.
4. Since dye front is a poor indicator of protein migration,use of pre-stained
molecular weight markers, such as the colored Rainbow markers from
Amersham allow the progress of protein separation to be monitored by simply
identifying the colored bands which are coded according to molecular weight.
5.It is essential that all fixing and staining steps occur at acidic pH. The
colloidal Coomassie G-250 procedure described under Methods has several
advantages: it is acidic, simple to perform and has higher sensitivity than other155
dye based staining methods including those using Coomassie R-250.
Additionally, non-specific background staining is very low so only minimal
de-staining is necessary to visualize protein bands.
6. Avoid using higher glycerol concentrations or prolonged incubation of the gel
in this solution. Otherwise the gel will be sticky after drying and contracts
sharply away from the paper backing upon cutting.156
Figure A1.3. Coomassie staining and autoradiography of complexprotein
mixtures by acidic discontinuous SDS gel electrophoresis. The following
experiment was performed to measure the varieties of age-alteredproteins in
cell cytoplasm. (A) Coomasie G-250 stained acidic discontinuousgel. (B)
Autoradiogram of same gel. Lane 1: Cytoplasmic proteins, followingincubation
of PC12 cells with 3H-S-adenosyl-L-methionine (Ado Met). Lane2: Cytoplasmic
proteins following incubation of PC12 cytoplasm with 3H-AdoMet.Lane 3:
Cytoplasmic proteins, following incubation of intact PC12 cells with3H-AdoMet
and purified rabbit PIMT. Lane 4: Cytoplasmic proteins followingincubation of
lysed PC12 cells with 3H-AdoMet and rabbit PIMT. Lane 5:Positive control; 20
mg of 3H-AdoMet and rabbit PIMT. Cells, lysates and subfractionswere
incubated with 1 unit of enzyme, 300 pmoles Ado Met ina final volume of 501.11of
0.2 M citrate, pH 6.0 for twenty minutes at 37°C.1 2 345 K D a 1 2 345
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Figure A1.4. Coomassie staining and radioactive methyl ester determinationin
gel slices of electrophoresed proteins from diseased human braintissue.
Extracts prepared from homogenates of Alzheimer's dieseased brain(obtained
from Department of Pathology, Oregen Health Sciences University)were
methylated in vitro with purified rabbit PIMT and 3H-AdoMet. Methylated
proteins were separated on 12% discontinuous, acid pH gels. Radioactivityin
each gel slice was quantified with scintillation countingas desrcibed under
section A.3. Top: Distribution of methyl accepting proteins in tissue thatwas
insoluble in the non-ionic detergent, Triton X-100. Middle: Distributionof methyl
acceptor proteins in tissue that was soluble in aqueous homogenizationbuffer.
Bottom: Distribution of methyl acceptor proteins in crude homogenatesof AD
brain. Incubation conditions are similar to those described for figureA.3.Figure A1.4
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A2.1 Introduction
The purpose of this chapter is to describe the types of protein methylation
that might be confronted in investigations of the nervous system, and to
summarize technical approaches which have proven to be useful in elucidating
the chemistries and identities of methylated proteins. Several distinct protein
methyltransferase activities have been described in nervous tissues, and there
are undoubtedly more to be discovered. It has often been the case that
identification of a methylation pathway in the nervous system has led to the
discovery of a similar system in some other tissue. An excellent recent example
is the characterization in the brain of isoprenylated protein methyltransferases
(Ben et al. 1993; Paz et al. 1993; Klein et al. 1994) which haveproven to have
important activities in many other cells (Clarke 1992b).
Nervous system protein methyltransferases discovered thus farcan be
categorized on the basis of their amino acid group specificities (e.g. lysinevs.
arginine vs. aspartic acid). However, issues of whether sequence specificities
play a role in methylation patterns are much less clear. Thereare many other
outstanding questions as well: How many proteins does a givenenzyme
methylate? How abundant and how subtly different are the isozymes ofa given
category of protein methyltransferase? What biological factors regulate the
expression and activities of these protein methyltransferases? And most hotly
debated: What are the functions of protein methyltransferases? Though all of
these questions remain unanswered, both general and specific observationscan164
be made regarding changes in the proteins that become methylated. Ingeneral,
both N-methylation and carboxyl methylation will cause small shifts ina
protein's pKa as a result of changes in charge distribution within theprotein due
to the methyl group. The consequences of such shifts in pKaare presently
unknown.Specifically, in several proteins, including histones, ribosomal
proteins, myelin and calmodulin, N-methylation has found to modulateactivity
(Rattan et al. 1992) and in some cases, protease resistance (Lischwe 1990).
Carboxyl methylation in prenylated, C-terminal cysteinyl residueson several
GTP binding proteins (Ong et al. 1989; Ota and Clarke 1989; Funget al. 1990;
Lerner et al. 1992; Clarke 1992b; Giner and Rando 1994; Ghomashchiet al.
1995; Volker et al. 1995) has been postulated to havea role in signal
transduction. Clearly, both N-linked and carboxyl methylation of proteins play
important roles in the nervous system, however the precise function ofthese
post-translational modifications remain to be elucidated.
There is a solid foundation of research methods from which to study
nervous system protein methylation. Most fundamental are the methods used to
describe protein methyltransferase reactionson the basis of it's amino acid
group specificity.So far, every nervous system protein methyltransferase has
been found to be either a carboxyl 0-methyltransferaseor an
N-methyltransferase. The carboxyl 0-methyltransferases includeenzymes that
methyl esterify the carboxyl groups of proteins, including the side chainsof
age-altered aspartyl residues, the C-terminal carboxylgroups of certain proteins,165
and the side-chain of glutamic acid (exclusively in bacteria). The
N-methyltransferases include enzymes that methylate nitrogenatoms of lysine,
arginine, histidine, and the amino terminus.
The differing chemical stabilities of carboxyl 0-methylatedsites and
N-methylated sites can be used as a diagnostic early in thecharacterization of a
protein methylation reaction. Which category of reaction isidentified will then
dictate the repertoire of approaches that can most effectively beused in the
further characterization of the methylation reaction.
A recurring theme of research with protein methyltransferasesis that
structure leads to function-- the identification and characterization of methylated
proteins has often led to the discovery of novel forms of cellularfunction and
regulation. A recent example is the series of investigationsthat yielded the
identity of the major methylated protein in brain extractsas protein phosphatase
2A (Lee and Stock 1993; Xie and Clarke 1993; Favreet al. 1994; Xie and Clarke
1994a; Xie and Clarke 1994b). The finding that the C-terminalleucine of this
protein undergoes carboxyl 0-methylation is interesting frommany perspectives,
notably as an interface between methylation andphosphorylation-control of the
nervous system. Perhaps future elucidations of methylated proteins will leadto
other such unexpected discoveries.
Several excellent reviews of the field of protein methylationhave been
published. A particularly helpful reference for thoseembarking on the study of a
protein methylation reaction is a bookon the subject edited by Paik and Kim166
(Paik and Kim 1990). Other very useful reviews on protein methylation and the
substrates for protein methyltransferases can be found in the following
references (Clarke 1992b; Clarke 1993; Aswad 1995).
A2.2 Methodological differences in studies of protein N-methylation and
carboxyl-O-methylation.
The single greatest factor in determining the choice of methods for
characterizing a protein methylation reaction is the distinction between
nonhydrolyzable N-linkages and hydrolyzable carboxyl 0-linkages. Thereare
three likely approaches: a) If a protein is N-methylated,many of the standard
techniques of biochemistry (e.g. SDS PAGE, electrophoretic immunoblotting,
and Edman degradation) can generally be employedas tools in establishing the
identity of the protein. b) If the protein is carboxyl 0-methylatedon its C-terminal
carboxyl group, these same standard techniques can probably also be used,
with a few precautions taken to avoid the hydrolysis of the relatively stable
methyl ester linkage. c) If the protein is carboxyl 0-methylatedon an altered
aspartyl residue, a less commonly used subset of acidic techniques will be
required since the methyl ester linkage will spontaneously hydrolyze underthe
conditions used for most standard biochemical techniques.
Some of the most commonly found types of methylated proteinsare those
that fall into category "c" because even thoughmany species of proteins are
likely to be N-methylated (Najbauer et al. 1992) or carboxyl 0-methylatedat their
C-termini (Clarke 1992b), essentially all cellular proteins have thepotential for167
being methylated on the carboxyl groups of age-altered aspartic acids (O'Conner
and Clarke 1984).
The methyltransferase that catalyzes the methylation of altered aspartyl
residues is protein (D-aspartyl/L-isoaspartyl) methyltransferase (E.C. 2.1.1.77).
This enzyme is also known as protein isoaspartyl methyltransferase (PIMT) in
recognition of the fact that the first synthetic substrate for thisenzyme contained
an L-isoaspartyl residue (Aswad and Guzzetta 1995). This enzyme is
ubiquitous, and notorious for its ability to transfer a methyl group to the
substoichiometric age-altered fraction of nearly any protein population. The
highly labile methyl esterification catalyzed by PIMT has been shown to be
capable of converting altered aspartyl residues in proteins back to their normal
L configuration (Johnson et al. 1987). In vitro studies with calmodulin have
shown that formation of isoaspartyl residues in calcium binding sites prevents
binding and that this binding activity can be restored following methylation with
PIMT and subsequent de-methylation (Johnson et al. 1987).The finding that
PIMT activity is highest in the brain, a tissue composed mostly of post-mitotic
cells, is intriguing (Aswad 1995) and suggests PIMTmay play a role in
maintaining the functional state of proteins.Reports of the presence of
significant levels of isoaspartyl residues inp-amyloid plaques in the brains of
Alzheimer's Disease victims lend support to this hypothesis (Payan et al. 1992;
Roher et al. 1993; Tomiyama et al. 1994; Iversen et al. 1995). PIMT activityis168
therefore responsible for an incredibly complex pattern of methyl group
incorporation into protein mixtures such as those found in neuronal cells.
A2.2.1 Hydrolytic lability of methyl croups incorporated by protein
carboxyl-0-methvItransferases
Four amino acid sites have been shown to be carboxyl 0-methylated by
nervous system protein carboxyl 0-methyltransferases: the alpha carboxyl
group of L-isoaspartic acid; the beta carboxyl-group of D-aspartic acid; the
C-terminal carboxyl group in isoprenylated L-cysteines; and the C-terminal
carboxyl group in L- leucine. The generic distinguishing feature of protein
carboxyl 0-methylation as opposed to protein N-methylation is the lability of the
methyl ester linkage to hydrolyzing chemical conditions. All of the known
carboxyl 0-methylation linkages are severed by strong acid (e.g. 6M NCI, 100C,
6 hours) and strong base (e.g. 1M NaOH, 37C, 6 h) (Terwilliger and Clarke
1981; Paik and Kim 1990). Furthermore, the methyl ester linkages to L-isoAsp
and D-Asp are hydrolyzed by mild alkaline conditions as a result ofa hydrolysis
mechanism that involves intramolecular displacement of the methyl ester by the
amide nitrogen of the neighboring amino acid (Murray and Clarke 1984;
Johnson and Aswad 1985). The product of methyl ester hydrolysis is methanol.
Therefore, if proteins containing radiochemical methyl groups (see below) yield
radiolabeled methanol upon hydrolytic treatment, this is a strong positive
indication of the involvement of a protein carboxyl 0-methylation reaction. By
varying the pH of the hydrolysis reaction it is possible to ascertain whetheror not169
the ester is of the extremely base-labile variety involving L-isoAsp and D-Asp
carboxyl 0-methylation (Clarke et al. 1988).
The simplest method for determining if the product is radioactive
methanol is a vapor-phase assay in which volatile productsare captured directly
into scintillation cocktail for radiometric measurements (Murrayand Clarke 1984;
Chelsky et al. 1989; Aswad and Guzzetta 1995). (Undersome conditions of
hydrolysis, the breakdown of methylargininecan also yield a potentially volatile
product, methylamine; but methylamine can be kept nonvolatile byperforming
the vapor-phase assay at low pH.)
Because methyl esterified amino acids are unstable to hydrolytic chemical
conditions, it is not possible to recover and analyze the free carboxyl
0-methylated amino acids by routine acid hydrolysis procedures used inamino
acid analysis. Other methods are thereforenecessary to positively identify the
amino acid group which is methyl esterified. The most commonly employed
method is to degrade the polypeptide as much as is practical withproteases,
followed by an analysis of the proteolytic digestion products for free aminoacids
with the methyl group still present (McFadden and Clarke 1982; Xie andClarke
1993).In the case of prenylated cysteine residues, the C-terminal methylated
product in rod outer segment membrane proteins was detected following
proteolytic digestion together with performic acid oxidation toremove the prenyl
moiety (Ong, Ota et al. 1989; Ota and Clarke 1989); and similar proceduresled170
to the positive identification of C-terminally methylated cysteines in brain G
protein gamma subunits (Fung, Yamane et al. 1990).
A2.2.2 Hvdrolvticallv stable protein methvlation
Conversely to what is found for carboxyl 0-methylation, hydrolytic stability
of a methyl group in a protein is strong evidence for N-methylation. Extensive
reviews are available which cite the many known examples of proteins thatare
N-methylated (Park and Paik 1990; Clarke 1992a). While many of these
studies have utilized tissues and cells outside of the nervous system, it is clear
that numerous proteins which have been characterized as being N-methylated
are present in many tissues and are therefore likely candidates for methylated
proteins in the nervous system. A means of increasing the sensitivity of
detection of N-methylated protein substrates in PC12 pheochromocytoma cells
involves pretreating the cells for a lengthy period with a pharmacological
inhibitor of methylation, and then incubating the now hypomethylated cell
extracts with radiolabeled S-adenosylmethionine (Najbauer et al. 1991;
Najbauer, Johnson et al. 1992).
The amino acids that are N-methylated include lysine, arginine, and
histidine. Each of these modified amino acids can be recovered after acid
hydrolysis of the protein (Park and Paik 1990). For lysine, the single nitrogen
atom of the side chain can be mono-, di- or tri-methylated. Calmodulin (Siegel et
al. 1990), actin, myosin, and histones are well-known proteins thatare
methylated on lysines and, of course, these proteins are abundant in the171
nervous system. For arginine modification, examples are known of methyl group
incorporation into a single nitrogen atom in the guanidinium group of the side
chain (monomethylarginine); methyl groups incorporated into both nitrogen
atoms of the side chain (NG,N'G-dimethylarginine); and two methyl groups
incorporated into one of the nitrogen atoms of the side-chain
(NG,NG-dimethylarginine). Arginine methylation has been observed inhistones,
myelin basic protein and other proteins (Ghosh et al. 1990). Histidine
modification occurs on actin, myosin, and histones among other proteins (Park
and Paik 1990).
A2.3 Radiochemical methyl groups, and their incorporation into proteins
of the nervous system
The commercial availability of radiochemically labeled methylgroups as
s-adenosyl-L-[methy1-3H1-methionine and s-adenosyl-LAmethy1-14C1-methionine,
as well as, L-[methyl-3F1]- and Lqmethyl-14C1-methionine is fundamentally
responsible for the spate of discovery of methylated proteins that still continues.
It is important to consider the chemical and radiochemical characteristics of
these commercially available reagents.It is also important to optimize the
assays and incubation conditions through which proteins are radioactively
methylated.
A2.3.1 Radiochemical characteristics of methylgroup donor compounds
As is true of any comparison of molecules which are singly labeled by
either tritium or carbon-14, the specific radioactivity of tritiumcan theoretically be
almost 500 times as high as the specific radioactivity of carbon-14 (e.g. 29 Ci172
mmo1-1 for carrier-free tritium versus 62 mCi mmo1-1 forcarrier-free carbon-14).
Even higher specific activities of s-adenosyl-L-[methyl-3F11-methionineare
available since up to 3 tritium atoms can be present per methylgroup. Thus, for
a given number of radiolabeled molecules it is technically possible to achieve
the highest number of incorporated dpm by using tritium labeling.This is not
always the overriding concern, however. Dependingon the specific application
it may be more important to take advantage of the relativelygreater decay
energies of beta particles emitted by carbon-14. For example, thegreater decay
energy of carbon-14 can be helpful if the radiolabeled protein is to be detected
as an electrophoretic band by autofluorography (Skinner and Griswold 1983).
Another practical consideration that may weigh in favor of theuse of
carbon-14 as the radiolabel is the typically greater degree ofradiation
decomposition of tritiated compounds. Manufacturers of radiolabeled
S-adenosylmethionine and methionine have endeavored to packagetheir
materials with stabilizers against radiation decomposition. However,the rate of
radiation decomposition of tritiated S-adenosylmethionine istypically about 1%
per month as compared to 1% per year for S-adenosylmethione labeled by
carbon-14.
Suppliers of [14C-methyl]- and [3H-methyl] -S-adenosylmethionineinclude
American Radio labeled Chemicals, Inc., Amersham, Inc., ICN,and New England
Nuclear. [3H-methyl]S-adenosylmethionine is sold by Sigma.Both
L-[methyl-3H]-methionine and L4rnethyl-14Cj-methionineare sold by each of these173
manufacturers. The availability of S-adenosylmethionine and methionine which
is radiolabeled in a position other than the methyl group can be useful in certain
control experiments. For example, a radiolabel transfer reaction that is
catalyzed by hemoglobin is evidently a methyl transfer reaction since
radiolabeled methyl groups are incorporated from S-adenosylmethionine, but not
the radiolabeled carboxyl moiety (Kimzey and McFadden 1994).
A2.3.2 Radiolabelina procedures in the methvlation of proteins
The starting point for essentially all studies of protein methylation is to
perform the radioactive labeling of proteins. Broadly speaking thereare two
ways in which this can be done: in vivo cell metabolism and in vitro
reconstitution assays.
A2.3.2.1 Protein methylation procedures in intact cells
The in vivo approach allows the machinery of living cells to accomplish
this radiolabeling in the course of cellular methylation metabolism. The
radioactive precursor can be methionine (either L-[methyl-31-1]-methionineor
[L.- [methyl -74C]- methionine), since cells are thought to not takeup
S-adenosylmethionine, but are generally capable of takingup methionine and
converting a portion of this methionine into S-adenosylmethionine. A popular
approach is to use cultured neuronal cells in such radiolabeling, includingclonal
lines such as PC12 cells (Najbauer, Johnson et al. 1991; Johnsonet al. 1993)
and murine neuroblastoma cells (O'Dea et al. 1987). Brain tissue sliceshave174
also been used in the study of protein methylation in intact nervous system cells
(Wolf and Roth 1985). The medium in which the cells are incubated should be
adjusted in its nonradioactive methionine content so that the specific
radioactivity of the radiolabel is high enough to result in the incorporation of
detectable levels of methyl group radioactivity in the proteins of interest. For
relatively short-term labeling experiments of less than a few hours,
methionine-free culture media can be used with additions of high specific
radioactivity methionine (including carrier-free radiolabel). For longer term
incubations the cells may require higher chemical concentrations of methionine
for growth, and so the addition of unlabeled methionine will dilute the specific
radioactivity and decrease the sensitivity with which radioactively methylated
proteins can be detected.
Of course, the direct incorporation of radiolabeled methionine into protein
will also occur in most cells through protein translation. In the case of protein
carboxyl 0-methylation, the incorporation of radioactive methyl esters can be
detected above the much larger background of protein backbone radiolabeling
by isolating the proteins, exposing them to an alkali treatment, and measuring
volatile radioactive methanol (Kloog et al. 1983; Chelsky, Sobotka et al. 1989).
Another way to work around the high background due to backbone radiolabeling
is to make use of a protein synthesis inhibitor to block protein translation, with
the assumption being made that at least some aspects of protein methylation will
continue. A good example of the latter approach is the use of cycloheximide to175
block protein translation in He La cells during their incubation with
[3H-methy/methionine (Ladino and O'Connor 1992). A further interesting
possibility is that some cells can in fact directly take up radiolabeled
S-adenosylmethionine and use it in the methylation of their proteins (Barten and
O'Dea 1989).
A2.3.2.2 In vitro protein methylation procedures
Since nearly every type of living cell contains many types of
methyltransferases and their substrates, there is a near certainty that when cell
extracts and subcellular fractions are incubated with radiolabeled
S-adenosylmethionine there will be a resulting incorporation of methyl groups
into proteins. Techniques of gel electrophoresis (see below) are often used in
conjunction with such radiolabeling in order to resolve the various methylated
species of proteins. Many discoveries of protein methyltransferases and their
substrates have been made with this basic approach. For example, guanine
nucleotide-dependent carboxyl methylation of proteins was investigated by
incubating cell membranes with S- adenosyl- [3H- methyl]- methionine and then
measuring how the incorporation of radiolabel into particular electrophoretically
separated proteins was affected by including GTP analogs in the incubation
mixtures (Backlund and Aksamit 1988). As another example, the identification of
protein phosphatase 2A as a C-terminally methylated substrate (Lee and Stock
1993; Xie and Clarke 1993; Favre, Zolnierowicz et al. 1994; Xie and Clarke
1994a; Xie and Clarke 1994b) ultimately stemmed from long-standing176
observations of highly methylated proteins formed during incubations of
cytoplasm with radiolabeled S-adenosylmethionine (O'Conner andClarke 1984).
A variation of the in vitro approach is to use cell extractsas the source of
the enzymatic activity, and to include either recombinantlyexpressed proteins or
synthetic polypeptide substrates as the methyl acceptor substrate.For example,
the methylation of recombinant protein Al by calf brainmethyltransferase led to
the identification of a specific arginine residue that is methylatedin this protein
component of the heterogeneous nuclear ribonucleoprotein complex(Rajpurohit
et al. 1994). As another example, pathways in the maturation ofC-terminally
modified proteins can be studied by in vitro methylation ofsynthetic polypeptides
that resemble protein carboxyl termini (Stephenson and Clarke1990;
Stephenson and Clarke 1992). High pressure liquid chromatography(see below)
has often been used to confirm that polypeptide species beingmethylated by a
cellular extract are indeed the synthetic polypeptide substrates(Murray and
Clarke 1986).
To demonstrate that polypeptide radiolabeling in vitro is dueto
methyltransferase activity and not some other spuriousprocess, a valuable
control experiment is to test whether the radiolabel incorporationis blocked by
micromolar concentrations of the end-product inhibitor ofmost
methyltransferases, S-adenosylhomocysteine.
Recent work has shown that RNA methylationcan potentially exhibit
some of the expected characteristics of protein methylation (including177
radiolabeled electrophoretic bands in SDS PAGE) (Hrycyna et al. 1994),and so
tests of the nuclease stability of methylated macromolecules might also bean
important control experiment to perform.
A2.3.2.3 Radio label quantitation
The quantitation of radioactivity and the conversion of dpm valuesto mole
quantities requires accurate knowledge of the specific radioactivity ofthe
radiolabel in the protein methylation reaction mixture. This is nottoo difficult in
in vitro reactions if no residual quantities of S-adenosylmethionineare
introduced from the cell extract or enzyme preparation; in thiscase the specific
radioactivity should be that of the added radiolabel.If on the other hand the
protein methylation reaction is performed by the uptake ofradiolabeled
methionine into cells, the specific radioactivity of the ensuingradioactive
S-adenosylmethionine will depend on the amount of nonradioactive
S-adenosylmethionine that is also present from cellular pools.In this case it is
necessary to independently measure the chemical concentrations of
S-adenosylmethionine and its radioactivity to arrive ata specific radioactivity
that can be used to convert dpm incorporated into proteininto mole quantities.
Fractionation procedures for purifying S-adenosylmethionineand determining its
concentration can be based on chromatography (Glazer andPeale 1978; Barber
and Clarke 1983); alternatively, the concentration ofS-adenosylmethionine can
be measured by standardized enzymaticassays such as the hydroxyindole
0-methyltransferase assay procedure (Baldessarini and Kopin1966).178
A2.4 Methylation procedures.
Of the several types of protein methylation reactions known, the study of
the methylation of altered aspartyl sites is most dependenton the use of
specialized techniques. These radiolabeled methyl ester moietiesare very labile
at neutral pH. Thus, methods of characterizing proteins with altered aspartyl
residues must employ acidic pH, which has been shown to stabilize the methyl
ester moiety.
As described under section A2.3.2, there are two generalways of
methylating altered aspartyl residues in cells and tissues. One method utilizes
the endogenous PIMT to methylate any proteins containing alteredaspartyl
residues in the intact cell, and the other employs exogenously added PIMTto
methylate altered aspartyl residues in proteins froma wide variety of sources
such as cell lysates, proteins isolated from specific subcellularcompartments, or
even highly purified proteins.
A2.4.1 In vivo methylation of altered aspartyl sites by PIMT
To identify which proteins are substrates for endogenous PIMT underin
vivo conditions, cells are incubated with radiolabeled methionine anda suitable
protein synthesis inhibitor, if necessary to prevent backbone radiolabeling
(Chelsky, Sobotka et al. 1989). PIMT subsequentlyuses the radiolabeled179
s-adenosylmethione produced in the cell to methylate proteins containing
altered aspartyl residues that are accessible to the enzyme under physiological
conditions.Following the period of radiolabeling, cell lysates prepared under
acidic conditions can be prepared and the individual proteins resolved and
analyzed by techniques described below.
A2.4.2 In vitro methylation of altered aspartvl sites
Under physiological conditions, PIMT endogenous to cells is localized
primarily in the cytoplasm. Thus, intracellular methylation studies do not provide
any information about the occurrence and distribution of many proteins
containing altered aspartic acid that are inaccessible to methylation (O'Conner
and Clarke 1983). This may include proteins enclosed in organelles, certain
cytoskeletal proteins, and integral membrane proteins with extracellular
domains. For these inaccessible proteins, an in vitro methylation assay is
required. Cell extracts and subcellular fractions can be prepared in several
ways, and then subjected to methylation with radiolabeled S-adenosylmethione
and purified PIMT (Kloog, Axelrod et al. 1983; O'Conner and Clarke 1983;
Barten and O'Dea 1989; Ladino and O'Connor 1992; Johnson et al. 1993). A
typical approach for examining the distribution of proteins containing altered
aspartic acid in cells involves subfractionating cellular proteins using differential
solubility in various aqueous buffers. Suitable subfractionation buffers should
avoid extremes of pH and ionic strength to avoid spurious alterations of aspartyl
sites. Strong denaturants such as sodium dodecyl sulfate (SDS) or urea should180
be avoided as they are incompatible with altered aspartyl detectionassays. A
generalized protocol for detecting altered aspartyl residues in proteins is
described below.
Altered Asoartvl Detection Assay
1-2 U purified PIMT
10011M radiolabeled Ado Met
10-20 pg of substrate protein
The components of this assay are incubated in a final volume of 50 µI in
0.2 M sodium citrate, pH 6.0 at 37 C for 20-30 minutes. PIMT (1 unit= 1 pmol
methyl esters/minute) can be purified as described (Gilbert et al. 1988; Aswad
and Guzzetta 1995).Acidic pH is used to stabilize any methyl esters formed
during the reaction. This assay is broadly applicable to analysis of altered
aspartyl residues in any protein-containing solution, ranging from cell lysatesto
highly purified proteins. Optimal reaction conditions can be determinedas
described in (Johnson and Aswad 1991).If a biochemical workup of native
proteins is anticipated as the next step in the analysis, 10-20 tiM of
S-adenosylhomocysteine (AdoHcy) can be added to quench the reaction.
Another common means of quenching the reaction is to inactivate the PIMT and
stabilize methyl esters is by adding a denaturing, acidic electrophoresis sample
buffer (see below).181
A2.5 Quantitation of sites methylated by PIMT
Methylated proteins obtained by either of the two methods described
under section 4.1, can be subjected to a variety of analyses, dependingon the
goal of the studies. However, special conditions must be employed in order to
minimize the loss of methyl esters, which are labile at neutral and alkaline pH.
For protein fractionation,it is imperative that cold temperatures and acidic
conditions be employed to minimize hydrolysis of methyl esters during the
isolation procedure. Additionally, depending on the preparation, isolation
buffers should possibly include a broader spectrum of protease inhibitors than
are used at neutral pH since proteases with acidic pH optimum will be favored
under acidic isolation schemes (Weber and McFadden 1995).
A2.5.1 Quantitation of total levels of altered aspartyl residues in proteins
To measure the total level of abnormal aspartyl residues present ina
specific sample, at the end of the altered aspartyl detectionassay, the reaction
is quenched by adding an equal volume of a 20% (v/v) solution of trichioroacetic
acid (TCA). The highly acidic pH inactivates the enzyme, stabilizes protein
methyl esters, and precipitates the protein substrates. The precipitated proteins
are then washed twice by resuspension in five volumes of 10% TCA and
centrifuged for five minutes at 5,000 x g to pellet the protein. This is doneto
separate any unincorporated radioactive Ado Met, which is soluble in 10% TCA,
from the methyl esterified proteins in the pellet.The level of altered aspartyl
residues in each sample is quantitated by taking advantage of the fact that the182
hydrolyzed by alkaline pH. Treatment with baseresults in the release of
radiolabeled methanol, a volatile compound.Each acid precipitated pellet is
resuspended in 200 ill of 0.2 M sodium hydroxidefor twenty minutes at room
temperature in a tightly capped polypropylene tube.During this time, all the
methyl esters will hydrolyze to form methanol.At the end of the hydrolysis
period, one tenth volume of 3M citric acid isquickly added, and the tube
re-capped. The acid stops the hydrolysis reactionand prevents the volatilization
of any incidentally formed methylamine.Aliquots of the radiolabeled methanol
containing samples are then transferred toa vial that is placed inside a
scintillation vial containing scintillation fluid (Murrayand Clarke 1984; Aswad
and Guzzetta 1995). The methanol in the innervial is given several hours to
volatilize and partition into the organicscintillation fluid. The radioactivity is
then quantitated in a scintillation counter andthe volatilization efficiency
corrected using an internal standard of radioactivemethanol.
A2.5.2Quantitation of the total level of alteredaspartvl residues in peptides
Since peptides are not quantitativelyprecipitated by TCA, an alternative
means to separate excess radioactive Ado Met from themethylated peptides has
been developed ( Figure A2.1). Peptideswhich have been radioactively
methylated by PIMT are loaded ontoagarose gels and electrophoresed in a
horizontal mini-agarose gel apparatus (BRL,Gaithersburg, Md) for 30 minutes at
100 V.183
Figure A2.1 Diagram of acidic pH 10% agarose gel system forseparating
methyl esterified proteins of peprtides from unicorporated radiolabeledAdo Met
remaining at the end of an altered aspartyl detectionassay. Aliquouts of PIMT
reaction mixtures (5 pi) are loaded into the centrally located samplewells and
electrophoresed for 30 minutes at 100 volts. The system takes advantageof the
small size of the radiolabeled Ado Met whcih willcarry two positive charges at
the acidic pH used in the system. As a small, doubly chargedmolecule, it will
rapidly migrate toward the cathode, well ahead ofany methyl esterified
polypeptides, which primarily due to size, migrate muchmore slowly. Theo low
molecular weight anodic and cathodic dyses included in the loadingbuffer
delineate the maximal distribution of any radiolabeled peptides. A histogram of
the typical localization of radiolabeled peptides between thetwo dye fronts is
shown. Radio labeled Ado Met runs at the leading edge of the cathodicdye on
the right of the diagram.Distribution
of methylated
peptides
within gel
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The gels are made by preparing 10% (w/v) ultra pure agarose (BRL) in an
Erlenmeyer flask containing a final volume of 100 mls of 50 mM NaH2PO4 pH
2.4. The flask is pre-weighed and the agarose melted by heating in a
microwave. The flask is then reweighed and enough diH2O added to attain the
original weight. While still hot, 20 mls of the viscous solution is cast into a
mini-agarose gel caster and an 8-well comb is inserted into the center of the gel.
After solidification, the comb is removed and the gel immersed in 150 mls of the
same buffer used to prepare the gel. The 2X loading buffer consists of 100 mM
NaH2PO4 pH 2.4, 5% ultra pure glycerol (USB), 0.5 mg bromophenol blue and
0.5 mg methyl green. The bromophenol blue migrates toward the anode while
the methyl green migrates toward the cathode.Excess radiolabeled Ado Met
comigrates with the cathode dye, while the radiolabeled peptides are distributed
between the two dye fronts, with the majority migrating only one to two
centimeters beyond the sample wells. Half centimeter gel slices of each lane
are made and the radioactivity is quantified by volatilization assay as described
above for TCA precipitated proteins. The total number of methyl esters present
in each lane is determined from summing over all the gel slices. This method
works equally well in separating radiolabeled s-adenosylmethione from high
molecular weight proteins, with the proteins tending to migrate only short
distances.
A2.5.3 Identification of proteins containing altered aspartvl residues186
The initial stages in the characterization of the distribution of altered
aspartyl containing substrates in cells and tissues are well suited to
polyacrylamide gel electrophoresis. This method allows complex mixtures of
proteins, such as those fractionated on the basis of differential solubility, to be
resolved on the basis of molecular weight; and multiple samples can be resolved
simultaneously. Unfortunately traditional methods of electrophoresis (Laemmli
1970), cannot be employed, since the system operates at an alkaline pH which
causes hydrolysis of any PIMT-methyl esterified proteins.Consequently, a
series of systems employing polyacrylamide gel electrophoresis at acidic pH
have been utilized in efforts to identify altered aspartyl containing proteins
(Fairbanks and Avruch 1973; MacFarlane 1984). The main drawbacks of these
systems are that they either produce broad electrophoretic bands or use cationic
detergents that may be incompatible with other protein analysis procedures.
Recently a new electrophoresis system has been developed which employs SDS
and an acidic discontinuous buffering system (Weber and McFadden 1996).
This procedure results in sharp electrophoretic bands and would be a good
choice for investigators wishing to adhere to SDS as the anionic detergent. An
example of the ability of this system to resolved methylated altered aspartyl
proteins is shown in figure 2.
A2.5.4 Localization of sites of altered asoartvl residues in protein sequences
To determine the total number of altered aspartyl residues in a given
protein or a preparation of proteins, it is frequently necessary to fragment native187
protein(s) into peptides using enzymatic or chemical cleavage techniques in
order to disrupt secondary or higher order structures that prevent sites from
being methylated by PIMT.Following a methylation reaction, any peptides that
are methylated can be isolated and the amino acid composition determined.188
Figure A2.2 Separation of methyl esterified, altered aspartyl containing proteins
on 12% acidic pH polyacrlyamide gels. Various subcellular fractions of PC12
cells were assayed for the presence of altered aspartyl containing proteins.
Protein fractions were obtained on the basis of solubility in various aqueous
buffers. Approximately 1 x 106 cells under went a cycle of freeze/thawing in
phosphate buffered saline (PBS), pH 7.4 containing protease inhibitors.
Following centrifugation of the lysates at 10,000 x g for 10 minutes at 4 °C, any
proteins recovered in the supernatant were designated "WS", for water soluble.
The insoluble pellet was washed twice by resuspending in 200 ill of PBS and
centrifugation as above. This pellet was resuspended in PBS containing 1%
(v/v) Triton X-100. Following a 30 minute extraction period on ice, the
supernatant was recovered by centrifugation as above and designated "DS", for
detergent soluble. The pellet that was insoluble in TX-100 was washed twice as
previously described and resuspended in 200 III of PBS by brief sonication on
ice. The fraction was designated "Dl" for detergent insoluble. Based on a dye
binding assay, equal amounts of protein in each fraction was methylated using
the altered aspartyl detection assay described in section A.4. Equal aliquots of
methylated proteins were then electrophoresed on a discontinuous, acid pH gel
system as described (Weber and McFadden, 1996). Following staining of the
gel with Coomassie blue, 0.5 cm gel slices of each sample lane were taken and
volatile radioactivity determined as described. Top: Distribution of altered
aspartyl containing proteins in the DS fraction. Middle: Distribution of altered
aspartyl residues in the DI fraction. Bottom: Distribution of altered aspartyl
residues in the WS fraction. The gel lanes follow the same order as the
histograms representing the distribution of methyl esterified proteins. Molecular
weights are shown at the bottom of the figure.Cn
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A2.5.4.1 Protein fragmentation methods
Cleavage methods have included trypsin digestion and cyanogen bromide
cleavage (Aswad and Guzzetta 1995). The cleaved proteins can then be
radioactively methylated using the altered aspartyl detectionassay as described
above, and the total amount of methylated residues present quantitated by
electrophoresis on 10% agarose gels as described earlier.This method should
also be useful for analyzing proteins, such as those of the neuronal cytoskeleton
that contain altered aspartyl residues, but which are relatively insoluble under
physiological conditions, and therefore incapable of being fully methylated in
their intact form.
A2.5.4.2 Separation of individual methylated peptides
Reverse phase high performance chromatography (RP-HPLC) of
fragmented proteins has proven to be the method of choice for characterizing
the location of methylated residues within the amino acidsequence of single,
purified proteins. All types of methylated amino acids can be localized in this
manner. Even the alkali-sensitive methyl esters formed by PIMT can be
localized by this approach since acidic, high-resolution solvent systems for
HPLC are well-established. In one common procedure,a purified protein is first
radioactively methylated by a purified methyltransferase. Following chemicalor
enzymatic cleavage, the methylated products are chromatographedon a191
reversed phase column using a solvent system consisting of 0.1% triflouroacetic
acid, water and acetonitrile (Ota and Clarke 1990; Aswad and Guzzetta 1995).
Column fractions containing radioactively methylated peptides are then
detected, and amino acid compositions are used to arrive at the identity of the
methylated peptide. The amino acid sequence of a methylated peptide can also
be determined using conventional sequence analysis or by mass spectrometry.
If only substoichiometric amounts of a protein are methylated, as is generally
true of PIMT reactions, the radioactively methylated peptide fragments may be
only a small subpopulation of the peptide whose composition is actually
measured. In many cases, the presence of the methyl group has led to only a
very slight shift in the chromatographic behavior of a peptide, which allows the
methylated peptide to be identified by the composition of its co-eluting,
unmethylated neighbors (Ota and Clarke 1990; Lindquist et al. 1996)
A2.6 References
Aswad, D. (1995). Purification and Properties of Protein L-isoaspartyl
Methyltransferase. Deamidation and Isoaspartate Formation in Peptides and
Proteins. D. W. Aswad. Boca Raton, CRC Press: 32-45.
Aswad, D. W. (1995) Deamidation and Isoaspartate Formation in Peptides and
Proteins: 260. Boca Raton, CRC Press.
Aswad, D. W. and Guzzetta, A. W. (1995). Methods for analysis of deamidation
and isoaspartate formation in peptides and proteins. Deamidation and
isoaspartate formation in peptides and proteins. D. W. Aswad. Boca Raton, FL,
CRC Press: 7-29.
Backlund, P. S. and Aksamit, R. R. (1988). Guanine nucleotide-dependent
carboxyl methylation of mammalian membrane proteins. J. Biol. Chem. 263:
15864-15867.192
Baldessarini, R. J. and Kopin, I. J. (1966). S-Adenosylmethionine in brain and
other tissues. J. Neurochem. 13: 769-777.
Barber, J. R. and Clarke, S. (1983). Membrane protein carboxyl methylation
increase with human erythrocyte age. J. Biol. Chem. 258(2): 1189-1196.
Barten, D. M. and O'Dea, R. F. (1989). Protein carboxylmethyltransferase
activity in intact, differentiated neuroblastoma cells: Quantitation by
S-[3-H]Adenosylmethionine prelabeling. J. Neurochem. 53: 1156-1165.
Ben, B. G.,Paz, A., et al. (1993). The uniquely distributed isoprenylated protein
methyltransferase activity in the rat brain is highly expressed in the cerebellum.
Biochem Biophys Res Commun 195: 282-8.
Chelsky, D., Sobotka, C. and O'Neil, C. L. (1989). Lamin B methylation and
assembly into the nuclear envelope. J. Biol. Chem. 264: 7637-7643.
Clarke, S. (1992a). The biological functions of protein methylation. In Chemistry
of the Living Cell: 413-436.,JAI Press.
Clarke, S. (1992b). Protein isoprenylation and methylation at carboxyl-terminal
cysteine residues. Ann. Rev. Biochem. 61: 355-86.
Clarke, S. (1993). Protein methylation. Curr Opin Cell Biol. 5: 977-83.
Clarke, S., Vogel, J. P., et al. (1988). Posttranslational modification of the
Ha-ras oncogene protein: Evidence for a third class of protein carboxyl
methyltransferases. Proc. Natl. Acad. Sci. (USA) 85: 4643-4647.
Fairbanks, G. and Avruch, J. (1973). Four gel systems forelectrophoretic
fractionation of membrane proteins using ionic detergents. J. Supramol. Struct.
1: 66-75.
Favre, B., Zolnierowicz, S., et al. (1994). The catalytic subunit of protein
phosphatase 2A is carboxyl-methylated in vivo. J Biol Chem 269: 16311-7.
Fung, B. K., Yamane, H. K., et al. (1990). The gamma subunit of brain
G-proteins is methyl esterified at a C-terminal cysteine. Febs Lett 260: 313-7.
Ghomashchi, F., Zhang, X., et al. (1995). Binding of prenylated and polybasic
peptides to membranes: affinities and intervesicle exchange. Biochemistry
34(37): 11910-8.
Ghosh, S. K.,Syed, S. K., et al. (1990). Substrate specificity for myelin basic
protein-specific protein methylase I. Biochim Biophys Acta 1039: 142-8.193
Gilbert, J. M., Fowler, A., et al. (1988). Purification of homologous protein
carboxyl methyltransferase isozymes from human and bovine erythrocytes.
Biochemistry 27: 5227-5233.
Giner, J. L. and Rando, R. R. (1994). Novel methyltransferase activity modifying
the carboxy terminal bis(geranylgeranyl)- Cys- Ala -Cys structure of small
GTP-binding proteins. Biochemistry 33(50): 15116-23.
Glazer, R. I. and Peale, A. L. (1978). Measurement of S-adenosyl-L-methionine
levels by SP sephadex chromatography. Anal. Biochem. 91: 516-520.
Hrycyna, C. A., Yang, M. C. and Clarke, S. (1994). Protein carboxyl methylation
in Saccharomyces cerevisiae: evidence for STE14-dependent and
STE14-independent pathways. Biochemistry 33: 9806-12.
Iversen, L. L., Mortishire-Smith, J., et al. (1995). The toxicity in vitro of B-amyloid
protein. Biochem. J. 311: 1-16.
Johnson, B. A. and Aswad, D. W. (1985).Enzymatic protein carboxyl
methylation at physiological pH: cyclic imide formation explains rapid methyl
turnover. Biochemistry 24: 2581-6.
Johnson, B. A. and Aswad, D. W. (1991). Optimal conditions for theuse of
protein L-isoaspartyl methytransferase in assessing the isoaspartate content of
peptides and proteins. Anal. Biochem. 192: 384-391.
Johnson, B. A., Langmack, E. L. and Aswad, D. W. (1987). Partial Repair of
Deamidation-damaged Calmodulin by Protein Carboxyl Methyltransferase. J.
Biol. Chem. 262(25): 12283-12287.
Johnson, B. A.,Murray, E., Jr., et al. (1987). Protein carboxyl methyltransferase
facilitates conversion of atypical L-isoaspartyl peptides to normal L-aspartyl
peptides. J. Biol. Chem. 262: 5622-5629.
Johnson, B. A., Najbauer, J. and Aswad, D. W. (1993). Accumulation of
substrates for protein L-isoaspartyl methyltransferase in adenosine
dialdehyde-treated PC12 cells. J. Biol. Chem. 268(9): 6174-6181.
Johnson, D. J., LaBourene, J., et al. (1993). Relative Efficiency of Incorporation
of Newly Synthesized Elastin and Collagen into Aorta, PulmonaryArtery and
Pulmonary Vein of Growing Pigs. Connect. Tissue Res. 29: 213-221.194
Kimzey, A. L. and McFadden, P. N. (1994). Spontaneous methylation of
hemoglobin by S-adenosylmethionine by a specific and saturable mechanism. J.
Protein Chem. 13: 537-546.
Klein, Z.,Ben, B. G., et al. (1994). Characterization of the prenylated protein
methyltransferase in human endometrial carcinoma. Biochim Biophys Acta 1226:
330-6.
Kloog, Y., Axelrod, J. and Spector, I. (1983). Protein carboxyl methylation
increases in parallel with differentiation of neuroblastoma cells. J. Neurochem.
40: 522-529.
Ladino, C. A. and O'Connor, C. M. (1992). Methylation of atypical protein
aspartyl residues during the stress response of He La cells.J. Cell. Physiol.
153: 297-304.
Laemmli, U. K. (1970). Cleavage of Structural Proteins during the Assembly of
the Head of Bacteriophage T4. Nature 227: 680-685.
Lee, J. and Stock, J. (1993). Protein phosphatase 2A catalytic subunit is
methyl-esterified at its carboxyl terminus by a novel methyltransferase. J Biol
Chem 268: 19192-5.
Lerner, S., Haklai, R. and Kloog, Y. (1992). Isoprenylation and
carboxylmethylation in small GTP-binding proteins of pheochromocytoma
(PC-12) cells. Cell Mol Neurobiol 12(4): 333-51.
Lindquist, J. A., Barofsky, E. and Mcfadden, P. N. (1996). Determination oftwo
sites of automethylation in bovine erythrocyte (D-aspartyl/L-isoaspartyl)carboxyl
methyltransferase. J. Protein. Chem. in press.
Lischwe, M. A. (1990). Amino Acid Sequence of Arginine Methylation Sites.
Protein Methvlation. W. K. Paik and S. Kim. Boca Raton, CRC Press:98-120.
MacFarlane, D. E. (1984). Inhibitors of cyclic nucleotides phosphodiesterases
inhibit protein carboxyl methylation in intact blood platelets. J. Biol.Chem.
259(2): 1357-1362.
McFadden, P. N. and Clarke, S. (1982). Methylation at D-aspartyl residuesin
erythrocytes: possible step in the repair of aged membrane proteins.Proc Natl
Acad Sci U S A 79: 2460-4.
Murray, E. D. and Clarke, S. (1986). Metabolism ofa synthetic
L-isoaspartyl-containing hexapeptide in erythrocte extracts. J. Biol. Chem.261:
306-312.195
Murray, E. J. and Clarke, S. (1984). Synthetic peptide substrates for the
erythrocyte protein carboxyl methyltransferase. Detection of a new site of
methylation at isomerized L-aspartyl residues. J Biol Chem 259: 10722-32.
Najbauer, J., Johnson, B. A. and Aswad, D. W. (1991). Amplification and
detection of substrates for protein carboxyl methyltransferases in PC12 cells.
Anal Biochem, 197: 412-20.
Najbauer, J., Johnson, B. A. and Aswad, D. W. (1992). Analysis of stable
protein methylation in cultured cells. Arch Biochem Biophys 293: 85-92.
O'Conner, C. M. and Clarke, S. (1983). Methylation of erythrocyte membrane
proteins at extracellular and intracellular D-aspartyl sites in vitro. J. Biol. Chem.
258(13): 8485-8492.
O'Conner, C. M. and Clarke, S. (1984). Carboxyl methylation of cytosolic
proteins in intact human erythrocytes. Identification of numerous
methyl-accepting proteins including hemoglobin and carbonic anhydrase. J. Biol.
Chem. 259(4): 2570-2578.
O'Dea, R. F., Mirkin, B. L., et al. (1987). Effect of adenosine analogueson
protein carboxylmethyltransferase, S-adenosylhomocysteine hydrolase, and
ribonucleotide reductase activity in murine neuroblastoma cells. Cancer Res 47:
3656-61.
Ong, 0. C., Ota, I. M., et al. (1989). The membrane binding domain ofrod
cGMP phosphodiesterase is posttranslationally modified by methyl
esterification at a C-terminal cysteine. Proc Natl Acad Sci U S A 86: 9238-42.
Ota, I. M. and Clarke, S. (1989). Enzymatic methylation of 23-29-kDa bovine
retinal rod outer segment membrane proteins.Evidence formethyl ester
formationat carboxyl-terminal cysteinyl residues. J Biol Chem 264: 12879-84.
Ota, I. M. and Clarke, S. (1990). The function and enzymology of protein
D-aspartyl/L-isoaspartyl methyltransferases in eukaryotic and prokaryotic cells.
Protein Methylation. W. K. Paik and S. Kim. Boca Raton, CRC Press: 179-194.
Paik, W. K. and Kim, S., Eds. (1990). Protein Methylation. Protein Methylation.
Boca Raton, FL, CRC Press.
Park, I. K. and Paik, W. K. (1990). The occurrence and analysis of methylated
amino acids. Protein Methylation. W. K. Paik and S. Kim. Boca Raton, FL,CRC
Press.: 1-22.
Payan, I. L.,Chou, S. J., et al. (1992). Altered aspartate in Alzheimer
neurofibrillary tangles. Neurochem Res 17(2): 187-91.196
Paz, A.,Ben, B. G., et al. (1993). Prenylated protein methyltransferase of rat
cerebellum is developmentally co-expressed with its substrates. Febs Lett 332:
215-7.
Rajpurohit, R., Park, J. 0., et al. (1994). Enzymatic methylation of recombinant
heterogenous nuclear RNP protein Al. Dual substrate specificity for S- adenosyl-
methionine: histone- arginine N-methyltransferase. J. Biol. Chem 269: 1075-82.
Rattan, S. I., Derventzi, A. and Clark, B. F. C. (1992). Protein synthesis,
posttranslational modifications and aging. Ann. N.Y. Acad. Sci. 663: 48.
Roher, A. E.,Lowenson, J. D., et al. (1993). Structural alterations in the peptide
backbone of beta-amyloid core protein may account for its deposition and
stability in Alzheimer's disease. J Biol Chem 268(5): 3072-83.
Siegel, F. L.,Vincent, P. L., et al. (1990). Calmodulin and protein methylation.
Protein Methylation. W. K. Paik and S. Kim. Boca Raton, FL, CRC Press.:
33-58.
Skinner, M. K. and Griswold, M. D. (1983). Flourographic detection of
radioactivity in polyacrylamide gels with 2, 5-diphenyloxazole in acetic acid and
its comparison with existing procedures. Biochem. J. 209: 281-284.
Stephenson, R. C. and Clarke, S. (1990). Identification ofa C-terminal protein
carboxyl methyltransferase in rat liver membranes utilizing a synthetic farnesyl
cysteine-containing peptide substrate. J Biol Chem 265: 16248-54.
Stephenson, R. C. and Clarke, S. (1992). Characterization ofa rat liver
protein carboxyl methyltransferase involved in the maturation of proteins with
the -000( C-terminal sequence motif. J Biol Chem 267: 13314-9.
Terwilliger, T. C. and Clarke, S. (1981). Methylation of membrane proteinsin
human erythrocytes: Identification and chracterization of polypeptides
methylated in lysed cells. J. Biol. Chem. 256(6): 3067-3096.
Tomiyama, T.,Asano, S., et al. (1994). Racemization of Asp23 residueaffects
the aggregation properties of Alzheimer amyloid beta protein analogues.
J-Biol-Chem 269(14): 10205-8 issn: 0021-9258.
Volker, C., Pi !linger, M. H., et al. (1995). Prenylcysteine analogs to study
function of carboxylmethylation in signal transduction. Methods Enzymol250:
216-25.197
Weber, D. J. and McFadden, P. N. (1995). A Heterogeneous Set of
Urea-Insoluble Proteins in Dividing PC12 Pheochromocytoma Cells is Passed
on to at least the Generation of Great-Granddaughter Cells. J. Protein. Chem.
14(5): 283-289.
Weber, D. J. and McFadden, P. N. (1996). Identification of Proteins Modified by
Protein (D-aspartyl/L-isoaspartyl) Carboxyl Methyltransferase. Protein Protocols
Handbook. J. M. Walker. Totawa, New Jersey, Humana Press.
Wolf, M. E. and Roth, R. H. (1985). Dopamine autoreceptor stimulation
increases protein carboxyl methylation in striatal slices. J. Neurochem. 44:
291-298.
Xie, H. and Clarke, S. (1993). Methyl esterification of C-terminal leucine
residues in cytosolic 36-kDa polypeptides of bovine brain. A novel
eucaryotic protein carboxyl methylation reaction. J Biol Chem 268: 13364-71.
Xie, H. and Clarke, S. (1994a). An enzymatic activity in bovine brain that
catalyzes the reversal of the C-terminal methyl esterification of protein
phosphatase 2A. Biochem Biophys Res Commun 203: 1710-5.
Xie, H. and Clarke, S. (1994b). Protein phosphatase 2A is reversibly modified
by methyl esterification at its C-terminal leucine residue in bovine brain. J Biol
Chem 269: 1981-4.198
APPENDIX 3
A Heterogeneous Set Of Urea-Insoluble Proteins In Dividing PC12
Pheochromocytoma Cells Is Passed On To At Least The Generation Of
Great-Granddaughter Cells.
Darin J. Weber and Philip N. McFadden
Published in Journal of Protein Chemistry
Plenum Publishing Co., New York
1995, 14(5): 283-289.199
A3.1. Abstract
About 5 percent of the total cellular protein synthesized in exponentially
dividing PC12 pheochromocytoma cells remains insoluble after extractions with
aqueous buffer, nonionic detergent, and a strong denaturant, 6M urea. Single-
and double-radiolabel pulse-chase labeling experiments with radioactive leucine
indicate that for much of the 6M urea-insoluble protein there is either a lag
between its synthesis and deposition in a urea-insoluble compartment and/or the
urea-insoluble protein is comparatively stabilized from destruction. Given the
doubling time of PC12 cells, much of the long-lived and urea-insoluble protein of
PC12 cells is passed on for at least three generations. Electrophoretic analyses
show there are many species of long-lived proteins in the 6M urea-insoluble
fraction, displayed as a near-continuum of subunit molecular weights.200
A3.2. Introduction
Age-related accumulations of insoluble protein in and around neurons is
common to many neuropathologies, but the biochemical mechanisms underlying
such accumulations are difficult to study. Because of their relative simplicity,
model neuronal cell lines are promising systems in which to define intracellular
factors that promote neuronal protein insolubilization and the intracellular
deposition of inclusion material. The well-characterized PC12
pheochromocytoma cell (Greene, et al., 1987) displays many of the biochemical
traits of neurons and so there is a possibility that protein insolubilization can be
detected in these cells over conveniently short time intervals. Thus, while it is
true that cultured cells continuously divide and live for relatively short periods,
there may be an opportunity to explore the fundamental biochemistry of protein
insolubilization in conveniently cultured neuronal cells.
For example, tyrosine hydroxylase is generally an easily solubilized
neuronal enzyme (Shiman, et al., 1971) that catalyzes the first committed step in
catecholamine biosynthesis, but a small portion of the immunodetectable
tyrosine hydroxylase in cultured PC12 pheochromocytoma cells is resistant to
solubilization with nonionic detergent and strong denaturants such as 6M urea
(Weber and McFadden, see accompanying manuscript).Pulse-chase
radiolabeling showed that there is a lag between synthesis of the enzyme and its
deposition in insoluble form.This result led to the question of whether other
cellular proteins may also enter a highly insoluble compartment.201
A3.3. Experimental Procedures
A3.3.1 Culture media.
"Growth medium" consisted of RPMI 1640 culture medium supplemented
with 10% heat-inactivated horse serum (Hyclone; Logan, UT), 5% fetal bovine
serum (Hyclone), 100 units m1-1 penicillin, 100 pg m11 streptomycin, and 20 mM
sodium Hepes, pH 7.4."Low-leucine pulse medium" was identical to growth
medium except that it was prepared with a deficient RPMI 1640 culture medium
containing 54 pM leucine (1/7 of the standard leucine concentration).
A3.3.2 Cell culture.
PC12 cells were obtained from the American Type Culture Collection and
were cultured at 37°C under a 5% CO2 atmosphere, using procedures based on
those described (Greene, et al., 1987; Greene and Tisch ler, 1976). The cells
were routinely subcultured into untreated T25 flasks (Falcon 3013) at a splitting
ratio of 1:10 every seven days, giving an exponential doubling time of 2.1 days.
For radiolabeling experiments, cells in growth mediumwere plated onto
1.5 cm diameter polystyrene wells (24-well dishes, Falcon 3047) that had
previously been coated for 1 hour with 0.88 pg of mouse-tumor collagen IV
(Collaborative Research Products, Bedford, MA) in 0.5 ml 50 mM HCI and then
rinsed with 1 ml of phosphate buffered saline (PBS). The plating densitywas
1-2 x 105 cells per well.202
A3.3.3 Measurements of protein fate by single pulse-chase radiolabelino.
Growth medium was removed by aspiration, and the cells (2x105/well)
were rinsed with 0.5 ml of low-leucine pulse medium. The cells were then
pulse-labeled for 24 hours with 0.3 ml of low-leucine pulse medium containing 1
pCi of L- [U- 14C]leucine (315 mCi mmo1-1, New England Nuclear).After the
"C-labeling period the cells were detached from their 1.5 cm dish and replated
in 4 ml of growth medium onto 3.5 cm collagen-coated dishes. Cell culture was
then continued for an additional variable chase period in the presence of growth
medium, with the medium changed every one- to three-days to minimize
reincorporation of radioactivity into newly synthesized protein, and to ensure that
exponential division continued throughout the chase period.
A3.3.4 Measurements of protein fate by double pulse-chase radiolabelino.
Plating medium was removed from dividing cells (1x105/well), whichwere
then rinsed with 0.5 ml of low-leucine pulse medium, and pulse-labeled for 24
hours with 10 pCi of L-[4,5-311]leucine (165 Ci Amersham) in 0.3 ml of
low-leucine pulse medium. After the 3H-labeling period, the cells were rinsed
twice with 0.5 ml low-leucine pulse medium, and the cells were pulse-labeled for
24 hours with 0.3 ml of low-leucine pulse medium containing 2 pCi of
L-[U-14C]leucine (315 mCi mmol-1).After the 14C-labeling period the cells were
rinsed twice with 0.5 ml of growth medium, replated in 4 ml of growth medium
onto 3.5 cm collagen-coated dishes, and then cultured for a chase period in the
absence of added radiolabel.203
A3.3.5 Extractions of cells.
After a given chase period, the cells were rinsed in their wells with
ice-cold PBS, and then detached with repeated streams of phosphate-buffered
saline from a Pasteur pipette. The cells were recovered by low-speed
centrifugation, and were then lysed by freeze-thawing (-20°C) in 0.1 ml of lysis
buffer, consisting of 25 mM sodium Hepes, pH 7.4; 1 mM disodium EDTA; 0.25M
sucrose; 2 pg m1-1 aprotinin; 2 pg m11 leupeptin; 1 pg m1-1 pepstatin; and 0.5 mM
phenylmethylsulfonyl fluoride. Centrifugation of the lysates (10,000 x g, 10
minutes) yielded the water-solubilized fraction (WS). The pellet from this
extraction step was extracted by resuspension and centrifugation (10,000x g, 10
minutes) from lysis buffer containing 0.1% (w/v) Triton X-100, yielding the
detergent-solubilized fraction (DS). The pellet from this step was washedonce
with detergent-containing extraction buffer, and was then further extracted by
resuspension and centrifugation (10,000 x g, 10 minutes) from lysis buffer
containing 6M urea and 0.1% (w/v) Triton X-100, yielding the 6M
urea-solubilized fraction (US). The pellet from this step was then washedonce
with detergent- and urea-containing extraction buffer, yielding a final pelletas
the 6M urea-insoluble fraction (UI).Aliquots of non-electrophoresed proteins of
the various solubility classes were mixed with sodium dodecyl sulfate (1%) to
ensure complete suspension of all protein, mixed with 10 volumes of liquid
scintillation counting cocktail (Scintiverse E, Fisher), and then assayed for
radioactivity.204
A3.3.6 Isolation of the histone fraction.
Following nonionic detergent extraction, each DI pellet was resuspended
in 0.1mIs of 0.25 N HCL containing 2mM dithiothreitol, as described (Bonner, et
al., 1980). The pellets were completely dissociated by 5 seconds of sonication
using a microtip sonicator. All operations were performed on ice. Following
sonication, the pellets were centrifuged at 18,000 x g for 10 minutes at 4
degrees. The acid-soluble histones were then precipitated with 10 volumes of
acetone overnight at -20°C, and the precipitated histones were collected by
centrifugation as above for 3H/ 14C ratio measurements.
A3.3.7 Gel electrophoresis of US and UI proteins.
Aliquots of the US and UI fractions were mixed with SDS sample buffer for
SDS polyacrylamide gel electrophoresis (Laemmli, 1970), using 12% (w/v)
acrylamide/ bisacrylamide (37:1) cast into 10 cm long, 1.5 mm thick resolving
slab-gels. Following electrophoresis the proteins were visualized by silver
staining, and the gels were impregnated with 5% (v/v) glycerol and dried onto
filter paper using a vacuum gel dryer. Gel lanes were sliced into evenly spaced
segments (3mm) for scintillation counting measurements. For measurements of
background radioactivity, slices of equivalent dimensions to the radioactive
slices were excised from gel regions which contained no electrophoresed
polypeptides.Gel slices were solubilized by heating them in capped
scintillation to 60°C for 12h in 0.3 ml in a mixture of 4-volumes of 30% H202 and
1-volume of Clorox laundry bleach (use caution when mixing this reagent since205
there is immediate gas evolution).Scintillation cocktail (5m1; Scintiverse E,
Fisher) was then added, and the samples were counted as described below.
A3.3.8 Liquid scintillation counting
Radioactivity was measured in a Beckman LS 6000 scintillation counter.
Quench correction was by the H-number method (Beckman Instruments) which
employs an external 137Cs source to quantify the shift in decay spectra due to
quenching. For measurements of3H/14C ratios, dpm values for both 3H and 14C
were determined with at least 5% precision, and tests with standard radioactive
samples showed that ratios were accurate as long as the 14C dpm did not greatly
exceed the 3H dpm since high energy 14C scintillations tend to mask the lower
energy scintillations due to 3H. In practice, accurate isotope discrimination was
achieved by arranging the experimental conditions so that 3H radioactivitywas in
relative excess over '4C.
A3.4. Results
Successive extraction of [14C]leucine-labeled PC12 cells withan aqueous
buffer, a nonionic-detergent containing buffer, and a 6M urea-containing buffer
yields on the order of 5% of the radiolabeled cellular proteinas an insoluble
residue (Table A3.1) Approximately the same fraction of cell protein remains
insoluble when cells are lysed and extracted directly, rather than successively, in
a buffer which contains both nonionic detergent and 6M urea (Table A3.1).206
Table A3.1. Percentage of PC12 protein in various solubility classes.
Protein Fraction Percentage of radiolabel recovered
from cells labeled 24h with 11 1C Leucinea
Trial l b Trial 2°
Water soluble 36 (5)
Detergent soluble 39 (3)
6M Urea soluble 19 (2)
6M Urea insoluble 6 (0.3) 4 (1)
'Values are averages of three determinations (std)
bExponentially dividing cells extracted successively by the listed procedures
°Exponentially dividing cells extracted directly in detergent and 6 M urea
containing buffer207
Protein-dye assays also show that about 5% of the cellular protein is resistant
to solubilization by denaturing buffers (data not shown).
The chase kinetics of [14C]leucine from pulse-labeled cellswas measured
in order to estimate the average protein half-life in the different solubility classes.
A 24-hour labeling period with [14C]leucine was employed toensure the
extensive labeling of cellular protein, including that which is synthesized slowly.
The loss of [14C]radioactivity was fastest from the water-soluble classof protein,
slowest from the 6M urea-insoluble protein, and intermediate in rate from the
detergent-solubilized and 6M urea-solubilized protein (Figure A3.1).
Not surprisingly in consideration of the complex mixture of proteins in
each of these fractions, the chase kinetics for each solubility class of protein
were more complex than first-order. However, biphasic exponential decay
curves lent reasonably good fits to the disappearance of radiolabel from
proteins in the various fractions, allowing a grouping of proteins fromeach
solubility class into two populations governed by exponential constantsas
determined by analytical curve-fitting (Table A3.2). By this method, the
exponential half-life of almost half of the 6M urea-insoluble radioactivityis
calculated to be about 8 days, a period greater than three cell-doublingtimes.
The most rapid exponential half-life calculated from thesemeasurements was for
a component of the 6M urea-insoluble fraction, in which about half of the
radioactivity exited with a half-life of 0.46 days (Table A3.2). Thus, inaddition to208
Figure A3.1. Loss of 14C radioactivity from PC12 protein fractionsas a function
of chase time. Cells were labeled for 24 hours with 1 pCi per well of
[14C]leucine, and then chased for the indicated periods with nonradioactive
medium containing excess nonradioactive leucine. Plotted here is the natural log
of the portion of radioactivity remaining in the following protein fractions:I,
water-solubilized;m, nonionic-detergent solubilized; n, 6M urea-solubilized;
p, 6M urea-insoluble; +, acid-soluble histone-containing fraction. The smooth
curves are plotted from double-exponential decay functions, y =e-kit+ a2e-k2t,
that achieved the best-fit to the data as determined by nonlinear leastsquares
curve fitting. The parameters a1, a2, k1, and k2 are given in Table A3.2.Figure A3.1
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Table A3.2 Exponential half-lives of PC12 protein fractions
Protein Fast Half-life of fast Slow Half-life of slow
Fraction component'- component (d) components componentk (d)
(% of total) (% of total)
Water
soluble 66.8% 0.660d 33.2% 3.05d
Detergent
soluble 73.1% 0.706d 26.9% 5.25d
6M urea
soluble 76.5% 0.711d 23.5% 6.03d
Insoluble
residue 56.0% 0.459d 44.0% 7.95d
Acid-soluble
histone-
containing
fraction 65.5% 0.653d 34.5% 6.04d211
harboring the most stable protein in the cells, the 6M urea-insoluble fraction
also rapidly loses a component of radiolabel.
As a check of our methods, the stability of the histone protein fraction was
measured since it is generally known that these proteins are turned over in cells
very slowly. The fact that our measurements indicated long half-lives for the
acid-soluble fraction enriched in the PC12 histones therefore validates the
measurements of similarly long half-lives for the urea-insoluble proteins (Figure
A3.1, Table A3.2).
Double-isotope radiolabeling was then tested as an alternate means of
following the fate of protein as a function of its solubility class. By this method, a
24-hour cohort of newly synthesized cellular protein was first radiolabeled by
exposure of cells to [3H]leucine, and then a second cohort was radiolabeled by a
24-hour exposure to [14C]leucine. The two cohorts of radiolabeled protein were
then followed over a chase period of 0 to 14 days (Figure A32). At 0 chase time,
the 6M urea-insoluble protein exhibited a 3H/14C ratio that was similar to that in
the other solubility classes of proteins. However, with increasing chase time the
3H/14C ratio in the 6M urea-insoluble protein steadily increased, presumably from
destruction of the more rapidly turned over 6M urea-insoluble protein that would
exhibit a low 3H/14C ratio, and/or from a lag-time that exists between synthesis of
relatively soluble protein and its entry into the urea-insoluble compartment. The
other solubility classes of proteins also showed increases in their 3H/14C ratios,
though not as dramatically as for the 6M urea-insoluble fraction. The 6M
urea-insoluble fraction in dividing cells was212
Figure A3.2. 3H/14C ratios as a function of chase-time in proteins fractionated
according to their solubility.Double isotope-labeling was performed as
desribed in "Experimental Procedures". After each chase period,
measurements were made of the 3H/14C ratio in the total cell protein and in the
various solubility classes of cell protein. The shading of the bars decreases
successively for the measurements of the ratio in the total cell protein,
water-solubilized, detergent-solubilized, urea-solubilized, and urea-insoluble.
Shown here are averages of triplicate measurements. For clarity, theerror
range is not shown, but typically ratio the standard error relative to the mean
3H/14C ratio was ± 15% or less.A
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thus indicated by double pulse-chase labeling to accumulate distinctlystable
proteins, a trend similar to that obtained with single pulse-chaselabeling.
The next question addressed was how heterogeneousare the stable
proteins of the UI fraction. Cells were double-isotope radiolabeled,proteins
were extracted according to their solubility class, and the proteinswere
electrophoresed in SDS polyacrylamide gels.While there were differences in
the 3H/14C ratios among individual protein electrophoretic bandsderived from the
WS and DS fractions,these differences did not cluster according to solubility
class (not shown). On the other hand, almost the entire lane ofelectrophoresed
protein of the Ul class exhibited a significantly higher 3H/14Cratio than other
classes of cellular protein, including the WS, DS, and USproteins (Figure A3.3).
Though the3H/14C ratio is seen to be nearly unvaryingover long stretches
of these gel lanes (Figure A3.3), this should not be interpretedas meaning that
there was no protein in these gel slices; the typical gel slicein this experiment
contained 1000- to 20,000 3H dpm and 100- to 5000 14C dpm,and therefore
contained enough radioactive protein to yieldvery accurate ratio measurements.
These measurements instead show that polypeptides ofa near-continuum of
molecular weights contribute to the relatively stability of theUI fraction.
In addition, several gel slices in the US and UI fractionexhibited 3H/14C
ratios that were well-above average. The UI fraction exhibiteda high
3H/14C-ratio in the 43kD zone; and both the USand UI fractions exhibited high
3H/14C-ratio in the zones below 21 kD (FigureA3.3).215
Figure A3.3 SDS polyacrylamide gel electrophoresis and 3H/14C ratio
measurements of cell proteins fof the US and UI fractions. In this experiment,
double-labeling involved first a 24-hour labeling period with 10 pCi [3H]Ieucine,
followed by 8 hours of cell incubation in the absence of radiolabel, and thena
24-hour period of radiolabeling with 1 pCi [14C]leucine. A two-day chase period
after the 14C labeling was employed; at this time the total cellular proteinhad a
3H/14C ratio of 3.1 (data not shown). Shown hereare the silver-stained US and
UI proteins after electrophoresis, with the migration of size markerson the left.
The plot on the right shows the 3F1/14C ratios in 3mm gel slices fromthe lane of
US proteins (lightly shaded symbols) and UI proteins (dark symbols)k
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A3.5. Discussion
These radiolabeling studies show that exponentially dividing PC12 cells
synthesize a heterogeneous set of relatively stable proteins that can be isolated
according to its insolubility in 6M urea. At least some of these UI proteins
persists for two weeks in the cell, near the practical limit for culturing
exponentially dividing cells without splitting them. Over three cell-cycle periods
are traversed in this period, and so by the end of the period the average cell has
inherited proteins that were synthesized three generations previously.
The conclusion that urea-insoluble protein is relatively slow to be cleared
from the cell is validated by the internal experimental control supplied by the
WS, DS,US and histone-enriched fractions.Thus, on an internally
standardized relative scale, there is significance to the slow disappearance of
radioisotope from the UI compartment in single-isotope experiments, seen
equivalently as the uniquely high3HP4C ratio compartmentation of radioisotope
in double-isotope experiments. However, the quantitation of protein half-lives
that we have performed is subject to uncertainty since it is well known that
radiolabeling experiments can yield inaccurate pictures of protein turnover for
reasons of radiolabel reutilization.In addition, isotope ratios obtained by the
double-isotope labeling method can only be related to protein half-lives if
steady-state conditions ensure that the rate of protein synthesis exactly matches
the rate of protein degradation, and the case of exponentially dividing cells
clearly deviates from steady-state conditions.218
While it is clear that radiolabel is slow to be cleared from the
urea-insoluble compartment, it is not obvious how this comes about. The two
broad explanations are that 1) proteins from other compartments enter into the
UI compartment after long lag periods, adding to the radioactivity of the UI
compartment over time even though UI proteins may also be steadily degraded;
and 2) newly synthesized protein is immediately targeted for the UI fraction and
is inherently stable. The first explanation might be favored for proteins suchas
tyrosine hydroxylase that are normally soluble but that enter into the UI fraction
in small amounts. Also requiring this explanation are proteins that exhibita
higher3H/14C ratio than was nominally used in the labeling experiment,such as
in the experiment shown in Figure 3 in which a -15:1 3H/14C ratiowas observed
in a -43 kD protein even though the isotope ratio of the media used for
radiolabeling was only 10:1 3H/14C.In such a case the lag between protein
synthesis and entry into the UI compartment can explain theexcess of the 3H
radiolabel.
The second explanation, stating that UI- targeted proteinsare inherently
stable, could account for some of the high3H/14C-ratio species seen upon
electrophoresis, such as the low molecular weight species that likely correspond
to a subfraction of the histones that resist denaturing extraction. In fact,our
measurements of slow turnover of the acid-extractable histone fraction of PC12
cells mirror other observations of stable histones (Commerford,et al., 1982;
Djondjurov, et al., 1983; Jackson, 1990).219
The relative stability of highly-insoluble protein in PC12 cells bearsa
resemblance to the finding of Rogers and Rechsteiner who found thatupon
microinjection of structurally defined proteins into cells of the He La human
epithelial cell line, several proteins that tended to become detergent-insoluble
inside the cell were somehow stabilized from proteolysis (Rogers and
Rechsteiner, 1988).Hare and Holocher have interpreted that behavior and
their own measurements of plasma membranes to suggest that there isa relative
stability of nonionic detergent-insoluble proteins due to strong association of
such proteins with the cytoskeleton which prevents them from diffusing toward
an endocytic degradation (Hare and Holocher, 1994).UI protein may be even
more extreme in its inaccessibility to degradation mechanisms.Clearly more
has to be known of the physical state of intracellular insoluble protein thatmay
sequester it away from clearance mechanisms.
Compared to most other living cells, mammalianneurons are very
long-lived. A problem in aging and in many neurological diseases is the
accumulation in and around neurons of insoluble protein derived from relatively
soluble precursors (Bordet and Destee, 1992; Braak, et al., 1993; Burkhardt,et
al., 1988; De Bernardez-Clark and Georgiou, 1991; Eisen and Caine, 1992;
Fifkova and Morales, 1992; Forno, 1986; Funata, et al., 1990; Goldman and
Yen, 1986; Hirano, 1994; Meier, et al., 1994; Perry, et al., 1987; Pollanen,et al.,
1993; Selkoe, 1994).It is not known if these accumulations are a continuous
by-product of cell metabolism, or if there are physiologicalor pathological
triggers for its accumulation. The formation of stable, insoluble protein inthe
PC12 cell line under culture conditions judged optimal for cell growth favorsthe220
idea that cells continually produce such materials. Unlikeneurons, dividing cells
probably outgrow the process of protein insolubilization andso may not be
adversely affected by it.However, the mechanisms of formation and
stabilization of insoluble protein in cultured cellsmay be similar to those in
differentiated neurons.
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